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ABSTRACT 
The dynamics of membrane proteins is an understudied area due to the difficulties in 
production and manipulation of samples. Interactions of the G-protein coupled receptor, 
rhodopsin, with an allosteric reagent were systematically investigated through absorbance 
spectroscopy. Folding mechanisms in particular are not understood for membrane proteins, 
due to the fact that even partial unfolding often leads to aggregation. There are few model 
systems for exploring membrane protein folding, but methods for obtaining large quantities 
of non-aggregating unfolded states of rhodopsin have previously been established. In this 
thesis the previous work establishing rhodopsin as a model system was extended with the 
use of isotope labelled methionines for NMR spectroscopy of unfolded states. The misfolding 
rhodopsin mutant, P23H, was compared with wild-type using this system, and found to have 
significant differences. The same mutant was also found to be destabilised by normally 
benign cysteine labelling, which has implications for concurrent research. The first 
membrane protein to have been fully unfolded and refolded is bacteriorhodopsin, to which 
sensory rhodopsin II (pSRII) is an analogue. Computational work suggests that pSRII has a 
folding mechanism somewhat like both bacteriorhodopsin and rhodopsin. The kinetics of 
unfolding and refolding pSRII were established using experiments with low sample 
requirements, and thoroughly analysed. Several analytical methods were applied to find 
underlying processes in unfolded states, revealed through NMR spectroscopy.  
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CHAPTER 1: INTRODUCTION 
1.1: Background 
1.1.1: Rhodopsin and vision 
There is a great variety in eye structure across the animals. It was thought that this variety 
came from multiple evolutionary origins, but similarities in the underlying transcription 
factors for eye development suggest a single, very ancient origin (Nilsson and Arendt, 2008). 
Some animals have “eyespots”, which only comprise a light-sensitive patch of tissue , though 
more complex structures have some form of image-resolving structure, from the simple 
pinhole eyes of the nautilus to the lens apparatus of mammalian vision (the evolution of 
these different eye structures is reviewed in Land and Fernald, 1992). In these eyes, light 
passes through the lens, the aperture and focus of which may be controlled by surrounding 
muscles. These can be adjusted to form a coherent image on the light sensitive retina, which 
has a diverse population of cells responsible for the detection of light and early processing 
of vision (Jeon et al., 1998). There are other cell types and structures within the eye 
responsible for the maintenance of the essential structures, and some animals also have 
adaptations for particular visual purposes, including especially low-light conditions, as 
outlined in section 1.1.1.2. 
The cells responsible for vision in vertebrates are the rod and cone cells of the retina. These 
cells have stacks of membrane discs in their outer segment containing high concentrations 
of opsins, a family of proteins which includes the mammalian cone and rod opsins 
responsible for daylight colour (photopic), and night-time (scotopic) vision respectively in 
mammals. Photoreceptor cells are specialized neurons, and have an inner segment providing 
energy to maintain a negative membrane potential, a nucleus, and an axon releasing 
glutamate (Lodish, 2008). 
 
β-ionone ring 
Figure 1.1: Photoisomerization of retinal. A photon is absorbed by 11-cis retinal, causing 
isomerization of the 11-12 bond from cis to trans.  
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1.1.1.1: Visual transduction 
The first event in the photocycle of rhodopsin, the opsin found in rods, is the isomerisation 
of 11-cis-retinal to all-trans-retinal by a photon (Figure 1.1). The retinal molecule is covalently 
linked to an opsin protein via a protonated Schiff base bond to a Lysine (K296 in the case of 
the dim-light rod photoreceptor, rhodopsin). The first state in the photocycle of rhodopsin is 
photorhodopsin. This excited state thermally decays to bathorhodopsin, in which the protein 
structure is mostly the same, but the retinal has isomerised, leading to a highly strained 
retinal chain. This is exacerbated by the β-ionone ring being held in place. Though the 
protein’s structure is mostly the same as the ground state, small changes have started in 
helix 3, and to the side chain of F212 in helix 5 (Nakamichi and Okada, 2006a). The retinal 
continues to relax through a blue-shifted intermediate to lumirhodopsin. In this state, the 
retinal has mostly reached a relaxed conformation, though there is some twisting in the 
chain. This relaxation moves the energy taken in by absorbing the photon from retinal to 
conformational changes in the protein. The ring is displaced towards helices 3 and 4, causing 
some local distortion to helix 3. The overall effects on the protein to this point are minor, 
mostly weakening the interactions between helices (Nakamichi and Okada, 2006b). The next 
state, metarhodopsin I, is very similar, the major change being to the Schiff base. In the 
ground state, and the preceding intermediates, the Schiff base is kept protonated by the 
counterions provided by E113 and E181, with the greatest effect coming from E113. In the 
metarhodopsin I state, the balance of this shifts to E181. The largest conformational changes 
to the protein occur in the transition to metarhodopsin II (Meta II). There are major changes 
to an internal hydrogen bond network (Vogel et al., 2008), and the Schiff base is 
deprotonated. The retinal binding pocket is opened by gaps forming between helices. Helices 
1 and 7 separate, and further opening occurs through tilting of helix 6 and rotation of helix 5 
(Choe et al., 2011). The transition from the ground state to Meta II takes ~7 milliseconds. 
When rhodopsin is in the Meta II state, the change in the tilt of helix 6 and the rotation of 
helix 5 provide an opening, allowing its cytoplasmic domain to activate G proteins, passing 
the signal across the membrane. The G protein, transducin, is a heterotrimer of α, β and γ 
subunits. When inactive, the complex binds guanosine diphosphate (GDP), but the 
conformational change induced by rhodopsin allows GDP to be exchanged for guanosine 
triphosphate (GTP). This exchange causes the α subunit to dissociate, though β and γ remain 
tightly associated and remain as one subunit. The βγ subunit is capable of some signalling, 
though this is of little relevance to visual transduction. The α subunit goes on to activate 
phosphodiesterase, which breaks down cyclic guanosine monophosphate (cGMP) to 
18 
 
guanosine monophosphate (GMP). The lower concentration of cGMP results in less opening 
of the cell’s cGMP-gated cation channels, and the membrane potential is hyperpolarised. 
This reduces the release of glutamate, thereby lifting its inhibitory effects on other neurons 
in the retina, allowing the propagation of the signal. A schematic of the process is shown in 
Figure 1.2. The processing of signals from rods and cones is complex and takes place both in 
the retina (Dowling, 1999) and in the visual cortex (Maier, 2013). 
 
After activation of rhodopsin, a dedicated rhodopsin kinase phosphorylates rhodopsin and 
the protein arrestin binds. This stops rhodopsin signalling. The bound retinal is released, and 
Meta II decays. There are several states like metarhodopsin III (Meta III) and another storage 
states to which it can decay, but to continue the photocycle both retinal and rhodopsin are 
modified to yield 11-cis-retinal and opsin capable of binding it once again (Heck et al., 2003). 
For human and bovine rhodopsin, the absorbance maximum is at 498nm, making it most 
sensitive to green light. It is the basis of scotopic, or dim-light vision. Other, less stable and 
less sensitive opsins are responsible for colour vision. All opsin functions are based on the 
same retinal cofactor for light detection, but the influence of different amino acids upon the 
retinal tune these to be most sensitive to different wavelengths, a mechanism referred to as 
the “opsin shift” (Bravaya et al., 2007). The different environments of animals results in the 
evolution of differently sensitive opsins, and other specializations in their visual apparatus. 
1.1.1.2: Adaptations in vision of deep-sea fish 
Fish in shallow waters tend to have vision not too dissimilar to terrestrial animals, often 
possessing both rods and cones and detecting light from a broad spectrum (Bowmaker, 
1995). However, with greater depth, adaptations for specialised vision become common, as 
light becomes less available with greater depth and bioluminescence from ocean creatures 
Figure 1.2: Visual transduction. 1) The retinal of rhodopsin is photoisomerized as in Figure 1.1 and rhodopsin 
undergoes conformational changes to metarhodopsin II. 2) Metarhodopsin II is able to activate transducin. 3) The GDP 
bound to inactive transducin is exchanged for GTP. 4) Active transducin splits into its α and βγ subunits. 5) The α 
subunit activates phosphodiesterase, decreasing cGMP concentrations in the cell. 6) The decrease in cellular cGMP 
closes the cGMP gated cation channels, causing hyperpolarisation of the cell. 
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takes over as eventually the only light source. Light is attenuated by the water, and is filtered 
to progressively narrower bandwidths (Arst et al., 1997; Smith and Baker, 1981). From 200 
to 1000 metres, downwelling light goes from being a twilight to a negligible influence 
(Warrant, 2000). Fishes in this region, the mesopelagic zone, are adapted to the almost 
exclusively blue-green space light (i.e. light from the sun or moon) in sometimes surprising 
ways. The visual pigments are commonly tuned to the downwelling light, around 470 nm. A 
strategy of many prey organisms is to use bioluminescence as camouflage, disguising their 
outline from deeper predators by counterillumination (Johnsen et al., 2004). 
The bioluminescence system dominant in marine 
ecosystems (Rees et al., 1998) is based on 
luciferases providing the right conditions for the 
chemiluminescence of coelenterazine (Figure 
1.3a), a luciferin with an imidazopyrazine 
skeleton (Shimomura et al., 1980). It has 
maximum emission around 465 nm (Shimomura 
and Teranishi, 2000), and its emission profile is 
broader than the downwelling light. While there 
are adaptations that can be made to more finely 
tune the spectral profile produced, the original 
emission is very resistant to modification (Rees et 
al., 1998). Predators may have countermeasures 
exploiting this mismatch, such as pigmented 
lenses (Douglas and Thorpe, 1992) that are 
proposed to increase contrast between space 
light and mismatched camouflage, with gaps in 
the lens (Douglas et al., 1998b) or accessory 
retinae (Pointer et al., 2007) to compensate for 
loss of sensitivity when avoiding predators. Other 
adaptations include tapeta, which reflect light 
passing through the retina, giving photoreceptors a second chance to capture the light. 
Interestingly, an eye with a tapetum may not use it to simply boost signal, but increase signal 
to noise by making a concomitant reduction in receptor pigment density (Denton and Nicol, 
1964), reducing thermal noise. Tapeta may also be pigmented, some in patterns adapted to 
the different sources of light (Shelton et al., 1992). A tapetum reduces the resolution of the 
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Figure 1.3: Compounds used by deep-sea fish. a) 
Structure of coelenterazine. b) Spectrum of chlorin 
e6, a porphyrin. c) Structure of chlorin e6. 
a 
b 
c 
20 
 
image due to  scattering, but in an environment where light comes as approximately a point 
source (Warrant, 2000), resolution reducing-features such as a tapetum or a large pupil  
aperture carry less of a penalty. 
 There are other uses for bioluminescence than camouflage. Deeper in the ocean, it becomes 
the dominant source of light, and a major method of all kinds of communication. It can be 
Genus Species Method Author Year Retinoid λmax 
Aristostomias grimaldii Retina extract Bowmaker, Dartnall, Herring 1988 A1 517/518 
      Bowmaker, Dartnall, Herring 1988 A2 552 
  scintillans Retina extract Crescitelli 1991 A1 524 
     O'Day, Fernandez 1974 A1 526 
     O'Day, Fernandez 1974 A2 551 
      Crescitelli 1991 A2 552 
  tittmannii Microspectrophotometry Partridge, Douglas 1995 A1 518 
      Partridge, Douglas 1995 A2 550 
      Partridge, Douglas 1995 A1* 581 
    Retina extract Partridge, Douglas 1995 A1 523 
      Douglas, Partridge, Marshall 1998 A1 523 
      Partridge, Douglas 1995 A2 551 
      Douglas, Partridge, Marshall 1998 A2 551 
    Whole mount (fresh) Partridge, Douglas 1995 A1 531 
      Partridge, Douglas 1995 A1 531 
      Partridge, Douglas 1995 A2 546 
      Partridge, Douglas 1995 A2 550 
      Partridge, Douglas 1995 A1* 586 
      Partridge, Douglas 1995 A1* 590 
    Whole mount (frozen) Partridge, Douglas 1995 A1 527 
      Partridge, Douglas 1995 A2 546 
  xenostoma Retina extract Knowles and Dartnell 1977 A1 514 
      Knowles and Dartnell 1977 A2 551 
Malacosteus danae Retina extract Crescitelli 1989 A1 514 
      Crescitelli 1989 A2 556 
  niger Microspectrophotometry Partridge et al. 1989 A1 521 
    † Bowmaker, Dartnall, Herring 1988 A1 522 (1.9) 
    † Bowmaker, Dartnall, Herring 1988 A1 522 (6.8) 
      Partridge et al. 1989 A2 538 
    † Bowmaker, Dartnall, Herring 1988 A2 548 (3.6) 
    † Bowmaker, Dartnall, Herring 1988 A2 549 (5.5) 
    Retina extract Somiya 1982 A1 510 
      Douglas et al 1998 A1 515 
      Bowmaker, Dartnall, Herring 1988 A1 517/522 
      Douglas et al 1998 A2 540 
      Bowmaker, Dartnall, Herring 1988 A2 545 
    Whole mount Unclear   A1 522 
      Unclear   A2 534 
Pachystomias microdon Intact retina Denton et al 1970 A2 575 
   Microspectrophotometry Partridge et al. 1989 A1 513 
     Bowmaker, Dartnall, Herring 1988 A1 514 
   † Bowmaker, Dartnall, Herring 1988 A1 515 
     Partridge et al. 1989 A2 539 
     Bowmaker, Dartnall, Herring 1988 A2 541 
   † Bowmaker, Dartnall, Herring 1988 A2 544 
   Retina extract Partridge et al. 1989 A1 513 
     Douglas, Partridge, Marshall 1998 A1 513 
     Bowmaker, Dartnall, Herring 1988 A1 524/525 
     Partridge et al. 1989 A2 539 
     Bowmaker, Dartnall, Herring 1988 A2 539/540 
     Douglas, Partridge, Marshall 1998 A2 540 
   Whole mount(fresh) Douglas, Partridge, Marshall 1998 A1 520 
     Douglas, Partridge, Marshall 1998 A2 563 
      Douglas, Partridge, Marshall 1998 A1* 595 
Table 1: Comparison of opsins from dragonfish. λmax coloured by wavelength: <530 nm : blue, 531 to 541 nm: green, 
542 to 563 nm: orange, >564 nm: red. *indicates non-rhodopsin, †indicates difference microspectrophotometry 
21 
 
used to signal between members of the same species (Herring, 2007), or in the same way 
bright colouring is used to signal danger (Grober, 1988) on land. Bioluminescence can be 
used to hunt, famously as a lure by the female anglerfish, or as a searchlight. Any exploitation 
of light can also be a vulnerability: if you can see it, so might the bigger fish. One interesting 
behaviour is that one fish may use other organisms’ tapeta against them by using 
bioluminescence to look for eyeshine (Howland et al., 1992). Most organisms do, however, 
have a limited spectral sensitivity. Though the blue-green space light may not reach the 
depths, visual pigments mostly still use the same wavelengths. This is not to capture any 
possible light from the surface, but because the maximum transmission of light is at these 
wavelengths. 
Dragonfish 
The stomiidae, or barbeled dragonfish, are a family of fish in the mesopelagic zone, some of 
which have attracted attention for unusual vision (Bowmaker et al., 1988) and behaviour. 
One way some dragonfish avoid detection is to change wavelengths. In addition to normal, 
blue luminescence they have a second set of photophores which contain a fluorescent 
protein which changes the light to red, around 700 nm (Campbell and Herring, 1987; Widder 
et al., 1984). These have red shifted visual pigments (O’Day and Fernandez, 1974) compared 
to other fish (see table 1), as well as pigmented lenses and tapeta in some cases (Douglas et 
al., 1998b; Somiya, 1982). The red photophores have been proposed to work as a sort of 
invisible flashlight, allowing the dragonfish to hunt unseen. Though the propagation of this 
light would be over very short distances, due to the high attenuation of red light, even in the 
purest seawater (Smith and Baker, 1981), many deep sea organisms camouflage themselves  
by red colouring (Johnsen, 2005), proof against blue searches, but fodder for the dragonfish. 
One of the dragonfish exploiting this strategy, Malacosteus niger (M.niger), also has a brown 
filter on its photophores (Widder et al., 1984) rendering its bioluminescence even dimmer in 
shortwave regions. It also may not have as far red-shifted visual pigments as other 
dragonfish. It was however, found to have deposits of a chlorophyll derivative (Douglas et 
al., 2016, 1999, 1998a) in its retina, which has been suggested (“Dragon fish see using  
chlorophyll | Nature”) to work as an antenna for its visual pigment. 
22 
 
1.1.1.3: Chlorin 
1.1.1.3.1: Porphyrins 
The chlorophyll derivative found in M. niger eyes is one of the porphyrin family of pigments 
(Figure 1.3c). These compounds comprise a macrocycle of four rings modified by functional 
groups. There are two major groups of biological pigments, the carotenoids like retinal, and 
porphyrins. Their biological roles of porphyrins exploit their strong absorbance in the visible 
range due to the large conjugated system of the macrocycle, such as in chlorophyll; and their 
ability to coordinate metals using the nitrogens in the centre, such as in haem and related 
compounds. An unmodified porphyrin has two significant sets of absorbances, the B- or Soret 
band, which is found around 400 nm; and the Q-band, which is found between 480 and 700 
nm (Figure 1.3b). Chlorins, which are porphyrins and include chlorophyll, can have additional 
strong absorbances in the far red. This is discussed in section 3.1. The far-red absorbance has 
been proposed to overlap with the emission from Malacosteid red photophores, then 
transferring the excitation to rhodopsin. This would require some form of uphill energy 
transfer, which has been observed in bacterial and insect systems (Balashov et al., 2005; 
Kirschfeld and Vogt, 1986). Possible mechanisms are discussed in section 1.1.1.3.2. 
A further question is how a fish would acquire such a compound. Though the metabolisms 
of all animals include a porphyrin pathway used to produce haem, the pathways for haem 
and chlorophyll divide at protoporphyrin IX (Kegg pathway ko00860 (Kanehisa and Goto, 
2000)). M. niger’s diet includes copepods (Sutton, 2005), zooplankton which commonly eat 
phytoplankton supposed to be the original source of chlorophyll digested to produce 
antenna compounds.  
1.1.1.3.2: Experiments with Chlorin 
Chlorins are used in photodynamic therapy (PDT) for cancer because of their high absorbance 
of infrared radiation (Zenkevich et al., 1996). There are anecdotal reports of PDT causing 
photosensitivity in humans (“Photodynamic Therapy for Cancer,” n.d.), i.e. patients have 
reported increased sensitivity to light after treatment. This prompted investigation into the 
possibility that sensitization by porphyrins might not require a specific adaptation of the 
rhodopsin. The first such experiments were using bovine rhodopsin (Ilyas Washington et al., 
2004), and showed a 2.9-fold enhancement in sensitivity to a narrow bandwidth of far red 
light. The same groups also administered the most promising compound, chlorin e6 (Ce6), to 
mice (Washington et al., 2007) and demonstrated both more bleaching by red light, and a 
larger electrical response from the retina; and have soaked salamander retinae in a Ce6 
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containing solution and demonstrated that rod bleaching by red light increased 180-fold 
(Isayama et al., 2006). A more questionable claim from this research is that Ce6 specifically 
targets the retina. While more Ce6 was found in the rods, specifically in their outer segments, 
which are very membrane dense, Ce6 is more soluble in lipids, which could explain this 
observation without resorting to targeting (Douglas et al., 2016). The observation of effects 
across species suggests that some form of enhancement of far-red sensitivity is, to some 
extent, independent of the rhodopsin. 
If absorbance of red light by Ce6 does lead to activation of rhodopsin, some form of energy 
transfer should take place between Ce6 and rhodopsin. The absorbance of a photon by a 
system excites an electron from the ground state. Normally, the excited electron returns to 
the ground state by a combination of thermal relaxation processes. However, it is possible 
for some systems to thermally relax to the ground vibrational state of the excited state, then 
return to the ground state by emission of a photon of lower energy (this change, called the 
“Stokes shift”, is due to the loss of energy by vibration). This process is fluorescence. It is also 
possible for the excited electron to have changed spin, which means it cannot directly return 
to the ground state by fluorescence. It has entered a forbidden “triplet” state. If it returns to 
ground state through another path involving emission of a photon, this emission is 
phosphorescence. There are processes by which the emitted energy from a donor can be 
transferred to an acceptor system. This can occur over long distances through resonance 
between the two in Förster resonance energy transfer (FRET) . The efficiency of the process 
depends on the sixth power of the separation between donor and acceptor, so the effect is 
exploited in microscopy and imaging applications (Jares-Erijman and Jovin, 2003). When 
FRET occurs, an alternative pathway for the return of the electron to the ground state is 
provided, so the measured fluorescence is decreased. Another mechanism by which energy 
transfer can take place is called Dexter energy transfer (DET) (Dexter, 1953). In this process, 
the excited electron itself is exchanged for a ground state electron, leaving a ground state 
donor and an excited acceptor. 
Both FRET and DET normally require that there is a significant overlap between the emission 
of the donor and the absorbance of the acceptor. This is because the promotion of an 
electron to an excited state requires energy, which is proportional to the wavelength of 
absorbance by Planck’s equation: E = hv, in which E is energy, h is Planck’s constant, and v is 
the wavelength of a photon. From this relationship, the energy of the emitted photon must 
be close to the energy required to promote the electron, thus the wavelength of the emitted 
photon must be close to the wavelength of absorbance. As the donor loses energy through 
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relaxation, the energy transfer is also usually “downhill”, so the absorbance of the acceptor 
is at a longer wavelength than the absorbance of the donor. There are mechanisms which 
allow violation of this principle, such as the absorbance of multiple photons (Singh-Rachford 
and Castellano, 2010). 
The normal requirement for downhill energy transfer would seem to forbid the transfer of 
the signal of a far-red photon from an absorbing porphyrin to isomerize the retinal of a 
rhodopsin with a λmax near 500 nm. Previous experiments with rhodopsin and Ce6 also show 
that energy transfer cannot occur as an alternative to fluorescence emission, as the 
fluorescence of Ce6 is unaffected by the addition of rhodopsin (Washington et al., 2007). 
There remain mechanisms by which the energy transfer could still happen. DET processes 
can involve the transfer of triplet-state electrons from donor to acceptor. Ce6 has long-lived 
triplet states which are more similar in energy to triplet states of retinal than the singlet 
states are to one another. The efficiency of energy transfer between these triplet states 
would, therefore, be more efficient. It has also been observed that isomerisation of retinal 
can proceed via triplet states (Rosenfeld et al., 1974), so this remains as a possible 
mechanism for energy transfer. 
Ce6 is not, however, simply an antenna pigment to rhodopsin which simply needs to be close 
enough to transfer excitation to retinal. Thermal stability of rhodopsin is improved by the 
addition of Ce6, and the effect increases with the addition of divalent metal ions, especially 
Zn2+ (F. Balem et al., 2009). Porphyrin metal binding is at the core of the function of 
haemoglobin and photosynthesis, so in some ways this is not surprising. Though in this paper 
the thermal stability measured was of the secondary structure of the opsin and not of the 
whole rhodopsin-retinal system, the fact that tapeta are used in fish to decrease dark noise 
and thereby enhance signal:noise suggests a similar possibility for chlorophyll derivatives. 
It remains to be seen how relevant the different effects porphyrins exert on rhodopsin are 
in a physiological context, and whether any of these make it a useful therapeutic. Before any 
firm conclusions can be made, the red-bleaching enhancement effect must be systematically 
investigated. Previous attempts in vitro have made no effort to separate the contributions of 
Ce6 and rhodopsin in absorbance spectra. The behaviour of both species upon illumination 
with red-light should be characterised, and some method used to determine which effects 
in a mixture arise from which species. If a reproducible enhancement of bleaching by red 
light is found, some effort should be made to probe the nature of the interaction. There are 
fluorinated analogues of retinal (Colmenares, 1991) which provide a sensitive probe through 
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nuclear magnetic resonance (NMR, introduced in section 1.1.4.1). If the binding of Ce6 
affects the retinal binding pocket, the NMR spectrum of fluorinated retinal should be 
affected. 
Beyond these effects, the interaction of Ce6 with rhodopsin is of broader interest. The 
possible binding site for Ce6 includes the D/ERY motif (Woods et al., 2017), which is very 
highly conserved among rhodopsins and related proteins (Rovati et al., 2007). The 
conservation of this site between dragonfish opsin and the bovine opsin of the common in 
vitro experimental system should be explored, as a lack of conservation between the two 
could make the normal experimental system a poor analogue for the natural system. The 
proteins related to rhodopsin are physiologically and medically important, and, as the 
thermal stability of rhodopsin is increased by Ce6, the interaction is unlikely to be simply an 
energy transfer to retinal and is therefore potentially useful or informative for wider studies. 
1.1.2: Rhodopsin as a folding model 
Rhodopsin is the canonical member of the class A G protein coupled receptors (GPCRs). 
These respond to various stimuli in the same way rhodopsin responds to the conversion of 
11-cis-retinal to all-trans, which is analogous to the binding of an agonist by a GPCR. Class A 
Figure 1.4: Structure of G protein-coupled receptors. The crystal structure of 
rhodopsin (PDB 1L9H) is used as a model. The extracellular domain is in black, 
the cytoplasmic in grey, and the transmembrane domain is coloured by helix. 
Retinal is represented as ball and sticks in cyan. Slanted dashed lines show the 
approximate ends of the membrane. 
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GPCRs are targets for a third (Santos et al., 2017) of all pharmaceuticals and control many of 
the processes vital for an organism’s health and survival. GPCRs are involved in responses to 
the outside world (e.g. rhodopsin for photons, odorant receptors (Malnic et al., 2004) for 
volatile chemicals) and signals generated in the body (e.g. chemokines (Krumm and 
Grisshammer, 2015), steroid hormones (Wang et al., 2015)). The activation of rhodopsin is 
relatively simple when compared to other GPCRs, whose activity can be heavily modulated, 
and exists on a spectrum of full and partial activation by different ligands (Hilger et al., 2018; 
Latorraca et al., 2017; Manglik and Kobilka, 2014).  
GPCRs comprise seven α-helices spanning the membrane, connected by a series of loops 
which are essential to both their structure and function, ending in a short, eighth helix 
outside of the membrane and a flexible C-terminus. Another useful way of dividing a GPCR 
structure is to identify cytoplasmic, extracellular, and transmembrane domains (Figure 1.4). 
Rhodopsin was the first GPCR to have its structure determined by x-ray crystallography 
(Palczewski et al., 2000). Crystal structures of other GPCRs have been determined since 
(Isberg et al., 2016), as have other states of rhodopsin (Ridge and Palczewski, 2007), which 
have been instrumental in understanding GPCR activation. 
Rhodopsin is both unusually stable and incredibly sensitive, allowing the detection of single 
photons (Baylor et al., 1979). It has been successfully unfolded without aggregation in vitro 
by addition of 30% SDS (Dutta et al., 2010a). This was arrived at as the best denaturant for 
later studies by screening a series of denaturants and comparing extent of unfolding and the 
stability of the unfolded states (Dutta et al., 2010b). Rhodopsin in 30% SDS has lost 45% of 
its helical structure, as measured by circular dichroism, and remains soluble long term. These 
experiments are further discussed in section 5.2.1. Unfolded states are of interest as they 
relate to the folding and stability of proteins. As an unfolding protocol exists for rhodopsin, 
and the folded protein is so well-investigated and stable compared with its relatives, it makes 
an ideal model system for the folding of class A GPCRS. 
There are diseases in which the unsuccessful folding of GPCRs is implicated, including 
reproductive disorders (Ulloa-Aguirre et al., 2014); some forms of Charcot-Marie-Tooth 
disease, a common neuropathy (Soong et al., 2013). The disease of rhodopsin misfolding is 
called retinitis pigmentosa. 
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1.1.3: Rhodopsin misfolding 
1.1.3.1: Retinitis pigmentosa 
Retinitis pigmentosa (RP) is a disease characterised by loss of night vision early in life, 
followed by loss of peripheral vision. The rod cells of the retina either fail to develop or die 
early. The death of the rods damages the retina, and later, even central vision can be lost. 15 
to 35% of cases are inherited as an autosomal dominant condition (ADRP), and 20-30% of 
these are due to mutations in rhodopsin (Sandberg et al., 1995), of which more than 150 
have been identified (Daiger et al., 2013; “RetNet: Disease Table”). Previous classifications of 
rhodopsin ADRP mutants have made divisions based on biochemical and cellular 
characteristics of mutants expressed in cell culture (Kaushal and Khorana, 1994), (Berson et 
al., 2002; Cideciyan et al., 1998; Sandberg et al., 1995), but more recent classification 
schemes have incorporated data from animal models and later established biochemical 
criteria to deliver seven classes of mutant (Athanasiou et al., 2018). These classes divide 
mutants by cellular dysfunction, stability, post-translational modification and disordered 
interactions with other proteins, so classes are not mutually exclusive.  
Clinically, ADRP can also be classified according to clinical phenotype as either class A, with 
severe, early-onset loss of rod function; or class B, with a milder phenotype. These can be 
associated with different mutations, but there are other sources of variability (Iannaccone et 
al., 2006). 
1.1.3.2: P23H 
The P23H mutation is the most common ADRP mutation found in the United States, the 
cause of 10% of total cases of ADRP in north American populations of western European 
origin, and was the first point mutation to be associated with ADRP (Dryja et al., 1990). The 
clinical phenotype is class B, and within the biochemical and cellular classification system 
above is class 2, meaning it misfolds, is retained in the endoplasmic reticulum and is unstable, 
though this can be partially pharmacologically rescued by administration of 9-cis or 11-cis-
retinal (Noorwez et al., 2004). P23H has been cloned into both transient and stable 
expression systems (Oprian et al., 1987; Reeves et al., 2002). Compared with wild-type 
rhodopsin, its yield of chromophore is low, though properly folded and misfolded P23H can 
be separated by control of elution conditions, and the folded fraction maintains WT-like 
secondary structure as measured by circular dichroism (CD) spectroscopy (Liu et al., 1996). 
However, P23H has compromised light response and thermal stability (Chen et al., 2014; 
Noorwez et al., 2004). As its yield can also be partially rescued by administration of 11-cis or 
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9-cis retinal during expression, it makes a good 
experimental system for rhodopsin misfolding. Any 
exploration of wild-type rhodopsin’s unfolding 
states could be extended to P23H, providing an 
example of folding gone wrong. Knowledge of 
P23H misfolding would also be of clinical relevance 
due to the occurrence of retinitis pigmentosa.  
The most widely used model for membrane 
protein folding does not account well for the 
folding behaviour of rhodopsin, but a newer model 
predicts a core of residues important for folding. 
The position 23 is found within the predicted 
folding core (Figure 1.5), and a proline at that 
position is well conserved within vertebrate and 
invertebrate opsins, as well as other GPCRs 
(Applebury and Hargrave, 1986; Dryja et al., 1990). 
The common model is the two-stage model, and 
the newer model, which accounts for aspects of rhodopsin’s folding, is the long-range 
interactions model. 
1.1.3.3: Two-stage model 
The first membrane protein to be refolded from a fully unfolded state was bacteriorhodopsin 
(bR) from Halobacteria salinarum  (Huang et al., 1981). This achievement made bR the 
principal folding model system for α-helical membrane proteins, especially 7-
transmembrane helix proteins. That bR could also be refolded from fragments (Liao et al., 
1983) to yield a protein indistinguishable from native bR (Popot et al., 1987) led in part to 
the formulation of the two-stage model for membrane protein folding (Popot and Engelman, 
1990). This is the idea that folding of helical membrane proteins starts with the formation of 
independently stable helices, which then diffuse laterally in the membrane until they 
associate into their final arrangement. There are more fundamental reasons to suppose the 
formation of stable helices is independent of final protein folding. Helices form by the 
satisfaction of local hydrogen bonds. In a hydrophobic environment, hydrogen bonds cannot 
be satisfied by interactions with solvent, so such conditions make helices very stable. This 
model explicitly forbids the rearrangement of these helices post insertion, as they should be 
Figure 1.5: Folding core of rhodopsin. Residues 
of the folding core indicated as green spheres. 
P23 is shown as blue spheres 
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so stable once inserted that this is impossible. There are proteins capable of the flipping of 
entire groups of helices (Vitrac et al., 2015; Woodall et al., 2015), and that have “frustrated” 
helices (Gafvelin and von Heijne, 1994) that are inserted or lie along the membrane under 
different conditions. 
1.1.3.4: Long-range interactions model 
Revisions to the two-stage model have been made (Engelman et al., 2003) to account for 
phenomena outside the partition and association of helices while maintaining these as the 
first and central events in helical membrane protein folding. While this paradigm is useful for 
understanding some proteins, there are others for which the observations cannot match up 
with the idea of independently stable helices. For these, there is a greater importance for 
long-range interactions; and loops, far from being irrelevances which can be cut apart with 
impunity, are essential for proper folding. A protein which seems more compatible with a 
long-range interactions model for folding is mammalian rhodopsin (MR). A comparison 
between the models is shown in Figure 1.6. 
 
Figure 1.6: Two-stage model and the Long-range Interactions model. a) The two-
stage model for membrane protein folding based on observation of bR. I) 
Independently stable helices form in the membrane. II) The helices condense to form 
a bundle. b) The long-range interactions model for membrane protein folding based 
on observation of MR. I) A folding core of loops and helix segments forms. II) The 
folding fore serves as a nucleus around which other structural elements form 
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The first evidence that MR might need a modified model for its folding mechanism came 
from co-expression studies of fragments which did not refold in the same simple fashion as 
bR (Ridge et al., 1995). More recently, the so-called Floppy inclusion and rigid substructure 
topography (FIRST) method of simulated unfolding was applied to MR and bR (Tastan et al., 
2007). FIRST analysis uses theory from a long lineage of analysis of stability and of the 
flexibility of glasses to identify rigid regions of proteins (Jacobs et al., 2001; Rader et al., 
2002). 
The algorithm first uses the interatomic distances in a structure to model the bonds as a 
network of constraints on distances and angles. Regions which are “overconstrained”, 
meaning that they have more bonds than are necessary to keep it rigid, some of which can 
be removed, are identified. Then “underconstrained” regions, which are rotatable parts 
between overconstrained regions, are identified. The energies of the hydrogen bonds are 
approximated and ranked by energy. They are then removed them in order of strength from 
the weakest (Hespenheide et al., 2002), which in the original application to glasses served to 
identify the point at which the glass melted. For proteins, this identifies a transition state in 
folding and finds folding cores, defined as the last rigid (or overconstrained) region 
containing two secondary structure elements. 
This application of the FIRST algorithm was found to be in good agreement with experimental 
results using H-D exchange NMR spectroscopy to identify folding cores in soluble proteins 
(Rader and Bahar, 2004). This approach measures how quickly hydrogens in a protein can 
exchange with deuterium in the solvent. Regions which have slow exchange are more tightly 
constrained and form the folding cores of proteins (Li and Woodward, 1999). The same 
regions were identified when using the ranking function on the bond energies. If the ranking 
was not used and bonds were removed randomly, the results failed to align with 
experimental data, showing that the overall approach of identifying constraints on regions 
by bond energy is a valid approach for exploring protein folding. 
When comparing bR and MR, it was found that FIRST fails to reliably identify a folding core 
in bR, which is in line with experimental results and the two-stage model (Tastan et al., 2007). 
It shows bR separating early on in simulated unfolding into its helices, which is appropriate 
for the two-stage model. MR, however, maintains a folding core between helices, suggesting 
that interactions between residues distant in sequence, but close in space in the folded 
protein, are important for its stability. The folding core also contains higher energy in the 
sum of its hydrogen bonds. These FIRST results provided a mechanistic explanation for why 
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the co-expression experiments with MR did not result in refolding of MR from fragments 
except for very specific cuts, and thus led to the proposal of a long-range interactions model 
(Klein-Seetharaman, 2005). 
The folding core of rhodopsin is found in the extracellular domain (Figure 1.6), including 
residues in the extracellular loops and to the extracellular end of helices. Experimental data 
(discussed in section 5.2) shows that the extracellular domain remains more rigid than the 
rest of rhodopsin in unfolded states. Development of experiments which can show the 
dynamics of different domains in rhodopsin will test the predictions of a folding core.  
1.1.4: Comparing rhodopsin and pSRII 
When comparisons were made between bR and MR using FIRST analysis, the same analysis 
was carried out on other prokaryotic rhodopsins, including the sensory rhodopsin of 
Natronamonas pharaonis (Tastan et al., 2007). Natronamonas pharaonis is an 
archaebacterium. It produces a sensory rhodopsin (pSRII) which is used for phototaxis. 
Having high homology to bR, it can, like bR, act as a proton pump. Unlike bR, it also has a 
transducing partner. pSRII is the first 7-transmembrane helical membrane protein to have its 
structure determined by nuclear magnetic resonance (NMR) spectroscopy (Gautier et al., 
2010), and its dynamics have been thoroughly explored by that technique. 
1.1.4.1: NMR 
Most protein structures are determined by X-ray crystallography (90% of structures 
deposited in the PDB were from x-ray crystallography at the time of writing). Though this is 
possible for membrane proteins, the need to incorporate some amphiphile to solubilise the 
molecule causes difficulty with crystallisation (Carpenter et al., 2008). Cryo-electron 
microscopy is another technique used for structure determination, but only recently has 
gained atomistic resolution (Kim and Sanbonmatsu, 2017). These techniques also only 
acquire limited information regarding the dynamics of molecules, as they often require low 
temperatures. 
NMR, however, can be carried out at physiologically relevant temperatures, does not require 
crystallisation, and provides information about dynamics. These characteristics make it a 
useful technique for investigating membrane proteins (Opella and Marassi, 2017). A 
significant disadvantage is the requirement of large masses of sample. It is relatively 
insensitive, requiring milligrams of protein. Production of such amounts of membrane 
proteins is very challenging (Junge et al., 2008). 
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The signal detected by an NMR spectrometer arises from the spin of nuclei. As the nuclei are 
charged, their movement produces magnetism. When an external magnetic field is applied 
to an NMR sample, the magnetism of the nuclei aligns in the direction of the field. A magnetic 
pulse called the RF pulse is applied at right angles to the first, and the magnetization of the 
nuclei changes to that direction instead. As this pulse ends, the magnetization returns to 
align with the initial field. As it returns, it revolves around the direction of the magnetic field 
in a characteristic motion called “precession” at a frequency characteristic of that nucleus 
(the Larmor frequency). As the magnetization crosses a probe of the spectrometer, it induces 
a current, and as this occurs at the Larmor frequency, this can be detected by the instrument. 
The magnetic field a nucleus actually experiences is not the applied magnetic field. Electrons, 
as moving charges, also respond to the applied field and influence the nuclei. Though this 
effect is small, it is detectable by NMR spectroscopy, and changes the resonant frequency of 
the nuclei. This phenomenon is known as chemical shift. Though these values have a value 
in Hertz (Hz), the values are small and depend on the strength of the applied field, so are 
reported as parts per million (ppm) relative to the frequency of a standard compound. As the 
environment the electrons produce is different for nuclei in all but symmetrical molecules, 
this allows NMR to discriminate between and identify nuclei. 
Another effect that conveys information about the identity of peaks is that the spins of nuclei 
can be coupled. The spectra of coupled nuclei have peaks which are split into multiplets. This 
means that the peak is divided into multiple peaks which have the same area as a single peak 
for that nucleus. Multiplets of coupled nuclei are split by the same amount, which allows 
identification of which peaks belong to which nuclei. There are other through-bound and 
through-space interactions which can be used to assign peaks to nuclei and obtain spatial 
constraints between them.  
Different ways of applying RF pulses can be used to detect different types of interaction 
between spins, so different pulse sequences are used in different NMR experiments which 
can be used alone or in combination to identify signals as belonging to particular nuclei. NMR 
experiments can be used to assign NMR peaks to residues in a protein, then connect the 
residues by bond (e.g. to ascertain primary structure) and through space (acquiring 
constraints on a protein’s tertiary structure). Secondary structure can be found either 
through this through-space information or by characteristic changes in chemical shift 
(Wishart et al., 1992). Two experiments very commonly used in protein NMR are 
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heteronuclear single quantum correlation (HSQC) (Bodenhausen and Ruben, 1980) and 
heteronuclear multiple quantum correlation (HMQC) (Bax et al., 1983). 
The “heteronuclear” part of each of their name refers to the fact that the experiment detects 
connected nuclei of different types, most commonly 1H and either 13C or 15N. Both return a 
two-dimensional (2D) spectrum (Aue et al., 1976), with peaks that have both a 1H and a 
heteronuclear component. These are commonly displayed as contour lines on a 2D graph. 
Both work by first exciting the 1H nucleus, then transferring the magnetization to the 
heteronucleus, allowing the magnetization to evolve for a time, then transferring the 
magnetization back to the proton for detection. Though both experiments return roughly 
the same information, differences in the pulse sequences mean that HSQC spectra have 
higher resolution, while HMQC spectra can be easier to perform (a detailed comparison can 
be found in (Mandal and Majumdar, 2004). The two steps involving the 1H nucleus deliver a 
stronger signal for the heteronucleus than excitation of that nucleus alone would produce, 
so these are relatively sensitive experiments. 
While HSQC experiments generally deliver higher resolution than HMQC, some interactions 
within the methyl group of methionine make HMQC experiments up to three times more 
sensitive than HSQC (Tugarinov et al., 2003). Methyl groups in proteins are sensitive probes 
for structural biology of large proteins in any case, as they have three proton resonances in 
a very flexible group, resulting in slow relaxation (Ruschak and Kay, 2010). 
Relaxation in NMR 
The processes by which magnetization returns to the equilibrium, where all magnetization is 
along the axis of the applied field, are called relaxation. Faster relaxation results in a weaker, 
broader signal. The three protons and ε carbon of methionine relax slowly due to the group’s 
flexibility and the three protons, which means they give a strong, sharp signal, which is very 
useful for proteins. Larger molecules in solution tumble more slowly, causing faster 
relaxation (Foster et al., 2007). This effect is exacerbated for membrane proteins, which 
require some membrane mimetic to stay soluble. The mass of the DM micelle solubilising 
rhodopsin is approximately 72 kDa (as measured by the manufacturer), increasing 
rhodopsin’s effective mass from 32 kDa to 104 kDa. 
Flexible parts of a protein relax more slowly than more rigid parts. There are methods which 
can precisely measure the different relaxation rates of specific sites in a protein, delivering 
details of the dynamics of the protein (Bracken, 2001; Ishima and Torchia, 2000). Less 
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precisely, the observation of narrower and broader peaks from normal experiments can be 
used to judge which sites are more or less dynamic. 
Paramagnetic species in a sample will increase the rate of relaxation. Paramagnetism arises 
from the spin of unpaired electrons, which also align with the applied magnetic field. The 
dipolar interaction between the paramagnetic centre and a given nucleus is responsible for 
the increased rate of relaxation, and is dependent on the sixth power of the distances 
between the two. This means that signals from nuclei near to the paramagnetic species will 
weaken. The effect is normally limited to 35 Å, a much greater distance than other types of 
spatial information acquired from NMR. 
A common source of paramagnetism for protein NMR experiments is the nitroxide radical, 
which contains an unpaired electron (Haugland et al., 2016; Sjodt and Clubb, 2017). There 
are reagents containing a nitroxide radical which will specifically react with surface cysteines 
of a protein. An example of the application of these labels to rhodopsin can be found in 
section 5.3.3. 
1.1.4.2: Comparison of pSRII with bR and MR 
pSRII takes an intermediate role between bR and MR: Based on its sequence and proton 
pumping activity, it is related to bR, but its transducing partner for signal transduction makes 
its role somewhat more like MR. Consistent with this intermediate role, FIRST analysis 
predicts that pSRII shares folding characteristics with both, as folding and conformational 
changes have been linked (Klein-Seetharaman, 2005; Tastan et al., 2014). Consistent with 
this comparison, FIRST analysis shows that the energy of the hydrogen bonds in its predicted 
folding core are somewhere between those found for MR and bR. 
As bR and MR have already been established as model systems for membrane protein folding 
and display different folding mechanisms, it would be useful to establish another model 
system. pSRII shares the characteristics of binding retinal and comprising seven 
transmembrane helices with both and shares functional aspects with each. A comparison of 
pSRII with both will provide experimental evidence for the validity of applying FIRST analysis 
to membrane proteins and may be useful in the determination of which characteristics make 
a protein follow a two-stage or long-range interactions mechanism for folding. Whether its 
folding mechanism falls along some continuum between the two-stage folding of bR and the 
long-range interaction dependent folding of rhodopsin is a question with implications for the 
folding of membrane proteins in general. The retinal chromophore and previous NMR work 
on pSRII provide groundwork for the characterisation of pSRII as a model system. 
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1.2: Aims and objectives 
1.2.2: Aims 
The nature of the interaction between Ce6 and rhodopsin is unknown and could have 
implications for either the evolution of opsins, or the activation of GPCRs in general. The 
systematic replication of the observed enhancement of bleaching of rhodopsin by red light 
in the presence of Ce6 will be used to confirm an interaction between the two. The 
characterisation of this interaction will be attempted by measuring any effect Ce6 has upon 
retinal’s chemical environment. MR and bR are already model systems for helical membrane 
protein folding but support different models for folding mechanisms. Finding the biophysical 
parameters for pSRII folding and establishing it as another model system with some 
characteristics in common with each may provide useful knowledge for the folding 
mechanisms of helical membrane proteins in general. MR will be further developed as a 
model system for membrane protein folding by characterising the NMR spectra of rhodopsin 
with isotope labelled methionines so that further experiments may explore the dynamics of 
different domains in unfolded states. Such new insight could have clinical relevance for the 
design of future approaches to treat retinitis pigmentosa. 
1.2.3: Objectives 
1. To probe the nature of the interaction between Ce6 and rhodopsin, bleaching 
experiments were conducted, recording the absorbance spectra of Ce6 and 
rhodopsin mixtures after irradiation with red light. The contributions of different 
concentrations of Ce6 and rhodopsin were separated during data analysis. The 
same data analysis approach was applied to different treatments of these mixtures 
to explore the effect of Ce6 on rhodopsin’s stability. The conservation of residues 
in a 151-sequence multiple sequence alignment (MSA) was compared at different 
positions of interest. Samples of rhodopsin were reconstituted with 14-
fluororetinal for 19F NMR spectroscopy to see if Ce6 had any effect on retinal’s 
environment. 
2. To investigate the unfolding reactions of pSRII, in collaboration with the University 
of Cambridge, an experimental system unfolding pSRII in sodium dodecyl sulphate 
(SDS) was established based on previous work on MR. The nature of these 
unfolding reactions was explored by decomposition of absorbance spectra and 
fluorescence time courses to establish kinetic parameters, using non-linear least 
squares (NLS) fitting. This data analysis was expanded to analyse refolding 
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reactions and unfolding in the presence of hydroxylamine, which modifies the 
kinetics. More detailed decomposition methods were also used to examine the 
changes in pSRII absorbance spectra in non-denaturing concentrations of SDS. 
3. Several data analysis techniques were applied to find underlying patterns in the 
changes of pSRII NMR spectra unfolded in different concentrations of SDS. Principal 
Components Analysis (PCA) was performed on a reduced dataset, and preliminary 
attempts were made to apply image analysis and clustering techniques. 
4. To establish a system to further characterise the nature of unfolded states of 
rhodopsin in SDS, 13C, 15N-methionine labelled rhodopsin samples were prepared 
for NMR spectroscopy.  HMQC spectra were recorded in various conditions in 
collaboration with the University of Cambridge and analysis of peak positions was 
used to assign peaks to rhodopsin methionines. Labelling with paramagnetic 
relaxation enhancement (PRE) reagents was attempted to assist ambiguous 
assignments. 
5. Samples of P23H rhodopsin were prepared as for WT as above so comparisons 
might be made. Density filtering and peak fitting algorithms were used to 
determine the weight and estimate the density of Western blots scanned to 
saturation and compare the deglycosylation of wild-type rhodopsin with the P23H 
and N15S mutants.  
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CHAPTER 2: MATERIALS AND METHODS 
2.1: Materials 
• HEK293T cells from Dr R Murthy (University of Warwick) 
• HEK293S with tetracycline inducible expression of rhodopsin 
o Expressing Wild-type a gift from Dr P Reeves, University of Essex (Reeves et 
al., 2002) 
o Expressing P23H from University of Pittsburgh (unpublished results) 
• Rod outer segment (ROS) suspension 
• Chlorin e6 (Ce6) from Frontier Scientific 
• 4,4’-dipyridyl disulphide (PDS) from Sigma Aldrich 
• S-(1-oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl 
methanesulfonothioate (MTSL) from Santa Cruz Biotechnology 
• Retinal 
o 11-cis from Dr R Crouch (Medical University of South Carolina) 
o 9-cis from Sigma Aldrich 
• TETSQVAPA nonapeptide from GenScript 
• Sodium dodecyl sulphate (SDS) from Fisher Scientific 
• n-dodecyl β-D-maltoside (DM) from Anatrace 
• Lauryl Maltose Neopentyl Glycol (LMNG) from Generon 
• Amphipol A8-35 from Anatrace 
• Tandem amphiphile (AM-2) a gift from Dr A Marsh (University of Warwick) 
• Foetal bovine serum (FBS) from Gibco 
• Pluronic F-68 from Applichem 
• Heparin (sodium salt) from Applichem 
• Sodium butyrate from Alfa Aesar 
• Glucose from Applichem for tissue culture, otherwise Fisher Scientific 
• Cyanogen bromide-activated Sepharose 4B from Sigma Aldrich 
• 4-chloro-1-naphthol from Sigma Aldrich 
• Geneticin (G418) from Cellgro 
• Hydroxylamine hydrochloride from Sigma Aldrich 
• 2-(N-morpholino)ethanesulfonic acid (MES) from Sigma Aldrich 
• PNGase F kit from New England Biolabs 
• Color Prestained Protein Standard, Broad Range (11–245 kDa) from New England 
Biolabs 
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• 1D4 antibody from Cell essentials 
• All other antibodies from Santa Cruz Biotechnology unless otherwise stated  
• Competent E. coli (BL21) from New England Biolabs 
• Vivaspin 20 concentrations, 30 kDa cutoff from Sigma Aldrich 
• Visking tubing with 12 kDa cutoff, 21.5mm diameter from Medicell 
• All other materials from Fisher Scientific unless otherwise stated 
Buffers and media 
• Sodium phosphate (NaPi) buffer (pH 6) 
o Ratio of 20:124 Na2HPO4:NaH2PO4 
o Adjust pH with phosphoric acid/sodium hydroxide 
o Used at 2mM unless otherwise stated 
• Phosphate buffered saline (PBS) 
o 8 g/L NaCl 
o 0.2 g/L KCl 
o 1.44 g/L Na2HPO4 
o 0.24 g/L KH2PO4 
o Adjusted to pH 7.4 with HCl 
o Either taken from University of Warwick media prep (1X, autoclaved) or 
prepared as a 10X stock and diluted. 
• From University of Warwick media preparation service 
o Dulbecco’s Modified Eagle Media (DMEM) 
From Gibco, high glucose DMEM (catalogue number 41965), buffered with 
NaHCO3 
o DMEM as above, but deficient in methionine. Buffered with 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) 
o 10000 I.U./mL / 10000 μg/mL Penicillin/Streptomycin (formedium) 
o 10 mg/ml Tetracycline (formedium) 
o Trypsin/EDTA in HBSS -Ca, -Mg 
▪ 8 g/L NaCl 
▪ 0.4 g/L KCl 
▪ 48 mg/L Na2HPO4 
▪ 1 g/L glucose 
▪ 60 mg/L KH2PO4 
▪ Phenol red to 1 part in 100,000 
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▪ 2.5 g/L trypsin(1:250) 
▪ 0.38 g/L ethylaminediaminetetracetic acid (EDTA) 
▪ 0.35 g/L NaHCO3 
o Super optimal medium with catabolite repression (SOC) medium as in 
(Hanahan, 1983)  
• 10x running buffer for SDS polyacrylamide gel electrophoresis (SDS-PAGE) (250 mM 
Tris, 1.92 M glycine, 1% SDS, pH 8.3): 
▪ Tris base 30.30 g 
▪ Glycine 144.10 g 
▪ SDS 10.00 g 
▪ H2O to 1 L 
o Dilute 100 ml 10x buffer to 1 L with sterile water 
• Gel for SDS-PAGE 
Reagent Resolving gel (per ml) Stacking Gel  (4%)(per 
ml) 
30 % Bis/Acrylamide X/30 ml 133 μl 
Tris-HCl 250 μl 252 μl 
10% SDS 10 μl 10 μl 
H2O 734.5 μl -X/30ml 599 μl 
TEMED 0.5 μl 1 μl 
10% APS 5 μl 5 μl 
For an X% gel 
o Tetramethylethylenediamine (TEMED) 
o Ammonium persulphate (APS) 
• Western blot transfer buffer 
o 1X Tris-Glycine (30g/L Tris, 144g/L glycine) 
o 20% methanol 
• Tris-buffered saline/Tween-20 (TBS-T) 
o 50mM Tris 
o 150mM NaCl 
o 0.1% Tween-20 
o Adjust pH to 7.4 with HCl 
• Blocking Solution for western blots 
o 3% w/v non-fat milk 
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o 1X TBS-T 
• Antibody solutions 
o Blocking solution (as above) 
o Required dilution of antibody 
▪ 1:2000 for 1D4 
▪ 1:2000 for anti-mouse 
• Developing solution 
o 25ml PBS 
o 175 μl 3% 4-Chloro-1-Naphthol 
o 25 μl H2O2 
2.2: Methods 
2.2.1: Rhodopsin production 
Rhodopsin samples were prepared from both rod outer segment suspension and from 
transfected cells. The HEK293T cell line is derived from human embryonic kidney cells, and 
expresses the SV40 large T antigen, allowing high levels of expression when transfected with 
plasmids containing the SV40 origin of replication (DuBridge et al., 1987). These were used 
for transient transfections, in which the cells are harvested shortly after transfection. The 
pMT4 plasmid used to express rhodopsin in HEK293T cells contains the SV40 origin of 
replication, first used to express rhodopsin in Oprian et al., 1987 using the p91023 plasmid 
(Kaufman, 1985; Wong et al., 1985).  The pMT4 plasmid is modified from the pMT2 plasmid 
to contain the NotI restriction site (Franke et al., 1988) to make cloning of the opsin gene 
easier (the pMT2 plasmid has a PstI site in that place, which also exists within the opsin gene), 
which in turn was modified from the p91023 plasmid to confer β-lactam resistance instead 
of tetracycline resistance. 
HEK293S cells are adapted for culture in solution, which allows higher density of cultured 
cells. HEK293S cells stably transfected with a tetracycline inducible expression system were 
used to produce samples in the milligram range (Reeves et al., 2002). It is possible to label 
protein produced from cell culture with amino acids containing isotopes useful for NMR 
spectroscopy, an approach used here to prepare NMR samples of rhodopsin. 
2.2.1.1: Cell culture 
2.2.1.1: Media 
DMEM was used for all cell culture. To this, FBS was added to 10%. FBS contains growth 
factors and other components essential for culturing eukaryotic cells. When maintaining 
stably transfected cells, a maintenance concentration of 250 μg/mL G418 was added, which 
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provides a selection pressure for the cells to keep the plasmid. For cells in dishes, 
supplementation with antibiotics was not usually necessary and avoided if possible. 
In preparation of NMR media 
13C, 15N-methionine was added to methionine deficient media to 30 mg/mL from a 100X stock 
which had been filtered through a 0.22 μm filter. FBS used for this media was dialysed to 
remove free amino acids and small peptides to limit unlabelled methionine contamination 
of the media. Visking tubing with a molecular weight cutoff of 12 kDa was cut to ~20 cm 
lengths, washed then filled with distilled water and submerged in distilled water for 1h, then 
filled with ~30 mL FBS. The FBS was dialysed against 4x2 L PBS, changing at 30 minutes, 1h, 
2h and 4h then left overnight. The dialysed FBS was filter sterilised. 
2.2.1.2: Small scale culture of cells 
HEK293T and HEK293S cells were maintained in 10 cm tissue culture dishes with 10 mL 
DMEM+10% FBS. Tissue culture took place in a class 2 laminar flow hood unless otherwise 
stated. Cells were incubated at 37oC and 5% CO2. When judged by microscope-aided eye to 
be 80-90% confluent, they were passaged by first aspirating the media, then rinsing with 5 
mL autoclaved PBS and adding 2 mL trypsin/EDTA, which was swirled around the plate to 
ensure good coverage. This was incubated at 37oC for 30 seconds, then examined under 
microscopes. If the cells had rounded up and detached, 8 mL DMEM was added, then they 
were taken up and down in a 10 mL disposable pipette until homogenous. This suspension 
was either decanted into plates as required and the medium supplemented, or used for 
spinner flask culture.  
2.2.1.3: Large scale culture of cells in spinner flasks 
For large quantities of rhodopsin, inducible cell lines were grown in 2 L spinner flasks 
(Corning). Confluent cells in 10 cm dishes were passaged and split into 15 cm dishes to a final 
dilution of 1:5 by volume, or 2:5 by plate as a 15 cm plate was given 20 mL media. Once the 
15 cm dishes reached confluency, for each spinner flask, 3 were passaged and used to 
inoculate 500 mL media in the flask. Media for the flasks was supplemented with 0.1% 
pluronic F-68 (a surfactant which reduces damage from the shear forces introduced by 
spinners), 500 μg/mL heparin (sodium salt) (a polysaccharide which encourages cell growth) 
and 1:200 penicillin/streptomycin. Spinner flasks were incubated at 37oC on a stirrer plate 
set to approximately 20 revolutions per minute (rpm). The stirring of the spinners aerates 
the culture, ensuring oxygen delivery to the cells. 
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2.2.1.4: Freezing of cells for long term storage 
When storage of the cell lines was required, confluent cells were passaged and when 
detached from the dish were centrifuged at 1000 rpm for 10 minutes in an Eppendorf 5810 
centrifuge. The supernatant was aspirated and the pellet gently resuspended in 2 mL 
DMEM+10% dimethyl sulphoxide (DMSO). When DMSO is added to water, the ice crystals 
formed in freezing are smaller. This protects cells from bursting while freezing. This was 
divided into two cryo-tubes and placed in a -80oC freezer in a polystyrene container 
overnight. For long term storage, these were subsequently moved into liquid nitrogen. 
To revive frozen cells, the cryo-tubes were heated in a 37oC waterbath for about 60 seconds 
or until a small lump of ice remained. If the cells were taken from liquid nitrogen, the tube 
was first opened in the laminar flow cabinet to release any liquid nitrogen which could 
explode the tube. The contents of the cryo-tube were transferred into a 15 mL falcon tube 
and diluted with 5 mL media dropwise. This was centrifuged at 1000 rpm for 10 minutes in 
an Eppendorf 5810R centrifuge. The supernatant was aspirated and the pellet resuspended 
in 5 mL media. This was added to 10 mL media in a 10 cm dish and swirled gently. The media 
was changed once the cells had attached (usually 4 to 6 hours later) to minimise DMSO 
exposure. 
2.2.1.6: Calcium phosphate transfection 
When small quantities of rhodopsin were required, HEK293T cells were transiently 
transfected with pMT4 plasmids containing rhodopsin. This was achieved using the calcium 
phosphate method, which forms precipitates between the phosphates of the DNA backbone 
and calcium introduced in the protocol. The precipitates settle against the membranes of 
cells and are endocytosed. The method is reliable, but requires a large amount of DNA, so is 
only appropriate for small quantities. 24 hours after passage, media was changed. Values 
given here are for one plate. To transfect multiple plates weights and volumes are simply 
multiplied by the number of plates. DNA solution equivalent to 20 μg was made up to 450 μl 
with sterile water. 50 μl 2.5M CaCl2 was added dropwise, shaking between drops and shaking 
to mix thoroughly once all CaCl2 was added. 500 μl HEPES buffered saline was added 
dropwise. The mixture was left to stand at room temperature for 1 minute. 1 ml of 
transfection mixture was added dropwise evenly across a plate, which was then swirled to 
mix. Plates were incubated for 48 hours before harvesting. 
2.2.1.7: Induction of stable lines for NMR samples of rhodopsin 
Stable lines used were inducible by addition of 2 μg/mL tetracycline. Spinner flasks grown for 
5 or 6 days until media had turned orange were supplemented with 100 μL 10 mg/mL 
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tetracycline and 5 mL 500 mM sodium butyrate. Sodium butyrate has several effects upon 
cells which are useful for protein production in cell culture. Primarily, it inhibits histone 
acetylation, increasing the expression of some genes, and increases yield from these cell lines 
(Davie, 2003; Kruh, 1981). It is essential for efficient production of rhodopsin using the 
tetracycline inducible system (Reeves et al., 2002) They were also fed each day post 
induction with 6 mL 20% (w/v) glucose and 8% (w/v) sodium bicarbonate was added for pH 
balancing, estimated by the colour of phenol red in the media. Cells expressing P23H were 
also supplemented at 2 and 24 hours with 50 μL 100 mM 9-cis retinal to improve expression 
(Noorwez et al., 2004; Saliba et al., 2002). It was also found that without retinal 
supplementation, induced cells in a dish would die (data not shown). Cells supplemented 
with retinal were wrapped in foil, so pH correction was not possible. Cells were grown for 48 
hours before harvesting. 
2.2.1.8: Harvesting of Rhodopsin 
2.2.1.8.1: Preparation of samples in dodecyl maltoside 
Dishes were first washed with 10 mL ice-cold PBS, then 2 mL PBS was added and the cells 
were removed with scrapers. A 5 mL pipette was used to resuspend the cells, which were 
added to a falcon tube on ice. Another 2 mL PBS was used to wash each plate into the falcon 
tube. Tubes were then centrifuged at 4000 rpm for 10 minutes at 4oC in an Eppendorf 
centrifuge with rotor. Supernatant was aspirated and the cell pellet was resuspended in 0.9 
mL PBS per plate. 0.5 μL retinal per plate harvested was added to cell suspension from a 100 
mM stock in absolute ethanol. The tubes were wrapped in foil and agitated for 90 minutes. 
DM was added to cell suspension to 1% from a 10% (w/v) stock. For dishes, DM was added 
to the whole solution after one addition of retinal. 
Cell suspension from spinner flasks was poured directly into 500 mL centrifuge bottles. Each 
flask was rinsed with 2 x 50 mL ice-cold PBS, which was added to the centrifuge bottles. These 
were centrifuged at 4000 rpm for 10 minutes at 4oC in a fiberlite F10BCI-6X500Y rotor. The 
supernatant was discarded and cell pellets resuspended in 25 mL ice-cold PBS and decanted 
into 50 mL falcon tubes. The bottles were washed with 25 mL ice-cold PBS. This was then 
centrifuged at 4000 rpm for 10 minutes at 4oC in an Eppendorf centrifuge. The supernatant 
was discarded and the cells were resuspended in 18 mL ice-cold PBS per flask. In 
solubilisation, each flask was treated as 20 dishes. However, due to the large potential yields 
of rhodopsin from the stable cell lines, after retinal had been added and the sample agitated 
for 90 minutes, a 1 mL aliquot was taken and DM added, and retinal was added to the sample. 
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This was repeated until no further increase in rhodopsin was observed by absorbance 
spectroscopy, then DM was added to the whole sample. 
Once reconstitution and solubilisation were complete, samples were centrifuged at around 
67000 g. For small samples, this was at 35000 rpm in a Beckman TLA100.3 rotor; for larger 
samples, a Beckman 60Ti rotor was used at 25000 rpm. 
2.2.1.8.2: Solubilisation of rhodopsin for LMNG samples 
DM creates a large background signal in NMR which conceals some of the peaks of 
rhodopsin. LMNG creates less of a background, so was used to solubilize rhodopsin for some 
NMR experiments. The efficiency of LMNG solubilisation of rhodopsin was tested using ROS 
suspension as described below. Yields were found to be lower (as shown in section 5.3.1) , 
so LMNG samples were solubilised as above. 
2.2.1.2: Harvesting of rhodopsin from bovine retinae 
10% (w/v) DM stock was added to ROS suspension to 1%, and nutated end over end for 90 
minutes. A difference spectrum (see below) was taken to determine the concentration of 
rhodopsin in the sample and purified as described below. 
When testing the ability of different amphiphiles to solubilise rhodopsin, two 900μL aliquots 
of ROS were used for each. 100 μL 10% (w/v) stock solution of amphiphile was added to each 
and the aliquots were nutated end over end for 90 minutes. The samples were centrifuged 
at 15000 rpm in a Beckman TLA 100.3 rotor, and the supernatant collected. The pellet was 
resuspended in PBS+1% DM and nutated end over end for 90 minutes. This was then pelleted 
at 35000 rpm in the same rotor and the supernatant collected. The rhodopsin content of the 
original supernatant and the pellet’s supernatant were measured by difference spectroscopy 
as described in section 2.2.2.2. 
2.2.1.3: Preparation of 1D4-sepharose beads for rhodopsin purification 
Rhodopsin was purified by affinity chromatography to the 1D4 monoclonal antibody raised 
against the C-terminal nonapeptide of rhodopsin, TETSQVAPA. The antibody was coupled to 
sepharose by the cyanogen bromide method. Cyanogen bromide activated beads were 
weighed out as a powder. Each gram of powder would bind 25-50 mg antibody, and have a 
final volume of 3.5 mL as a slurry. 
The powder was suspended in 1 mM HCl, then washed in 200 mL 1 mM HCl per gram on filter 
paper in a Buchner funnel. The HCl was added in several aliquots, drawn through carefully 
with a vacuum pump and not allowed to dry completely. The antibody was supplied in 0.1 M 
NaHCO3 + 0.5 M NaCl, pH 8.3, and was at a concentration of 3 mg/mL. The ideal concentration 
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of antibody for binding is between 5 and 10 mg/mL. As the antibody concentration was 3 
mg/mL, it was decided that concentrating the antibody would have been inefficient, so the 
antibody was used as supplied. The desired mass of antibody for the mass of powder was 
added to the prepared beads in a stoppered flask or a falcon tube and nutated end over end. 
Each hour, the mixture was centrifuged and an aliquot of the bead-free supernatant was 
taken. The A280 of this aliquot was measured to assess the unbound protein concentration 
using the extinction coefficient of 1.4 Absorbance = 1.0 mg 1D4. Once 96% of antibody had 
been bound, excess ligand was washed away on filter paper on the Buchner funnel using at 
least five bead volumes of coupling buffer. Remaining CNBr groups were blocked by 
transferring the beads to 3.5 mL per gram powder 0.1 M Tris-HCl, pH 8, left to stand overnight 
at room temperature. 
The beads were then washed in 3 cycles of 5 volumes, alternating between 0.1 M acetic 
acid/sodium acetate + 0.5 M NaCl at pH 4 and 0.1 M Tris-HCl + 0.5 M NaCl at pH 8. The beads 
were then transferred to PBS as a 50% slurry. 
The binding capacity of the beads was assessed by taking a sample of rhodopsin of a known 
concentration, then adding enough beads to bind half of that rhodopsin, assuming a bead 
capacity of 1 mg rhodopsin per mL beads. The purification protocol was followed, and the 
fraction of rhodopsin bound measured. If all the rhodopsin in the sample was bound, a 
smaller volume of beads was added and the measurements repeated. 
2.2.1.4: Purification of rhodopsin 
2.2.1.4.1: Binding to beads 
Once the rhodopsin concentration of a sample had been determined by absorbance 
spectroscopy, the volume of bead slurry was added to bind the amount of rhodopsin in the 
sample +10% to ensure all rhodopsin was bound. This was agitated overnight or for more 
than six hours at 4oC. After rhodopsin binding to the beads, the mixture was added to a 
column. For bed volumes over 1 mL, a reusable column was used, and for smaller bed 
volumes, a disposable 10 mL column was used 
2.2.1.4.2: Elution 
The column was washed with 50 column volumes of PBS + 0.05% DM, then, if using NaPi to 
elute, 10 bead volumes of NaPi+0.05% DM. For 10 mL columns, the flow was not controlled, 
and for reusable columns, the flow rate was set between 0.5-1 mL/min. Protein was eluted 
with NaPi + 0.05% DM with 70 μM nonapeptide. For 10 mL columns, five initial elutions of 
500 μL were made. The first elution was done without first incubating, and all subsequent 
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elutions were done after 20 minutes of incubation. For reusable columns, seven initial 
elutions of 4 mL were made with a flow rate of 0.2-0.5 mL/min. Absorbance spectra were 
taken of each fraction and the A500 used to calculate concentration. If the A500 of the last 
elution was over 0.02, further elutions were made. 
2.2.1.4.2.1: Elution of P23H 
Elution of P23H rhodopsin was carried out as above, but NaPi was found to be an ineffective 
buffer for elution, as only small yields of protein were eluted when using NaPi. As a higher 
salt concentration will elute more rhodopsin, NaPi was replaced with PBS. Though this 
increases the elution of misfolded rhodopsin, yields of P23H were prohibitively low when 
using NaPi. 
2.2.1.4.2.2: Elution with LMNG 
Rhodopsin samples in LMNG were first solubilised in DM, then eluted in PBS + 0.01% LMNG. 
NaPi + 0.001% LMNG was found to be ineffective, yielding a low proportion of the rhodopsin 
to which beads had been added. 
2.2.1.5: Concentration of samples for NMR spectroscopy 
 To raise the concentration of eluted samples for NMR spectroscopy, they were concentrated 
using centrifugal filtration units with a cutoff of 30 kDa. Eluted fractions were added 4 mL at 
a time and centrifuged at 4000 rpm, in the dark, initially for 10 minutes. As the concentration 
rose, the concentration of detergent also rose, and the time taken for a given volume of 
solution to clear the column increased, so centrifugation time was increased as necessary. 
Once all the desired rhodopsin was in the filtration unit, the sample was washed with 4x1 mL 
NMR buffer. The sample was resuspended in the final desired volume of NMR buffer and 
transferred to NMR sample tubes. Concentration of rhodopsin and of detergent was 
calculated from their respective quantities in the samples added and the final volume 
achieved. 
2.2.1.6: Production of DNA for transfections 
Top10 E. coli were transformed with pMT4 plasmids containing rhodopsin by heat shock. 1-
2 x 109 cells were mixed with 100 ng DNA in 50 mM Tris-HCl (pH 8). These were placed in a 
42oC water bath for 45 seconds, then cooled on ice for 2 minutes. The mixture was made up 
to 1 mL with SOC media and placed in a shaking incubator at 37oC for 1 hour, then 200 μL 
was spread onto 10 cm plates of LBA ampicillin and incubated at 37oC overnight. Colonies 
were picked and used to inoculate 500 mL LB medium with 100 μg/L ampicillin. This was 
incubated overnight, then used with a Maxiprep kit (Qiagen) to the manufacturer’s 
instructions. 
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2.2.2: Absorbance spectroscopy 
2.2.2.1: Data collection 
The retinal chromophore of both rhodopsin and pSRII absorbs light strongly at ~498nm. This 
is useful for biophysical characterisation of these proteins, as the sample requirements are 
relatively low (rhodopsin samples of 20 μg/mL and below are usable for absorbance 
experiments), and the measurements are quick and relatively simple to perform. The ratio 
of the 500 nm peak and the 280 nm peak from the absorbance of aromatic residues gives an 
idea of the quality of purified samples, as only properly folded rhodopsin has 500 nm 
absorbance. Activation of rhodopsin or denaturation of rhodopsin or pSRII causes a loss of 
500 nm absorbance and a gain in 380 nm absorbance. Though absorbance experiments alone 
cannot deliver precise information about these proteins, the experiments provide some 
insight into the proteins’ tertiary structure. 
Absorbance spectra were recorded on a Perkin-Elmer Lambda 35 spectrophotometer. Most 
spectra were recorded with a scan speed of 480 nm/min, though time courses with fast cycle 
times were recorded with a scan speed of 960 nm/min. Unless specified, all spectra were 
recorded from 650 to 200 nm. Measurements requiring temperature control were made 
using a water jacketed cell holder and a circulating waterbath. For experiments requiring 
side-by-side comparison of time courses, the water jacketed cell holder is capable of 
changing cells without opening the sample chamber. 
Absorbance spectra of the pSRII samples were recorded at the University of Cambridge using 
a UV-1800 spectrophotometer (Shimadzu). Spectra were recorded between 250 and 600 nm 
with a fast scan rate (accumulation time = 0.05 s) and a sampling interval of 1 nm. 
2.2.2.2: Difference spectra 
For samples with high background such as cell lysates, difference spectra were recorded. To 
this effect, a spectrum was taken, the cuvette was illuminated with a Schott KL 1500 cold 
light source with an open aperture and colour temperature set to 3400 K for 60 seconds, 
using a fibre optic accessory. A second spectrum was recorded and the difference in A500 used 
to measure rhodopsin concentration. 
2.2.3: Biochemical assays 
2.2.3.1: Experiments with Ce6 
2.2.3.1.1: Bleaching experiments 
The interaction between Ce6 and rhodopsin, it is claimed, causes an increase in the bleaching 
of rhodopsin at 500 nm when illuminated with red light. To test this, samples of rhodopsin 
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mixed with different concentrations of Ce6 were illuminated with light shone through a 
longpass filter (a filter which allows light with a longer wavelength than its cutoff to pass 
through). The rates of bleaching at 500 nm after the subtraction of the Ce6 in the spectrum 
were used to establish whether an increase could be observed. 
Rhodopsin in 2 mM sodium phosphate pH6, 0.05% DM was diluted to 400 μL at ~1 μM, and 
a spectrum recorded from 750 to 250 nm. Ce6 was added from 100 mM stock, or a dilution 
thereof, in DMSO so the volume added was between 1 and 4 μL, at the final concentrations 
indicated. The same protocol was followed adding 4 μL DMSO alone to obtain a baseline. An 
initial spectrum was recorded. The cuvette was illuminated with a Schott KL 1500 light source 
with an open aperture set to 2900 K through a fibre-optic accessory and a 630 nm long-pass 
filter (HV Skan) for 30 seconds, then another spectrum recorded. This was repeated until the 
sample had been illuminated for five minutes. For two samples, to confirm no bleaching was 
due to ambient light, the same procedure was followed, but covering the end of the fibre-
optic, and no bleaching occurred. 
After five minutes of red illumination, the 630 nm filter was exchanged for a 495 nm filter 
and the light source was set to 3400 K, and the sample illuminated for 60 seconds for full 
bleaching of rhodopsin. 
Ce6 was added to the same buffer, omitting rhodopsin, from a DMSO stock as above. Such 
samples were diluted with buffer, illuminated as above, or had SDS added to 3 and 0.5% 
(w/v). The sample in 3% SDS was also diluted with buffer to test the effects of reducing SDS 
concentration. 
Samples either diluted or illuminated were fitted as a multiplication of the original spectrum 
(details in section 2.3 below). The diluted spectra were recorded to ensure that the fitting 
protocol was appropriate to test the linear response of recorded spectra to reduced Ce6 
concentration. These spectra, after multiplication by the fitted value, matched the original 
spectra very precisely (data in Chapter 3), so residuals fitting an illuminated spectrum to the 
original arise from uneven bleaching as discussed in results. The same procedure was 
followed when diluting SDS treated samples with buffer, and assumed to be valid for the 
same reasons. 
2.2.3.1.2: Dark noise experiments to test stability of rhodopsin with Ce6  
To ensure that only the light shone through the longpass filter was causing bleaching of 
rhodopsin when mixed with Ce6, rhodopsin was diluted and Ce6 added as for bleaching 
experiments. The cuvettes were in a water jacketed cell holder with the water set to the 
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desired temperature. Spectra were recorded every 20 minutes for 420 minutes. A final 
difference spectrum was obtained to determine the exact concentration of rhodopsin. 
Remaining rhodopsin over time was plotted as a fraction of the difference between the first 
spectrum and the illuminated spectrum. 
2.2.3.1.3: Reconstitution of rhodopsin with 14-fluororetinal 
Rhodopsin was reconstituted with 9-cis-14-fluororetinal to introduce a 19F label in retinal for 
NMR studies. The reconstitution protocol was designed to allow for the reaction to take place 
in an NMR sample tube so it could be followed by NMR spectroscopy. A rhodopsin spectrum 
was measured, the cuvette was illuminated with the Schott KL 1500 cold light source as 
described, and a second spectrum was taken. Fluororetinal was initially added so that the 
absorbance at 380 nm was roughly equal to the difference in A500 brought about by 
illumination, though, later, multiples of this value were added. It was added from a stock in 
absolute ethanol made so that this addition was between 1 and 10 μL. Time courses of 
spectra were taken of this reaction to follow the kinetics and final yield. These were assessed 
using the A523 rather than the A500, in agreement with published values for the λmax of 
fluororhodopsin. The cuvettes were held in a water jacketed cell holder with temperatures 
set as indicated. When Ce6 was added, a mixture of Ce6 from a stock in DMSO as described 
above, and retinal in ethanol was made and added in place of the retinal. 
2.2.3.2: PDS labelling of rhodopsin 
Accessible cysteines in P23H rhodopsin were labelled by reaction with PDS. Rhodopsin in 
NaPi, pH 6 + 0.05% DM was diluted to 1.5 μM. PDS was added to the same buffer to 37.5 μM 
from a 0.1 M stock in ethanol. 300 μL PDS in buffer was made up to 400 μL with buffer in the 
reference cuvette, and with 1.5 μM rhodopsin (final rhodopsin 0.5 μM) in the sample 
cuvette. Time courses of spectra were recorded to follow the reaction at 20oC 
2.2.3.3: MTSL labelling of rhodopsin 
Rhodopsin was derivatized with S-(1-oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-
yl)methyl methanesulfonothioate (MTSL) to label specific cysteines with a nitroxide spin 
label, which increases the relaxation of magnetization in NMR experiments. Through this it 
was hoped that distances between methionines and cysteines could be used to assign peaks 
in an NMR spectrum (see section 1.1.4.1 for discussion of relaxation and section 5.3.3 for the 
rationale behind MTSL labelling). 
Accessible cysteines in rhodopsin were labelled with MTSL for the paramagnetic relaxation 
enhancement effects upon its NMR spectrum. The protocol for MTSL labelling (Resek et al., 
1993) was adapted in two ways for different desired results. The first adaptation was to scale 
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up the labelling from ~200 μg to ~4 mg. This adaptation was based on the scaling up of 4-
PDS labelling (Hwa et al., 1999) from 500 μg to 10 mg rhodopsin, as both protocols are used 
to label free cysteines. From the small to the large quantities of rhodopsin, there is a five-
fold increase in rhodopsin concentration (and a change in volume) and a ten-fold increase in 
4-PDS concentration. As the existing protocol for labelling small amounts of rhodopsin with 
MTSL used a 1:42.02 ratio of rhodopsin:MTSL, the new protocol used ~84.04 MTSL per 
rhodopsin. 
Total beads containing 2 mg rhodopsin were then incubated with spin label (200 μM in 10 
mL 5 mM MES). After 3 hours reaction at RT, the resin was washed with 30 bed volumes (24 
mL) of 5 mM MES. 
The second adaptation was also for a large-scale labelling, but attempting to label one of the 
two accessible cysteines, and without labelling on the column. The excess was reduced to 
10X MTSL for this protocol, but was otherwise unchanged. 
2.2.3.4: SDS denaturation 
For both pSRII and bovine rhodopsin, SDS was added to denature the protein. A 30% (w/v) 
stock of SDS was made up in their respective buffers, and kept in a 25oC water bath to keep 
the SDS from precipitating. SDS was added to the cuvette in the dark to the desired 
concentration and mixed end over end. The time of addition was noted, and a time course 
of spectra was recorded to follow the unfolding reaction. Notes on the decomposition of 
spectra can be found in sections 2.3.2.1 and 4.3.2. 
SDS denaturation with hydroxylamine 
pSRII was denatured as with SDS above, but hydroxylamine hydrochloride (Sigma Aldrich) 
was added to 10 mM. 
2.2.3.5: PNGase F treatment 
Recombinant rhodopsin displays heterogeneous glycosylation, the pattern of which differs 
in some ADRP mutants (Kaushal et al., 1994). PNGase F is an effective and non-specific 
enzyme which removes N-linked glycosylation. By treating rhodopsin and ADRP mutants with 
PNGase F, the sources of different weights of bands in western blots was examined. 
The concentrations of WT and N15S and P23H mutant rhodopsin samples were determined 
by absorbance spectroscopy, and diluted to match concentrations. PNGase F treatment was 
carried out according to manufacturer’s instructions. 
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2.2.3.6: Western blots 
Acrylamide gels were prepared with the stacking gel at 4% and the resolving gel at 10%. 
PNGase F treated rhodopsin samples were mixed with Laemmli buffer (Laemmli, 1970) and 
added to sample wells, along with a marker lane. A voltage of 5-10 V/cm gel was applied for 
around 10 minutes until the dye front reached the resolving gel, then a voltage of 120 V 
applied until the dye front neared the end of the gel. 
The gel was equilibrated in ice cold transfer buffer with two sponges and Whatman paper. A 
polyvinylidene fluoride membrane (Thermo scientific) was wetted in methanol for 30 
seconds, then incubated in transfer buffer. These were assembled into a sandwich and 
clipped into a gel holder cassette. This was placed into an electrode assembly and a buffer 
tank, which was then filled with transfer buffer. A current of 250 mA was applied for 70 
minutes at 4oC. 
The membrane was incubated in blocking solution for 1 hour at room temperature, and in a 
solution of the 1D4 antibody, raised against the C-terminal nonapeptide of rhodopsin, 
overnight at 4oC. The antibody solution was recovered for up to 3 times of reuse and the 
membrane washed in TBS-T three times for 20 minutes each, then twice in distilled water for 
20 minutes. A solution of anti-mouse antibody (to detect the bound 1D4 antibody) was 
added. The antibody is joined to horseradish peroxidase, which stains purple when 4-chloro-
1-naphthol and hydrogen peroxide is added in the developing solution. The developing 
solution was added and development allowed for ~3 minutes, then washed with tap water. 
2.2.4: NMR of rhodopsin 
2.2.4.1: 1- and 2D NMR of 13C, 15N-methionine rhodopsin 
All protein samples containing [13C5, 15N]methionine rhodopsin were placed in Shigemi NMR 
tubes. 1D 1H NMR spectra were measured using a Bruker Avance DRX800 equipped with a 5 
mm TXI CryoProbe (HCN/z). 1D 1H spectra were recorded with 512 complex data points 
(acquisition time = 1 s). Water suppression is achieved using a 3-9-19 WATERGATE sequence 
in combination with gradient pulses.  
2D {1H, 13C} HMQC spectra were measured using either the Bruker AvanceIII AV600 
spectrometer with 512 × 76 complex data points (t1,max = 25.2 ms) or the Bruker Avance 
DRX800 with 512 × 100 data points (t1,max = 25.0 ms). All spectra were recorded with 256 
scans unless indicated otherwise. 
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2.2.4.2: NMR of rhodopsin reconstituted with 14-fluororetinal 
A sample of rhodopsin in NaPi buffer with ~1% DM (depending on the original volume 
concentrated into an NMR sample) was diluted into two 300 μL volumes of ~47.6 μM in 
Eppendorf tubes. The samples were reconstituted with a five-fold excess of 14-fluororetinal 
as described above, keeping the samples in a 4oC waterbath for 50 minutes, as the yield 
reached its maximum by this time in previous attempts. One sample was reconstituted in the 
presence of 10-fold excess Ce6. The samples were transferred to Shigemi tubes (Sigma 
Aldrich). 
1D 19F NMR spectra were measured using a Bruker AvanceIII AV600 spectrometer equipped 
with a 5 mm QCI CryoProbe (HCNF/z). All 19F NMR chemical shifts were referenced to CFCl3 
(trichloro-fluoro-methane) as external standard. All spectra were recorded with 4997 
complex data points (acquisition time = 1 s) and without broadband proton decoupling. 
Comparison against spectra recorded with broadband proton decoupling showed no 
differences (data not shown). Water suppression was achieved using a 3-9-19 WATERGATE 
sequence in combination with gradient pulses.  
2.2.5: pSRII biophysical experiments 
2.2.5.1: Collection of fluorescence timecourses of pSRII unfolding 
Fluorescence spectra were measured at 25 °C using a LS55 fluorescence spectrometer 
(Perkin Elmer) (excitation slit: 5.0 nm, emission slit: 17.5 nm). Excitation was at 295 nm, and 
emission was measured at 335 nm and an integration time of 3 s. The typical experimental 
dead-time was 25 s. 
2.2.5.2: Collection of circular dichroism timecourses of pSRII unfolding 
Circular dichroism (CD) in the far UV reflects changes in secondary structure of a protein. 
Ellipticity of pSRII samples was recorded at fixed wavelengths of 222 nm, the wavelength at 
which maximum signal for helix content is found, at 30-second intervals for 2 hours, using an 
Aviv 410 spectrometer (Aviv Biomedical Inc.) and a 1×1 mm cuvette. The typical experimental 
dead-time was 1 min. 
2.3: Data Analysis 
All data analysis was performed in R (R Core Team, 2015), and non-linear least squares fitting 
performed with the minpack.lm package (Elzhov et al., 2016) unless otherwise stated. 
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2.3.1: Conservation of rhodopsin 
2.3.1.1: Selection of residues for analysis 
2.3.1.1.1: G-protein binding 
To probe the interference of Ce6 with the G-protein binding, the conservation of relevant 
residues was investigated. Candidate residues were selected using the G-protein bound 
crystal structure of β2 adrenergic receptor (β2AR). All residues within 5 Å of any G-protein 
subunit were candidates for analysis. The β2AR primary sequence was aligned against B. 
Taurus rhodopsin using clustal ω (Noorwez et al., 2004; Saliba et al., 2002). 29 of the 33 
candidates aligned with rhodopsin. 
2.3.1.1.2: Ce6 binding 
A putative Ce6 binding site was identified with docking in (Woods et al., 2017). These 
residues were used as the Ce6 binding site. 
2.3.1.1.3: Retinal binding 
Using the 1L9H rhodopsin crystal structure, all residues within 5Å of retinal were selected. 
2.3.1.2: ConSurf 
The sequence of bovine rhodopsin was submitted to the ConSurf server, and set to search 
the “clean Uniprot” database with default settings to collect 150 sequences that sample the 
list of homologues. The resulting multiple sequence alignment (MSA) was downloaded and 
the partial rhodopsin sequence from M. niger was added and aligned to the MSA using clustal 
ω. This was resubmitted to the ConSurf server. Part of ConSurf’s output capability is an 
annotation of the original uploaded sequence indicating the relative conservation at each 
position which can be used to colour the PyMol model of the protein. This was used to colour 
the G-protein interface of bovine rhodopsin (1L9H) with the colour-blind friendly colour key. 
2.3.1.3: Conservation plots 
The 151 sequence MSA from ConSurf was imported into R, as well as the ConSurf output. R 
scripts were written so that plots could be made indicating the percentage identity to the 
most common residue for specific positions, and how specific sequences compared with the 
consensus at these positions. The consensus sequence used is the most common residue 
letter code found at that position. The average conservation of the consensus is calculated 
as the mean of the count of this code divided by the total number of sequences with a read 
at this position. 
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When referring to specific positions, the user specifies a reference sequence within the set 
and positions in that sequence. In these results, the B. taurus sequence was used as a 
reference, but in future any sequence within the alignment could be used. The script 
removes any gaps in the reference sequence caused by alignment and retrieves the positions 
specified as they are in the potentially gappy alignment. The user also specifies a set of 
sequences to compare with the reference and the consensus. These are entered as strings 
which must match a sequence name in the alignment, which the script uses to retrieve the 
letter codes (or gaps) at the specified positions, counts the instances of that code at that 
position and divides that count by the total sequences to deliver a fraction. The fraction of 
sequences matching consensus are plotted as a grey bar of width matching the number of 
query sequences. The fraction of sequences matching the query sequences are then plotted 
as coloured bars on top. The mean fraction matching the consensus is plotted as a dotted 
line across the plot. 
The residues at the query positions are also displayed as a table underneath the bars. The 
possible combinations of matches/mismatches are calculated and a colour palette with that 
many colours is generated and assigned to the possibilities. If all sequences match the 
consensus, no colour is produced. Cells with mismatches in any sequence are coloured 
accordingly, e.g. if the first sequence matches but a second does not, one colour is used; and 
if the first does not match but the second does, another colour is used etc. 
2.3.2: Unfolding kinetics 
2.3.2.1: Absorbance 
2.3.2.1.1: Consecutive reactions 
Individual spectra of unfolding time points were imported as comma separated values (csv) 
files and compiled into a matrix, with each spectrum making up a column. The first column 
of this matrix is the wavelengths of recorded values. A second matrix of guesses for 
parameters (extinction coefficient, width and centre for peaks as described in 4.3.2) for each 
of the peaks is provided by the user. To further define the model, a Boolean value for 
whether a scattering baseline should be added is provided, as well as a numerical vector 
defining which rows of the matrix of guesses refer to peaks which remain static throughout 
(in all examples, a single peak for the 280nm absorbance). Further information about the 
sample is supplied by the user as a numerical vector of the times for each spectrum in 
minutes, numerical values for the concentrations of pSRII and SDS, a numerical value for the 
wavelength cutoff (used early on when terms for the scattering and static peaks were not 
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included and maintained in later versions for completeness), and a numerical value for the 
repeat, as experiments were performed in triplicate. 
If any static peaks were included in the model, the first spectrum is fit by NLS as the sum of 
all peaks in the initial guesses. A function within the script generates models for any number 
of peaks, with or without a baseline as defined by the user. The fitted values for the static 
peaks are recorded. If a wavelength cutoff is supplied by the user, rows of the matrix of 
spectra with wavelengths below this value are discarded. 
The fitting model used for the time course is then defined. The mixed kinetic/Gaussian terms 
are augmented with the scattering and static terms as required, yielding a formula like 
equation 7 in chapter 4. The rationale for mixing kinetic and peak fitting terms is also 
explored in chapter 4. 
The matrix of spectra is then unfolded into a three-column matrix in which the first column 
is the vector of wavelengths of recorded values, taken from the original matrix, repeated as 
many times as there are timepoints; the second is the time of recording each value, requiring 
each value is repeated as many times as there are recorded wavelengths. The last column is 
the corresponding absorbance value recorded at each timepoint and wavelength. This matrix 
is fitted to the model, using the supplied guesses as starting parameters. Limits are applied 
so that no peak can be negative and that no peak’s centre will fall outside the recorded 
spectrum. 
Once fitting has taken place, the data and fitted peaks can be plotted. The plot area is divided 
in two, the left for the absorbance spectrum, and the right for the progress of the reaction. 
Each plot is for a single time point. The spectrum for that time point is plotted as points first, 
with the y-axis limits fixed to the minimum and maximum absorbance for the whole data set 
so that all plots are scaled the same. A line for the predictions of the total model is then 
plotted as a dashed line, followed by coloured curves for the scattering baseline and each of 
the fitted peaks, then the residual for that timepoint is plotted as a finely dotted line. The 
right side has axes plotted between 0 and 1 in the y-axis and 0 to the last timepoint recorded 
in the x axis. Fitted curves for the relative concentrations of the three components described 
in the kinetic model (chapter 4) are plotted with colours corresponding to their curves in the 
fitting on the left side. A dotted line is added, indicating the time. 
The script returns the fitting as an NLS object, the fitted coefficients in a separate list for ease 
of access, and can optionally output plots either as a .pdf (useful for producing vector 
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graphics which can be separated and rescaled freely) or a .jpg (useful for producing 
animations).  
2.3.2.1.2: Single reaction 
Refolding pSRII and pSRII unfolded in the presence of hydroxylamine were modelled as single 
reactions between native pSRII and free retinal as described in chapter 4. Spectra were 
imported as for the consecutive reactions. Each spectrum was fitted to a model combining a 
scattering contribution, a static protein peak and the retinal contributions. These 
contributions were divided into the native profile and free retinal as described in chapter 4. 
A function fitting the data to this model is applied to each column of the matrix. The 
amplitudes of the retinal peaks in these fits are put in one column of a data frame, and the 
multiplier of the native profile (“B” in the model) in the other. The data frame is fit to 
equation 13 in chapter 4, as the two should account for all retinal present. As one increases, 
the other will decrease, but by how much is unknown. By fitting the two to a constant, this 
ratio can be calculated. A data frame containing the concentrations at each timepoint, as 
calculated from this, is constructed, with another column containing the time points. The 
concentration of free retinal is fitted to an exponential growth decay model. The function 
returns a list containing the data frame of concentrations, the fitted models for all spectra, 
the concentration fitting, and a figure for the fraction of pSRII permanently unfolded. This is 
estimated by taking the asymptote (“C” in the model, chapter 4, equation 15) and dividing it 
by the total concentration of the sample, supplied by the user. 
Optionally, similar plots to those for consecutive reactions can be returned. 
2.3.2.2: Fluorescence and Circular dichroism 
The changes in fluorescence emission at 340nm and in molar residue ellipticity (MRE) at 
222nm for unfolding pSRII were tracked over time. The data were imported into R as two 
column matrices, one column for time and the other for the recorded value. The minimum 
recorded value for a timecourse was subtracted from the second column (rationale can be 
found in chapter 4). Initial parameters were not user supplied but found using a self-starting 
algorithm. This assumes the data follows a single exponential growth curve with an 
amplitude A, meaning the maximum recorded value can be used as a starting parameter for 
A. The rate constant of an exponential decay is approximated by 
ln⁡(2)
𝑡1/2
, where t1/2 is the half-
life. The recorded value closest to half of the maximum was used for the half-life. 
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The data is then fitted to an exponential growth decay curve as described in chapter 4. The 
self-starting algorithm is then applied to the residual. The fitted values and the guesses for 
the residual are used as starting parameters for a double exponential model as described in 
chapter 4. A third column is added to the matrix which shows only the user supplied 
concentration for pSRII in the sample. If the second fitting is successful, the fitted values are 
used (with the amplitudes divided by the concentration) to fit a combination of kinetic terms 
described in chapter 4, which can also be expressed as a superposition of two exponential 
growth decay curves: 
𝐹𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒⁡~⁡[𝐴]0 (
𝑘1
𝑘2 − 𝑘1
(𝑒−𝑘1𝑡 − 𝑒−𝑘2𝑡))
+ [𝐴]0 (1 +
1
𝑘1 − 𝑘2
(𝑘2𝑒
−𝑘1𝑡 − 𝑘1𝑒
−𝑘2𝑡)) 
Bracket out [A]0 
𝐹𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒⁡~⁡[𝐴]0((
𝑘1
𝑘2 − 𝑘1
(𝑒−𝑘1𝑡 − 𝑒−𝑘2𝑡))
+ (1 +
1
𝑘1 − 𝑘2
(𝑘2𝑒
−𝑘1𝑡 − 𝑘1𝑒
−𝑘2𝑡))) 
Remove inner brackets 
𝐹𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒⁡~⁡[𝐴]0 (
𝑘1
𝑘2 − 𝑘1
(𝑒−𝑘1𝑡 − 𝑒−𝑘2𝑡) + 1 +
1
𝑘1 − 𝑘2
(𝑘2𝑒
−𝑘1𝑡 − 𝑘1𝑒
−𝑘2𝑡)) 
Expand brackets 
𝐹𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒⁡~⁡[𝐴]0 (
𝑘1
𝑘2 − 𝑘1
𝑒−𝑘1𝑡 −
𝑘1
𝑘2 − 𝑘1
𝑒−𝑘2𝑡 + 1 +
𝑘2
𝑘1 − 𝑘2
𝑒−𝑘1𝑡
−
𝑘1
𝑘1 − 𝑘2
𝑒−𝑘2𝑡) 
Collect terms 
𝐹𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒⁡~⁡[𝐴]0 (1 +
𝑘1
𝑘2 − 𝑘1
𝑒−𝑘1𝑡 +
𝑘2
𝑘1 − 𝑘2
𝑒−𝑘1𝑡 −
𝑘1
𝑘1 − 𝑘2
𝑒−𝑘2𝑡
−
𝑘1
𝑘2 − 𝑘1
𝑒−𝑘2𝑡) 
Bracket out exponentials 
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𝐹𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒⁡~⁡[𝐴]0 (1 + (
𝑘1
𝑘2 − 𝑘1
+
𝑘2
𝑘1 − 𝑘2
)𝑒−𝑘1𝑡 − (
𝑘1
𝑘1 − 𝑘2
−
𝑘1
𝑘2 − 𝑘1
)𝑒−𝑘2𝑡) 
Expand 
𝐹𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒⁡~⁡[𝐴]0 + [𝐴]0 (
𝑘1
𝑘2 − 𝑘1
+
𝑘2
𝑘1 − 𝑘2
) 𝑒−𝑘1𝑡 − [𝐴]0(
𝑘1
𝑘1 − 𝑘2
−
𝑘1
𝑘2 − 𝑘1
)𝑒−𝑘2𝑡 
The LM algorithm for fitting is tolerant enough of poor starting parameters that no other 
conversion has been necessary to use the parameters for the two-curve model for fitting the 
kinetic model. 
At this point, the single exponential model is compared with the kinetic model to test which 
is more appropriate. When using Akaike’s “An Information criterion” (AIC), functions built 
into base R are sufficient. The fitting with the lower AIC is used. 
Packages in R do exist allowing cross validation, but the process is simple enough that 10-
fold cross-validation was written directly into the script. Briefly, the data is trimmed to be 
divisible into ten evenly, removing random data. An additional column is added, placing the 
numbers one to ten randomly an equal number of times in this column. This divides the data 
into ten “folds”. For each fold, the procedure is as follows: each fold is used as a test set. All 
other folds are the training set. The training set is used as the data for fitting to the model 
under examination. The predicted values for each value in the test set are calculated and the 
residual sum of squares between the predicted and actual values for the test set are 
recorded. Once this has been performed on all folds, the mean residual sum of squares for 
that model is calculated. This is performed on both the single exponential and kinetic models. 
The model with the lowest mean residual sum of squares is selected as the preferred model. 
The data and the fitted values of the preferred model are then plotted with the residual. 
2.3.3: Automatic peak picking 
A common method of smoothing data is to calculate each point as a moving average of some 
window to either side of that point. However, if too broad a window is used, the spectrum 
becomes distorted, especially at peaks. While this is not desirable in displaying data, or 
making calculations, it does act as a discriminant of peaks. 
A vector of the length of the original data minus the averaging window side was filled with 
the average of the window size from the same position in the original data. A disadvantage 
of using a large averaging window is that a region the size of half the window is lost from 
either end of the spectrum, so any peaks within this window will not be estimated in the 
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early stages. The smoothed values were subtracted from the original values from half the 
window into the data until half the window from the end to reflect this. 
When using the oversmoothing strategy, an issue is that, because it works by averaging, half 
of the points are negative (chapter 4, figure 4b). This means that although small peaks 
register, they are not necessarily even local maxima. In image analysis there is a class of filters 
called geometrical filters, which simulate the reaction of some shape to features in the data. 
A useful background subtraction can be achieved by the rolling ball filter (Sternberg, 1983), 
which establishes a background accessible by an imaginary ball being rolled over a surface of 
the intensity values in an image. A rolling disc filter for two dimensions was written for the 
difference between the oversmoothed and original data, which rolls a disc along the bottom 
of the spectrum and brings the points the disc touches to zero, making all peaks local maxima 
between zeroes (Chapter 4, figure 4b (II)). 
The filter calculates the point at which an imaginary circle touches the data at every point. 
As the data are discrete, this is actually half of an imaginary regular polygon with a vertex at 
each value of x within the radius chosen by the user. The difference in y between the centre 
of the polygon and each vertex is calculated. For each value of the data within the radius of 
the point in question, the centre of the polygon as it would touch this point is calculated. The 
lowest of these values is equivalent to where the imaginary disc would touch the data, and 
recorded as the baseline of the filter. The filter requires the radius of the circle and a scaling 
factor between the values of the x and y values. This baseline is subtracted from the data, 
pushing all values above or equal to zero. 
After the rolling disc has been applied, a list is made of all regions above zero, recording the 
width of the region and the location of the local maximum. This is achieved by listing all the 
places where the filtered data is zero, then recording the mean and difference between 
values. The value of the original spectrum at that local maximum is added to the list (chapter 
4, figure 4a). These values are used as starting parameters for the next stage. 
This stage refines the peaks. For each peak, a region of the original spectrum two widths 
wide around the centre is fitted, using the parameters from the previous stage. This region 
is fitted to a Gaussian peak using the previous stage to provide guesses. The predicted values 
from this fitting are subtracted from the whole spectrum. 
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To ensure no peaks are missed, fitting is carried out until all residual values have an absolute 
value less than a predefined threshold, currently set arbitrarily by the user. The areas of the 
refined peaks are calculated and used as rankings for the next stage. 
Fits are made to the whole dataset, adding peaks in order of their area. As each peak is 
added, the AIC between the model with and without that peak is made. This is repeated until 
model selection indicates that further peaks are extraneous.  
2.3.4: Image analysis 
NMR spectra were unfolded in the MatNMR toolbox for MatLab by collaborators at 
Cambridge, and exported as matrices which were opened in R. The 151x97 matrices were 
then exported as 97x151 images (Figure 4.15) with the 1H data along the x axis and the 15N 
data along the y axis to resemble the standard display of NMR spectra. Each pixel of the 
image represents the intensity of the spectrum at that point. 
To identify features in this image, BLOB (Binary Large Object) detection was implemented. 
This is a relatively simple object recognition technique in image analysis. Pixels of interest in 
the image are separated by some criterion from the background and grouped into objects 
by a filter. In this implementation, the discriminant was  threshold on intensity applied, 
where all values below the threshold are false, and all above it are true (chapter 4, figure 9b). 
The threshold is supplied as a fraction of 1 by the user. Continuous areas of true values are 
labelled as a blob. Blobs are assumed to be roughly circular and the centre and radius are 
recorded (chapter 4, figure 9c). This method is somewhat vulnerable to picking up noise, so 
all blobs with a radius smaller than a threshold can be filtered out. With the low resolution 
of the bucketed spectra used this was of limited use, but higher resolution spectra may 
benefit from such a filter. 
2.3.5: Decomposition of Ce6 + rhodopsin spectra 
Spectra of Ce6 and rhodopsin mixtures were imported from csv files and collated into 
matrices as for pSRII unfolding time courses. The first spectrum was a pure rhodopsin 
spectrum, and the second an unilluminated rhodopsin/Ce6 mixture, for which the volume of 
Ce6 added had been recorded. The change in rhodopsin concentration from volume change 
was corrected by multiplying the initial spectrum by 400/(400+Vchlorin). The chlorin 
contribution was calculated by subtracting the initial spectrum from the second and was 
appended to the matrix. 
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A vector of the ratios of the 664nm value of each of the original Ce6/rhodopsin spectra was 
divided by the 664nm value in the extracted chlorin spectrum. To each of these spectra, a 
function was applied which subtracted the chlorin spectrum multiplied by the relevant value 
from the ratio vector. This accounted for the chlorin contribution after any bleaching, 
assuming uniform bleaching over all wavelengths. The shortcomings of this approach are 
discussed in chapter 3. 
The A500 values for each of these chlorin-subtracted spectra were stored in a vector, along 
with the 660nm value for the first spectrum containing Ce6. The change in A500 was fitted to 
an exponential decay model, and the rate constant was plotted against the concentration as 
estimated by using the 660nm value and an extinction coefficient of 59000 (Oseroff et al., 
1986). 
2.3.6: Decomposition of Western blot data 
The pixel density across lanes was extracted using imageJ (Schneider et al., 2012). To ensure 
the lanes were aligned in later stages, a pure white line was drawn across the top of each 
blot. The csv files produced were imported into R, and any values found outside the two 
values reading 255 (the maximum for 8-bit greyscale) were discarded. The values were then 
inverted so 0 became 255, 1 became 245 etc. and scaled between 0 and 1. The peaks caused 
by the ladder were automatically picked using a Savitzky-Golay filter to estimate the second 
derivative (Savitzky and Golay, 1964). This operation was performed, then the local minima 
within a user defined window were found, and ranked by magnitude. The user supplied a 
vector of the ladder molecular weights (MW), and the top n (where n is the length of this 
vector) local minima were assigned as the ladder positions. 
A linear regression was performed on the log-values of the pixel position of each peak against 
the log-values of the theoretical MW. This regression was used to estimate a MW for each 
pixel value of blot profiles. 
Four blots were prepared in this way and collated for analysis. As the acquired images had 
regions in which the signal was saturated, each band was assumed, in the pixel density 
profile, to have a normal distribution. The lanes were separated into a list of matrices in 
which the first column is MW and the second intensity at that position. Any row where 
intensity was greater than 0.95 was removed so all values above 95% density for each lane 
were discarded as saturated. For most blots, the profile above 50 kDa was largely discarded 
in this way, so further analysis was limited to the region between 20 and 50 kDa. The 
background signal was then corrected for by using the rolling disc filter as described for 
62 
 
automatic peak picking above. Gaussian peaks were then fitted by non-linear least squares 
to the remaining data, and the peak centres (in kDa) and share of the total area occupied by 
each was recorded. Boxplots summarising this information were constructed, with band 
centre in the y-axis and relative width of boxes representing fraction of total area occupied. 
2.3.7: PDS time courses with P23H 
The reaction of 4-PDS with cysteine results in a peak centred at 323nm. To follow this 
reaction and the bleaching observed with P23H, the spectra were decomposed into a 
scattering baseline, a protein peak at 280nm, a 323nm peak for 4-PD, a 380nm peak for 
retinal, and 500nm peak for P23H. Unlike for SDS unfolding, this reaction had no explicit 
kinetic model, so this could not be used to use the entire dataset to decide on peak 
parameters. Instead, each spectrum was fitted separately, and the parameters (amplitude, 
centre and width) of the peaks over time were plotted. As the area of the rhodopsin peak 
decreases significantly within the first few minutes, the fitted centre and width for the initial 
spectrum was taken and fixed as the centre and width of that peak and other parameters 
were allowed to vary. The parameters of the other peaks were plotted, and the timepoints 
for which the centres and widths were stable were judged by eye. The means of these 
parameters were taken and fixed. The amplitudes were allowed to vary, and these were 
taken as the absorbances of the different species present. 
The centre of the P23H rhodopsin peak was found to be at 476nm, similar to previously 
published values for P23H (Noorwez et al., 2004). The extinction coefficient of this was 
assumed to be the same as WT rhodopsin’s at 500nm. The ε323 of 4-PD is 19000 cm-1M-1, and 
was used to calculate the concentration of 4-PD at a given time. This was divided by the 
concentration of rhodopsin present to find the number of cysteines reacted. This was fitted 
to a single exponential decay curve and a superposition of two exponential decay curves, and 
the AIC was used to compare the models of labelling kinetics.  
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CHAPTER 3: RHODOPSIN AND VISION 
3.1: Summary 
Chlorin e6 (Ce6) has been shown to enhance bleaching of rhodopsin by far-red illumination 
by an unknown mechanism, which indicates a possible role for chlorophyll derivatives found 
in the eyes of dragonfish . Previous characterization of this enhancement has made no 
allowance for the bleaching of Ce6 itself, and has left the mechanism unclear. To address this 
gap, systematic bleaching experiments have been carried out, which, coupled with effective 
decomposition methods, have allowed accurate analysis of the kinetics and spectral features 
of rhodopsin bleaching enhancement by Ce6. The effects are shown to increase with greater 
Ce6 concentration, and to be strictly light dependent. The subtraction method used enables 
the examination of higher ratios of Ce6:rhodopsin. The G-protein binding activity of bovine 
rhodopsin is inhibited by the addition of Ce6, so the conservation of the G-protein binding 
and putative Ce6 binding sites were investigated using the ConSurf server, and new 
visualisations of sequence comparisons for specific residues for selected species within a 
larger dataset were devised. The binding sites were found to be highly conserved both across 
the dataset and between bovine and M. niger rhodopsins. To probe specific interactions 
between retinal and Ce6, rhodopsin was reconstituted with 14-fluororetinal, and an in-
cuvette reconstitution protocol optimised for 19F NMR. The addition of Ce6 to 
fluororhodopsin made no significant differences to the retinal environment as detected by 
NMR. 
3.2: Introduction 
Porphyrins absorb strongly both in the UV and visible to near infrared (Figure 3.1a). Their 
spectra arise from the 18-electron aromatic system in the macrocycle of four joined pyrrole 
units (Gouterman, 1961). Peaks arising from transitions in this system can be divided into the 
strongly allowed transitions of the B-band around 400 nm and the weakly allowed transitions 
in the Q-band from 480-700 nm. The transitions leading to the Q-band are “forbidden” 
transitions in porphyrins, but are weakly allowed by molecular vibrations in the macrocycle. 
Chlorins are porphyrins in which one of the pyrrole rings has been reduced. This forces 
asymmetries upon the macrocycle, making the orbitals involved separate in energy, unlike 
their degeneracy in porphyrins. This increases the intensity of the peaks of the Q-band, and 
makes the furthest red transition more intense than the others. This makes chlorins appear 
dark green, unlike the red or magenta common in porphyrins. Further modifications are 
made to spectra by substitutions at different positions around the macrocycle, and 
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modifications making the core of the 
macrocycle more symmetrical, such as 
coordination of a metal ion or protonation, 
simplify the Q-band.  
Previous biochemical investigation of 
enhancement of red light bleaching of 
rhodopsin has been limited (Ilyas Washington 
et al., 2004; Washington et al., 2007). Peaks of 
the Q-band of Ce6 overlap with rhodopsin’s 
retinal peak, and the B-band overlaps the 
absorbance of free retinal. Ce6 itself bleaches 
a small but significant amount upon 
illumination, and Ce6’s absorbance is stronger 
than rhodopsin’s at the same concentration, so 
when Ce6 is added to a rhodopsin sample at 
increasing concentrations its bleaching can 
dominate changes in spectra. The goal of this 
work was to adapt methods described for 
decomposition of absorbance spectra used to 
determine unfolding kinetics in pSRII (Chapter 
4) and determine whether they could better 
define the effects of Ce6 on rhodopsin by 
separating their contributions to absorbance. 
Ce6 seems to also inhibit the interaction 
between rhodopsin and its G-protein (Eric 
Gardner, Kalyan Tirupula and Judith Klein-
Seetharaman, unpublished results). 
 
               
 
 
 
 
  
 
 
 
 
  
 
  
  
               
 
  
 
 
  
 
 
  
 
Soret band 
Q-band 
Figure 3.1: Spectra of chlorin e6 (Ce6) a) An example 
spectrum of Ce6, showing the Soret or B-band and 
the peaks of the Q-band. As the B-band is much more 
intense than the peaks of the Q-band, the output has 
been truncated. b) An absorbance spectrum of 
chlorin was taken, then the sample diluted with NaPi 
buffer. The spectrum of the diluted sample was fitted 
as a multiplication of the original spectrum and the 
original and diluted spectra match. c) The same fitting 
procedure was followed after bleaching instead of 
dilution and mismatches can be seen in the residual, 
especially around 400 and 665nm 
a 
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3.3: Results  
3.3.1: Conservation of Chlorin binding domain 
3.3.1.1: ConSurf analysis of putative binding site 
Chlorin binds in the cytoplasmic domain of rhodopsin (Woods et al., 2017). To better 
understand the potential functional significance of this finding, we conducted conservation 
analysis. Figure 3.2a shows the 1L9H structure of bovine rhodopsin coloured according to 
the relative conservation of residues. The Ce6 binding site from (Woods et al., 2017) is shown 
as a surface, and shows that, though some residues around the periphery of the binding site 
are poorly conserved, this region is highly conserved across a wide range of species.  
 
  
 
 
 
  
  
       
            
            
               
 
  
 
 
 
  
  
 
  
  
  
  
   
         
          
                      
                 
                            
                            
                            
Figure 3.2: Consurf analysis: Interspecies conservation of putative Ce6 binding residues: (a) The 
1L9H structure of rhodopsin coloured with the ConSurf scores. The Ce6 binding pocket identified 
by docking is represented as a surface, the rest in cartoon representation. (b) Conservation plots 
comparing 3 rhodopsin sequences with the consensus for 150 species with M. niger added. 
Residues identified for Ce6 binding, as described in methods. 
a 
b 
66 
 
3.3.1.2: Conservation plots 
Though the ConSurf coloured structure is useful to represent the relative conservation of 
residues, it does not show where M. niger is identical to mammalian rhodopsin. For this 
purpose, plots were devised to compare the same sites in different organisms to one another 
and the consensus sequence. 
The MSA from ConSurf analysis was exported as a text file and imported into R. Scripts were 
written to compare any given sequence to the rest of the sequences at a given position. 
Building on this, a script was designed to graphically represent these comparisons. Examples 
are shown in Figure 3.2b and Figure 3.3. The percentage of sequences matching each 
sequence compared at the positions queried is shown as a coloured bar superimposed on a 
grey bar showing the percentage of sequences matching the most common residue at that 
position. Below the bars, a table shows the residues at the queried positions for each 
 
  
 
 
 
  
  
       
            
            
               
 
  
  
  
  
   
         
          
                      
                 
                               
                               
                               
 
  
 
 
 
  
  
       
            
            
               
 
  
 
 
 
  
  
 
  
  
  
  
   
         
          
                      
                 
                      
                      
                      
Figure 3.3: Conservation of other binding sites in rhodopsin. Plotted as in Figure 3.2b for (a) G 
protein and (b) retinal binding sites, as identified in methods 
67 
 
sequence compared. Coloured columns in this table represent which of the compared 
sequences agree with consensus. Positions corresponding to predicted Ce6 and G-protein 
binding sites were compared between B. taurus, M. niger, and Aristostomias tittmanni (A. 
tittmanni), a species within the same family (Stomiidae) as M. niger which was part of the 
original ConSurf MSA. 
Rhodopsin is well conserved, especially in key residues identified as being of interest for Ce6. 
B. taurus and M. niger rhodopsins are identical for most residues in the putative Ce6 binding 
site (Figure 3.2b) and are also identical with the consensus sequence of 151 species. In seven 
positions, the sequences of both A. tittmanni and M. niger show gaps. This is not due to the 
MSA carried out, but only partial sequences being available for alignment. One potentially 
significant difference is the substitution of alanine for proline at position 71 in both A. 
tittmanni and M. niger. The proline is fairly well conserved at 78% across the dataset, and 
the secondary amine group has unique structural characteristics. P71 is found at the 
interface between cytoplasmic loop 1 and helix II. The N-terminus of an α-helix is a common 
position for prolines (Kim and Kang, 1999), and it is unlikely that the structure breaking 
characteristics of proline are in effect here. 
31 residues were used to represent transducin (Gt) binding as described in section 2.3.1.1. 
Of these, seven had below average conservation (Figure 3.3a). Nine residues displayed a 
mismatch between the query sequences and consensus. All but two of these had below 
average conservation, one of these being P71. The other was M253. Though this residue is 
almost universally conserved in this dataset, it has been chosen in the past for labelled with 
azido groups specifically because it has no reported functional interactions (Ye et al., 2010). 
There is significant overlap between Ce6 and Gt binding sites, so it is possible to explain the 
conservation of the Ce6 binding site without a selection pressure maintaining Ce6 binding. 
However, the aim here was simply to show that the binding site does not differ and that 
conclusions about Ce6 binding based on bovine rhodopsin were transferable. 
The retinal binding residues are less well conserved (Figure 3.3b) because the dataset 
includes differently tuned opsins. Five of the 22 residues are of below average conservation, 
but the query sequences agree with the consensus here. Three positions have a degree of 
mismatch, though F208 only mismatches due to a misread. The other two positions, S186 
and F261 are replaced by A and Y in the fish respectively. Modifications to the 261 position 
result in a red spectral shift (Yokoyama et al., 1995), and specifically the F261A mutation is 
known to reduce Gt activation (Han et al., 1996) and affect early photolysis events (Jäger et 
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al., 1997). S186 is known as a spectral tuning residue (Sekharan et al., 2013; Yokoyama et al., 
2007) and important for the internal hydrogen bonding network of rhodopsin (Okada et al., 
2002), though it should be noted the other residues important for this network are 
conserved between B. taurus and the fishes. 
Overall, the conservation of the residues relevant for the interaction between Ce6 and 
rhodopsin is high. Differences between B. taurus and M. niger specifically are minor and 
seem unlikely to have any functional relevance. The differences in the retinal binding pockets 
between these species are consistent with a red-shifted absorbance. 
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Figure 3.4: Absorbance spectroscopy. (a) 
Absorbance spectra of Rhodopsin bleaching 
by 630nm light in the presence of Ce6. (I): 
Raw spectra with chlorin added to half the 
concentration of rhodopsin. The initial 
Rhodopsin spectrum was multiplied by the 
dilution factor from adding Ce6 and 
subtracted from the spectrum with chlorin 
added to obtain a spectrum for the Ce6 
contribution. Between each subsequent 
spectrum, the sample was illuminated through 
a 630nm long-pass filter for 30 seconds. A 
spectrum was taken after exposure to the 
room’s ambient light to ensure all bleaching 
was caused by the light source. 
(II): Subtraction of the Ce6 contribution from 
the bleaching time course. The Ce6 
contribution was calculated by multiplying the 
reference spectrum acquired by subtraction 
by the ratio between the A665 of the reference 
and that timepoint. The dashed line running 
through 500nm is shown to indicate that 
without the Ce6 contribution the rhodopsin 
spectrum is not altered. The black line shows 
the initial spectrum. The green line in a(I) 
shows the first spectrum with chlorin added. 
Spectra at 60, 120 and 300 seconds are shown 
as blue, red, and purple lines respectively. (b) 
Enhancement of bleaching rates by chlorin. 
Remaining rhodopsin was estimated using the 
A
500
 of chlorin subtracted spectra. These were 
normalised between the initial spectrum and 
the 495nm bleached spectrum to calculate the 
extent of bleaching, and single exponential 
decay curves were fitted to the timepoints to 
estimate rate constants. Chlorin concentration 
was estimated using the A
664
 of the initial Ce6 
spectrum, and rhodopsin from the range of 
A500 values. Rates are shown relative to the 
rate of bleaching with DMSO alone. (c)Dark 
noise in the presence of chlorin. Rhodopsin 
was kept at the temperatures indicated in the 
presence and absence of ~5X chlorin. Chlorin’s 
contribution was subtracted as described, and 
the dark noise estimated using the A500 at each 
timepoint. Similar results to 37
o
C were 
observed at 25
o
C but omitted for clarity. 
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3.3.2: Bleaching experiments 
To investigate the effects of Ce6 upon the red sensitivity of rhodopsin, mixtures of rhodopsin 
and Ce6 were illuminated with light with wavelengths below 630 nm filtered out for 30 
seconds at a time and measured after each illumination. After five minutes of illumination 
total, the sample was illuminated through a 495 nm filter. Normally rhodopsin is not reactive 
to the red light through the 630 nm filter but will be quickly bleached by the light through 
the 495 nm filter. 
3.3.2.1: Ce6 subtraction method 
To properly assess the effects of Ce6 upon rhodopsin bleaching, a protocol to subtract Ce6’s 
spectrum from the overall spectrum was devised. It is difficult to reliably add equal Ce6 to 
both the reference and sample cuvette, and previous investigations simply ignored any 
changes to Ce6. With high relative concentrations of Ce6, any changes in the rhodopsin 
sequence will be bleached by small changes in the Ce6 spectrum, so the decomposition 
method made mixtures with high Ce6 accessible to analysis, while making it possible to 
analyse the kinetics of rhodopsin bleaching separately from any Ce6 changes. 
To decompose spectra, an initial, rhodopsin only, spectrum was measured. Then a known 
volume of Ce6 stock was added, and a spectrum measured. The initial spectrum was 
corrected for the change in rhodopsin concentration and this spectrum was subtracted from 
the second to isolate the Ce6 contribution. The 664 nm peak was unaffected by rhodopsin, 
so this spectrum was multiplied by the ratio of the A664 for any mixed spectrum to the 
calculated Ce6 spectrum to subtract its contribution and account for its bleaching. Generally, 
this successfully yielded normal looking rhodopsin spectra (Figure 3.4a II), with small 
amounts of deviation in the far red, and increased noise around 400nm, presumably due to 
the high absorbance of chlorin in that range. 
3.3.2.2: Ambient light 
To check that the bleaching of rhodopsin in the presence of Ce6 was solely due to 
illumination with the filtered light, samples at 1 and 0.5:1 Ce6 were treated as illuminated 
samples, but with the fibre optic covered (Figure 3.5a). This was to check both that ambient 
light, such as unfiltered light from the light source, was not interfering and that no light-
independent effects of Ce6 were relevant on the experimental timescale. At the lower Ce6 
concentration there is no discernible difference between before and after 30 seconds of 
ambient light. At 1:1 Ce6, there is some small amount of change in the spectrum resembling 
increased scattering, but rhodopsin seems stable. 
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3.3.2.3: Addition of DMSO 
Adding Ce6 involves introducing small amounts of DMSO to the sample. Most of the samples 
had <1% DMSO added, so to control for any DMSO effects, DMSO was added to a final 
concentration of 1% (w/v) and the bleaching protocol followed. This rate was used as the 0 
Ce6 rate when comparing with Ce6 samples for this reason. 
3.3.2.4: Addition of chlorin 
Using the ratio of A664 between spectra in a timecourse to judge the chlorin spectrum to 
subtract performed well, with the caveats described above. There is a small amount of 
deviation in the Q band around 665 nm, but the contributions in the rhodopsin relevant 
regions from 650-350nm are well controlled. A more time-consuming option here would 
have been to have decomposed the spectra into the individual chlorin and rhodopsin peaks, 
but significant optimisation would be required as the Soret peak, which overlaps with the (in 
some cases much) smaller 380 nm retinal peak is skewed. The gains in accuracy measuring 
the rhodopsin peak would have been marginal however.  
 
               
 
 
 
 
  
 
 
 
 
  
 
  
  
 
  
 
 
 
  
 
 
 
  
 
 
               
               
 
 
 
 
  
 
 
 
 
  
 
  
  
 
  
 
 
  
 
 
  
 
 
  
 
               
         
 
  
 
  
 
 
  
 
 
 
  
  
 
              
 
  
 
  
 
  
        
        
        
      
      
                 
 
  
 
  
 
 
  
 
  
  
 
  
  
 
  
  
 
  
 
    
 
  
 
  
 
  
 
  
 
  
Figure 3.5: Other aspects of analysis of the bleaching of Rhodopsin in the presence of Ce6. a) Bleaching 
without illumination to test the effects of ambient light on rhodopsin with I) 0.5:1 and II) 1:1 Ce6:rhodopsin. 
Spectra before (black) and after (blue) exposure to ambient light are shown, though the spectra are similar, 
and the first spectrum is not visible in I. The difference between the two is shown as a dashed line. b) Example 
timecourses of bleaching of rhodopsin in the presence of Ce6 with illustrative fitting curves. c) Bleaching of 
the 665nm peak of Ce6 after five minutes in the presence of rhodopsin. 
a 
b c 
I II 
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The bleaching of Ce6 alone is not uniform, with some peaks bleaching more than others, as 
can be seen in Figure 3.1c. This can be seen in contrast with the linear response across 
wavelengths to dilution in Figure 3.1b. The differences caused by bleaching could account 
for the deviations in spectra after Ce6 subtraction, as the subtraction was necessarily 
performed using an unbleached spectrum. This is a minor effect and is unlikely to significantly 
affect the later analysis after decomposition of spectra. If some greater sensitivity was 
required, exploring the nature of the uneven bleaching might provide an alternative to peak-
by-peak decomposition of the spectra.  
There is a definite effect of relative chlorin concentration on the bleaching of rhodopsin 
illuminated with wavelengths beyond 630 nm. As shown in figure 3.4b, the trend is an 
increased rate of bleaching with greater Ce6 concentration, rising to a maximum of ~4 times 
greater than DMSO alone. The effect was not reliable, with great variability between samples 
at roughly the same concentration. Figure 3.4b shows all the rates collected, which have not 
been averaged as there was variance from the intended concentration of Ce6 added. 
There is some evidence that the bleaching of chlorin is itself affected by mixing with 
rhodopsin. Figure 3.5c shows that a great difference in the relative concentration of chlorin 
to rhodopsin causes changes in the chlorin bleaching after five minutes, but the effect is 
variable and may not be observed after protocol improvements. 
3.3.2.5: Dark noise with Ce6 
The method for subtracting the Ce6 contribution to rhodopsin absorbance spectra in the 
dark and in the light developed above opened the door to previously inaccessible 
investigations of the interaction between rhodopsin and Ce6 by absorbance spectroscopy. It 
removes changes in the spectrum due to changes in Ce6 and allows the observation of 
rhodopsin in a strong Ce6 background. Because earlier studies had found that rhodopsin is 
more stable as measured by circular dichroism in the presence of Ce6 (Fernanda Balem et 
al., 2009) a stabilization of tertiary structure and retinal protein interactions was possible. 
On the other hand, cone opsins sensitive to red light are more prone to dark noise than 
rhodopsin and the other cone opsins (Luo et al., 2011), so another possibility was that dark 
noise of rhodopsin in the presence of Ce6 might be increased because its interaction leads 
to higher sensitivity to red light. Thus, it was possible that Ce6 might either stabilize or 
destabilize rhodopsin. To test for thermal activation, or dark noise, of rhodopsin, the 
bleaching effects of Ce6 in the dark were measured as for bleaching by red light. As shown 
in figure 3.4c, the dark noise at least does not increase upon addition of Ce6 at 37oC. Similar 
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results were observed at 25oC (data not shown). At 42oC, the loss of chromophore may be 
slightly slowed by addition of Ce6, though the difference is small and replication has not been 
attempted.  
3.3.3: Chlorin and SDS 
3.3.3.1: Chlorin SDS sensitivity 
Another way of assessing protein stability is by quantifying its sensitivity to denaturation by 
SDS. Rhodopsin is often suspended in DM (Ramon et al., 2003), but can be denatured without 
aggregation by mixing with SDS (Dutta et al., 2010a). While assessing whether Ce6 affects 
the unfolding of rhodopsin by SDS, it was found that Ce6’s absorbance spectrum is sensitive 
to SDS, which complicates analysis. The B-band is red-shifted by SDS, and the 665nm peak of 
               
 
 
 
 
  
 
 
 
 
  
 
  
  
               
 
  
 
  
 
  
 
  
      
      
               
 
 
 
 
  
 
 
 
 
  
 
  
  
               
 
  
 
 
  
 
 
  
 
      
        
      
         
        
        
 
 
 
 
  
 
 
 
 
  
 
  
  
 
  
 
 
  
 
 
  
 
      
                
         
 
 
 
 
  
 
 
 
 
  
 
  
  
 
  
 
 
  
 
 
  
 
         
               
 
 
 
 
  
 
 
 
 
  
 
  
  
 
  
 
 
  
 
 
  
 
               
Figure 3.6: Chlorin and SDS a) Comparison of Ce6 spectra in the presence of (I) 3% and (II) 0.5% SDS (w/v) 
with SDS-free spectra. In (II), measurements were taken before and after addition of SDS, and the 0.5% SDS 
spectrum is corrected for volume. In (III) the spectrum of Ce6 in 0.5% SDS was modelled as a combination 
of Ce6 spectra in 0 and 2% SDS. The Ce6 spectrum at 0.5% SDS was the sum of 0.62 times the same 
concentration of Ce6 at 2% SDS, and 0.30 times the same concentration of Ce6 at 0% SDS. b) Comparison of 
rhodopsin unfolding by 3% SDS in the presence of Ce6 at (I) 5 minutes, (II) 40 minutes, and (III) 75 minutes. 
Spectra with chlorin added (red line) have had the chlorin contribution subtracted as described for bleaching 
experiments. 
a b 
I 
III 
II 
I 
III 
II 
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the Q-band is modified. With SDS, this peak seems to divide into two peaks, one around 
640nm and another around 670. The effect seems to increase with more SDS (Figure 3.6a) 
up to 2% SDS but does not then change up to 3% SDS (data not shown). The intermediate 
concentration of 0.5% SDS can be modelled as a mixture of Ce6 spectra at 0 and 2% SDS. The 
relative intensity of the Q-bands to the B-band is also reduced, as can be seen in figure 3.6a 
I, where the major Q-band peaks are at around the same intensity, but the B-band peak is 
much higher with 3% SDS.  When subtracting the contribution of Ce6 from rhodopsin 
experiments including SDS differences must be considered, and a fresh chlorin spectrum 
must be obtained, as previously acquired spectra will not be a good fit. 
3.3.3.2: Chlorin and SDS with rhodopsin 
The unfolding of rhodopsin by 3% SDS in the presence and absence of Ce6 was monitored by 
absorbance spectroscopy. The Ce6 contribution was subtracted from relevant spectra, and 
spectra compared. Figure 3.6b shows that there is little difference between spectra across 
time points between the two. There is some additional absorbance in the Ce6 spectrum, 
despite the rhodopsin concentration being the same in both samples, but as the λmax is the 
same with and without chlorin (after subtraction of the Ce6 spectrum), it seems likely this is 
due to scattering. 
3.3.4: 19F NMR 
One previously proposed hypothesis for the mechanism of red light sensitization of 
rhodopsin by Ce6 was through direct energy transfer (Ilyas Washington et al., 2004). Direct 
energy transfer from Ce6 to retinal would require proximity, and binding within ~10Å 
(Kvíčalová et al., 2016). Binding so close to the retinal pocket might be expected to affect the 
environment of retinal, and thus the NMR spectrum of rhodopsin reconstituted with a 
fluorinated derivative of retinal, so 19F NMR spectroscopy was used to compare the 
environment of 14-fluoro-9-cis-retinal bound to rhodopsin in the presence and absence of 
Ce6. 
3.3.4.1: Reconstitution 
14-fluororetinal has previously been used to reconstitute rhodopsin (Colmenares, 1991; 
Steinberg et al., 1993). First, retinal was added in the dark prior to illumination, but the yield 
of reconstitution was negligible, as shown in figure 3.7a (I), which shows spectra of mixtures 
of rhodopsin and fluororetinal before and after illumination, including a spectrum taken after 
12 hours.  Adding fluororetinal after illumination raised yield to 25.1%, so further 
reconstitution was carried out in this way. Initially, fluororetinal was added so the change in 
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A380 was equal to the A500 of the original sample, with the aim of rhodopsin and fluororetinal 
being equimolar. When this failed to reconstitute most rhodopsin, excesses of fluororetinal 
were added. Adding 5X excess fluororetinal raises yield to 29.3% at 20oC (Figure 3.7a II). 
Rhodopsin solubilised in DM, though equally stable in its dark-adapted state compared with 
native lipid, is less stable in Meta II, with an increase in Meta III formation (Ramon et al., 
2003). To further increase yield, the temperature of reconstitution was reduced, and it was 
found that carrying out the reconstitution at 4oC increases yield to 42.5% (Figure 3.7a III). 
The decrease in temperature decreases the loss of reconstituting material to aggregation of 
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Figure 3.7: (a) Reconstitution of rhodopsin with 9-
cis-14-fluororetinal: (I) Reconstitution of 
rhodopsin with 14-fluororetinal. 14-fluororetinal 
was added (solid black line), then the sample 
illuminated through a 495nm filter (solid grey line). 
Reconstitution was <10% of original concentration 
(dashed black line). (II) Fraction of bleached 
rhodopsin reconstituted over time measured by 
the increase in A523 relative to the A500 difference 
between dark adapted and light-activated 
rhodopsin. Comparison of efficiency 
between equimolar (triangles) and 5-fold excess (circles) 14-fluororetinal. (III): Fraction of bleached 
rhodopsin reconstituted over time measured by the increase in A523 relative to the A500 difference 
between dark adapted and light-activated rhodopsin. At 20
o
C (triangles) yield is 29.3%, at 4
o
C (circles), 
42.5%. (IV) Comparison of A523 change between samples with (triangles) and without added Ce6 
(circles). Addition of Ce6 and retinal at the same time complicates spectra too much to compare light 
activated spectrum, so time points are compared with the 2 minute measurement. (b) Bleaching of 
fluororhodopsin with red light monitored with absorbance spectroscopy as with rhodopsin. The 
wavelength measured was 523nm rather than 500nm, as the fluorinated chromophore has a maximum 
at this wavelength. The enhancement of bleaching rate is 3.92-fold 
b 
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opsin (Lewis et al., 1997; Sudhoelter et al., 1982). Maximum yield was achieved within ~30 
minutes. 
Previous experiments reconstituting rhodopsin with 14-fluororetinal have had a reported 
efficiency of 70-100% (Steinberg et al., 1993). However, these reconstitutions were carried 
out on rod outer segment (ROS) suspension rather than detergent solubilised rhodopsin. It 
was also treated with NH2OH, which rapidly reacts with the Schiff base to remove retinal, 
followed by extensive washing steps. The loss of yield may then have to be accepted as the 
price of reconstitution in situ. 
Adding chlorin 
Ce6 was added with fluororetinal during reconstitution at 4oC. As reconstitution efficiency is 
reduced the longer the time between illumination and addition of retinal, both Ce6 and 
fluororetinal were added at the same time, so the differences introduced by adding them 
are complex: a mix of Ce6, free retinal and whatever quantity of rhodopsin was reconstituted 
in the dead time. For this reason, the reconstitution with and without chlorin were compared 
from two minutes onwards (figure 3.7a IV) and decomposition was not attempted. The 
fractions reconstituted from this timepoint were very similar, so it was assumed that Ce6 has 
no effect on reconstitution. 
19
F Chemical shift [ppm] 
Rhodopsin
-bound 
9-cis-14-fluororetinal 
9-cis-10-fluororetinal 
9-cis-10,14-difluororetinal 
19
F Chemical shift [ppm] 
Figure 3.8: 
19
F NMR spectra of rhodopsin reconstituted with fluorinated retinal. 
1D 19F NMR of 150 µM [13C5, 15N]methionine 9-cis-14-fluororhodopsin in DDM, in 
the absence (magenta; 54318 scans; rg = 912) or presence (blue; 60110 scans; rg = 
912) of chlorin e6, and 150 µM 9-cis-14-fluororetinal in 1.33% DDM in the absence 
of chlorin e6 (black; 50176 scans; rg = 256). All spectra were processed with line 
broadening of 80 Hz. The 
19
F chemical shift of rhodopsin-bound 9-cis-14-
fluororetinal is -123.76 ppm, with linewidths of 1.92 ppm and 1.75 ppm in the 
absence and presence of Ce6, respectively. Other peaks correspond to recorded 
values  for free 9-cis retinal (Colmenares, 1991) with fluorines at positions 10 (-119.6 
ppm), 10 and 14 (-128.5 ppm), and 14 (-131.7 ppm). a) shows the region containing 
the Rhodopsin-bound peak in the recorded spectra in b) 
a b 
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Chlorin’s ability to photosensitize fluororhodopsin was tested as above, and 3.92 fold 
enhancement was measured with 29.4:1 Ce6:rhodopsin (Figure 3.7b). 
3.3.4.2: NMR spectra 
The 19F NMR spectra of rhodopsin carrying the fluorinated retinal in the presence and 
absence of Ce6 are shown in Figure 3.8. There are four peaks present in these spectra (Figure 
3.8b). The retinal peak at -123.76 ppm is essentially unaffected by Ce6 binding (Figure 3.8a), 
supporting the conclusion that Ce6 most likely does not bind near the retinal, and nor does 
it induce major structural changes that lead to perturbation of the retinal environment. The 
peak at -128.5ppm present in fluororhodopsin spectra is not found in the fluororetinal 
spectrum and is found at different intensities between spectra with and without chlorin. 
There are also differences in intensities between the peaks at -119.7 and -131.7. The -119.7, 
-128.5 and -131.7 peaks are similar to peaks reported for 9-cis-10-fluororetinal, 9-cis-10,14-
difluororetinal and 9-cis-14-fluororetinal respectively (Leticia U. Colmenares et al., 1996). 
The apparent increase in retinal analogues other than 9-cis-fluororetinal in the absence of 
chlorin is surprising, as the same aliquot of fluororetinal was divided in two and added to 
each sample. Despite the apparent variation of the composition of free retinal in the sample, 
the broad peak of fluororetinal bound to rhodopsin is the same between samples, showing 
that any influence of Ce6 on rhodopsin does not affect the chemical environment of retinal. 
3.4: Discussion 
G protein conservation analysis. Prior work has suggested that binding of Ce6 to rhodopsin 
inhibits G protein activation (Gardner, Tirupula, Yanamala and Klein-Seetharaman, 
unpublished results). If the sequence of dragonfish rhodopsin had been significantly different 
in the region binding Ce6, it could be proposed that these differences could reconcile the 
fact that bovine rhodopsin’s G-protein activation is compromised by Ce6 binding and an 
increase in signal in dragonfish. Analysis of a broad swathe of species’ rhodopsins show that 
this region (as much of it is part of the G-protein binding site), is well conserved. Most of the 
residues are identical, though some are missing from the sequence, so this would benefit 
from a fuller sequencing of M. niger. This similarity shows that such an argument cannot be 
made. Other considerations are described below. 
Red light sensitivity enhancement. The development of a subtraction method able to 
separate Ce6 and rhodopsin spectra has made higher ratios of Ce6 to rhodopsin accessible 
to experiment and has provided two conclusions. The first is to show that Ce6 enhances 
bleaching by red light in a dependent fashion. The variability between rate increases is so far 
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unexplained. The effect had also not saturated at the concentrations used. Ce6 binding to 
rhodopsin is in the micromolar range (around 8 μM, unpublished data), so much greater 
enhancement might be achievable by higher Ce6:rhodopsin ratios. Previous analysis did not 
separate Ce6 and rhodopsin bleaching, and has called Ce6 “unbleachable”. This can be seen 
not to be true, as the spectra of Ce6 alone will show bleaching. Whether or not this is truly 
affected by the presence of rhodopsin is uncertain, as it does not vary strictly with 
rhodopsin:chlorin ratio. It is possible that, upon further examination, this effect may be 
simply dependent on the concentration of Ce6 itself, and perhaps the singlet oxygen 
produced by Ce6 excitation reacts with other Ce6 molecules, producing the observed 
bleaching. The rhodopsin bleaching rate enhancement can still be observed in the rhodopsin 
spectra with Ce6 subtracted. The subtraction method is not necessary to make this 
conclusion, but the concentrations of chlorin accessible to experiment are increased. 
However, the poor reproducibility of the experiment itself is a limiting factor here. The 
second conclusion is to show that rhodopsin’s spectrum is not affected by Ce6 binding, as 
the bleaching, once the Ce6 contribution has been removed, proceeds as expected for 
rhodopsin: with a bleaching peak at 500nm, and an increasing peak at 380nm. That the 
retinal binding pocket is not directly affected by Ce6 is backed up by the lack of differences 
between 19F NMR spectra of fluororhodopsin with and without Ce6. 
If the in vivo sensitivity enhancement effects of Ce6 are moderate, it is possible that the 
stabilization of rhodopsin by Ce6 extends to reduction of dark noise, thus increasing 
signal:noise ratios. By lowering overall G-protein activation, it may yet increase red 
sensitivity through a combination of this effect and increasing the proportion of rhodopsin 
activations caused by red light. The adaptations of deep-sea fish eyes often show a pattern 
of sacrificing overall photon gathering capability in favour of greater discrimination as 
discussed in the introduction. Some dark noise reduction can tentatively be observed in 
samples with Ce6 added, though the data have not been replicated. 
The additional stability conferred upon rhodopsin by Ce6 does not extend to SDS 
denaturation, which appears to proceed as normal. This data would need replication to draw 
a proper conclusion, but as this was the null hypothesis of the experiment, the line of enquiry 
was not pursued. 
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CHAPTER 4: ESTABLISHMENT OF PSRII AS AN EXPERIMENTAL MODEL 
SYSTEM FOR UNFOLDING 
4.1: Summary 
Previous theoretical considerations had indicated the unfolding of Natronomonas pharaonis 
sensory rhodopsin II (pSRII) may have similarities to both that of mammalian rhodopsin (MR) 
and bacteriorhodopsin (bR). The unfolding of pSRII by SDS was therefore monitored for the 
first time experimentally by UV/Vis absorbance spectroscopy, fluorescence emission at 
335nm, circular dichroism and NMR spectroscopy. The circular dichroism data revealed a 
single first order process in the small loss of secondary structure. The absorbance and 
fluorescence data held information about the kinetics and physical characteristics of the 
tertiary structure changes which allowed the construction of a model of pSRII unfolding. 
Kinetics models were combined with existing knowledge of the interactions of retinal with 
retinal binding proteins to derive kinetic and photophysical parameters for this model across 
SDS concentrations. 
Reversing this unfolding by dilution of SDS with 1,2-diheptanoyl-sn-glycero-3-
phosphocholine (c7-DHPC) was observable by absorbance spectroscopy over minutes and 
hours, timescales amenable to similar analysis. The rate and extent of this refolding were 
useful for extending the model of unfolding to include reversible and irreversible unfolding. 
Peaks of the NMR spectra recorded of pSRII unfolded in different concentrations of SDS 
display changes in chemical shift and peak intensity as a function of SDS concentration. The 
overall intensity of spectra decreases with higher SDS, so fewer peaks can be distinguished 
from the noise. Principal components analysis has been previously used to interpret NMR 
spectra and was applied here to the chemical shifts of assigned peaks. Physical 
interpretations of PCA distinguished two opposing patterns in the data with increasing SDS, 
and their implications for the folding mechanisms of pSRII are discussed. An additional 
intended purpose of this PCA was to add values for missing peaks in NMR spectra and predict 
where peaks going below the noise threshold at high SDS concentrations are expected. 
However, the low proportion of values remaining in the dataset made predictions inaccurate, 
so attempts to use image analysis techniques were made for this purpose with a dataset with 
limited resolution, showing that similar approaches may be useful for tracking signals across 
spectra in different conditions.  
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4.2: Introduction 
4.2.1: Unfolding of MR by SDS 
As discussed in section 1.1.2, MR folding is not adequately explained by the two-stage 
hypothesis. Ideally, the folding of MR would be explored with the refolding of the protein 
after unfolding, but the refolding of MR from unfolded states has not been possible. 
Examination of the unfolded states of proteins has been useful in the investigation of protein 
folding, as the remaining interactions in the residual structure of the unfolded state are 
indicative of interactions stabilizing the native structure in folded protein (Judith Klein-
Seetharaman et al., 2002). For this reason, a range of denaturants were tested for their 
ability to unfold MR and keep it stable in unfolded states (Dutta et al., 2010b). Though 
sodium dodecyl sulphate (SDS) was not the most effective denaturant as determined by loss 
of secondary structure, unlike the other denaturants, the unfolded states did not aggregate, 
so SDS was used to characterize unfolded states of MR solubilised in DM (Dutta et al., 2010a). 
The unfolded states were then explored by absorbance spectroscopy, which showed the 
rapid loss of retinal-protein contacts at low concentrations of SDS, followed by the hydrolysis 
of the Schiff base covalently linking retinal to opsin. There was also loss of the quenching of 
the fluorescence of the five intrinsic tryptophans by retinal, indicating loosening of the helical 
bundle. These tryptophans are in close contact with retinal in the native structure. This data, 
with other biophysical techniques, indicated the formation of unfolded states with different 
characteristics dependent on the geometry of SDS micelles. 
This work was followed up with NMR and electron paramagnetic resonance (EPR) 
spectroscopy of unfolded states of MR, demonstrating differences between the dynamics of 
the cytoplasmic domain when compared with the transmembrane and extracellular 
domains. For further discussion, see the introduction to chapter 5.  
4.2.2: Least squares fitting 
Physical data can be fitted to a mathematical model by the method of least squares, first 
used by the French mathematician Legendre (Merriman, 1877), and to track the asteroid 
Ceres as it passed behind the sun by the German mathematician Carl Friedrich Gauss (Stigler, 
1981). A model for the data is formulated from knowledge of the system’s behaviour, and 
least squares fitting chooses values for the model’s parameters that minimise the squares of 
the residual error between the model and the data. For most models formed of a linear 
combination of parameters, a unique solution can be found, but for non-linear models, 
parameters are estimated by iterative refinement. The iterative nature of non-linear least 
squares (NLS) fitting means that the algorithms used will find a local minimum for residuals, 
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but not necessarily the global minimum. This becomes more important as the number of 
parameters increases. For the optimization of the parameters, initial estimates must be 
supplied, and as the likelihood of not finding the global minimum increases, the importance 
of good initial estimates increases. Poor estimates for complex models will result in finding 
a poor solution or not finding a minimum at all. Initial guesses very far from any minimum 
will not have any nearby estimates offering any improvement, and the fitting will not start. 
The Gauss-Newton algorithm is commonly used for NLS problems, but this method is not 
robust against poor guesses. The Levenberg-Marquardt (LM) algorithm alternates between 
the Gauss-Newton algorithm and another method, the method of gradient descent, which 
makes it more robust (Marquardt, 1963). This makes it especially useful when attempting to 
automate fitting, as guesses supplied by algorithm may be poorer than those on a case-by-
case basis. 
There are many software programs capable of deconvoluting absorbance spectra by using 
NLS to fit the spectra to a model. For maximum control over fitting and for incorporation of 
kinetic models, scripts using the minpack.LM (Elzhov et al., 2016) package for R (R Core Team, 
2015) were written for the purpose. 
4.3: Methods development 
The retinal chromophore makes a serendipitous tertiary structure reporter, but the 
overlapping absorbance peaks produced by the conformational states of unfolding pSRII and 
the single-dimensional nature of the fluorescence emissions measured over time pose 
challenges for analysis of the experimental data. However, non-linear least squares fitting, 
when combined with photophysical knowledge of the system for absorbance data and model 
selection methods for fluorescence data respectively allows the separation of consecutive 
reactions in the unfolding of pSRII, as described in detail in this chapter. For descriptions of 
methods used, refer to section 2.3.  
4.3.1: Kinetics derivation 
All SDS denaturation experiments were measured as a function of time. For a first order 
reaction 𝐴
𝑘
→𝐵, the rate law for [A] is that 
−𝛿[𝐴]
𝛿𝑡
= 𝑘[𝐴]. This rate law can be integrated to 
ln[𝐴]0 = ln[𝐴]0 − 𝑘𝑡 and rearranged as [𝐴]𝑡 = [𝐴]0𝑒
−𝑘𝑡 to find [A] at a given time. 
For two consecutive first order reactions, 𝐴
𝑘1
→𝐵
𝑘2
→ 𝐶, the rate law for A is unchanged, but 
the rate law for B depends on both rate constants (k1 and k2) and the concentration of A, 
such that 
𝛿[𝐵]
𝛿𝑡
= 𝑘1[𝐴] − 𝑘2[𝐵] . C depends on the concentration of B and k2, so the rate law 
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is 
𝛿[𝐶]
𝛿𝑡
= 𝑘2[𝐵]. The differentiation of these rate 
laws is more complicated but can be found in 
many physical chemistry textbooks (Atkins et 
al., 2014).  
In this case, species A is the folded protein, in 
which retinal is covalently bound to the protein 
by a Schiff base linkage to a lysine, and native 
contacts between retinal and the protein are 
maintained. In species B, the specific native 
contacts have been lost, but the covalent 
linkage remains, though the Schiff base has 
been protonated. Species C represents free 
retinal after the Schiff base has been 
hydrolysed. The ways these species can be 
distinguished by both absorbance and 
fluorescence are discussed below, and 
summarised in Figure 4.1. 
The derivation of these equations from the rate 
laws by differentiation means that the reactions 
can be modelled as: 
         
         
         
• Folded 
• Absorbs at 500 nm 
• Trytophan fluorescence 
quenched by retinal 
• Native contacts between 
retinal and protein 
• Schiff base 
• Unfolded 
• Absorbs at 380 nm 
• Trytophan fluorescence not 
quenched by retinal 
• Native contacts between 
retinal and protein lost 
• No Schiff base 
• Unfolded 
• Absorbs at 440 nm 
• Trytophan fluorescence less 
quenched by retinal 
• Native contacts between 
retinal and protein lost 
• Schiff base protonated 
a 
b 
c 
Figure 4.1: Schematic of the differences between 
unfolding species. (a) Species A, native pSRII. (b) 
Species B, unfolded pSRII with retinal attached. (c) 
Species C, unfolded pSRII and free retinal 
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[𝐴]𝑡 = [𝐴]0𝑒
−𝑘1𝑡 (1) 
[𝐵]𝑡 = [𝐴]0 (
𝑘1
𝑘2 − 𝑘1
(𝑒−𝑘1𝑡 − 𝑒−𝑘2𝑡)) (2) 
[𝐶]𝑡 = [𝐴]0 (1 +
1
𝑘1 − 𝑘2
(𝑘2𝑒
−𝑘1𝑡 − 𝑘1𝑒
−𝑘2𝑡)) (3) 
where [X]t is the concentration of species X at time t. Under conditions when k1<<k2 the 
contribution from [B] will be negligible, as the 
𝑘1
𝑘2−𝑘1
 term will become very small. 
Concentrating on the contribution from [C], 
[𝐶]𝑡 =⁡ [𝐴]0 (1 + (
1
𝑘1 − 𝑘2
) (𝑘2𝑒
−𝑘1𝑡 − 𝑘1𝑒
−𝑘2𝑡)) 
The −𝑘1𝑒
−𝑘2𝑡  term will be much smaller than −𝑘2𝑒
−𝑘1𝑡 , as k2 will be large enough that 
𝑒−𝑘2𝑡 will be close to zero. 
[𝐶]𝑡 =⁡ [𝐴]0 (1 + (
1
𝑘1 − 𝑘2
) (𝑘2𝑒
−𝑘1𝑡)) 
In 
1
𝑘1−𝑘2
, k1 will be negligible, and k2 will cancel in 𝑘2𝑒
−𝑘1𝑡, leaving 
[𝐶]𝑡 =⁡ [𝐴]0(1 − 𝑒
−𝑘1𝑡) (4) 
In the context of the reactions under examination here, this means that when the rate at 
which retinal loses specific contacts with the protein (k1), forming the protonated Schiff base 
absorbing at 440nm, is lower than the rate at which the Schiff base is hydrolysed (k2), forming 
free retinal which absorbs at 380nm, the 440nm species might not be able to accumulate 
sufficiently to be observed. 
4.3.2: Absorbance 
Most absorbance spectra can be modelled as a combination of Gaussian peaks of the form  
𝐴𝑏𝑠𝜆 =∑𝑎𝑥𝑒
−
(𝜆−𝑐𝑥)
2
2𝑤𝑥
2
(5) 
Where ax is the amplitude, or absorbance at the peak’s centre cx, equivalent to the λmax. The 
peak’s width is defined by its half width at the half maximum, wx. The absorbance peak of 
free retinal has a centre at 387 nm, very close to the deprotonated Schiff base absorbance 
maximum of 380 nm (Doukas et al., 1978). A protonated Schiff base has an absorbance 
maximum at 440 nm. The further red shift of the absorbance maximum in both folded pSRII  
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(to 498nm) and MR (to 500nm) is due to further spectral tuning by the protein (Bravaya et 
al., 2007; Ren et al., 2001; Teller et al., 2003). In the unfolding of these proteins, a mixture of 
~500 nm, 440 nm, and 380 nm peaks can be observed due to the presence of retinal in native 
I. II. III. 
I. II. III. 
IV. 
IV. 
a b 
c 
Figure 4.2: Decomposition of absorbance spectra (a) pSRII spectrum after 5 
minutes unfolding in 1% SDS (dark grey dots), showing the native pSRII peak 
(red), the protonated Schiff base peak (green) and the free retinal peak (blue). 
The dashed line shows the total model, including a 280nm peak and a scattering 
baseline (not shown). The residual of the model is shown (dotted line). (b) 
Example timecourse of pSRII unfolding in 3% SDS. (I), (II), and (III) show 0, 20 and 
60 minutes respectively. Spectra are displayed as in (a). (c) Example timecourse 
of MR unfolding in 3% SDS for comparison. (I), (II), and (III) show 0, 40 and 80 
minutes respectively. The reaction was fitted as a single first order reaction. Inset 
shows the progress of the reaction from 0 to 400 minutes. 
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protein, retinal which has lost specific protein contacts and retinal hydrolysed from the 
protein.  
The relative contributions of the different peaks across time can be measured by recording 
many timepoints during the unfolding reaction. By applying the Beer-Lambert equation to 
the peaks, the amplitude of the peak can be converted into concentrations so, if ax is the 
absorbance of a species at a given wavelength, [X] is the concentration of that species, and 
εx is its extinction coefficient at that wavelength, ax=[X]εx. Assuming the three peaks 
represent all the retinal present in a cuvette and that the overall concentration does not 
change over time, application of mass action law means 
[𝑅𝑒𝑡𝑖𝑛𝑎𝑙] = ⁡
𝑎380
𝜀380
+
𝑎440
𝜀440
+
𝑎500
𝜀500
(6) 
The concentration and extinction coefficient terms can be substituted for the amplitude of 
the peaks in the decomposition of spectra. One approach for determining the kinetics is to 
decompose the spectra, then to fit the three amplitudes at each timepoint to the overall 
concentration as in the mass action law above. However, this is limited because the choice 
must be made either to fix the peak parameters and accept a potentially poorer fitting at 
each timepoint, or to allow the peaks to vary and risk a poorer fitting of the extinction 
coefficients. However, if a model for the kinetics of the reaction can be assumed, as in the 
case of the unfolding of retinal binding proteins, the kinetic equations for the reaction 
𝑁𝑎𝑡𝑖𝑣𝑒
𝑘1
→𝑃𝑟𝑜𝑡𝑜𝑛𝑎𝑡𝑒𝑑⁡𝑆𝑐ℎ𝑖𝑓𝑓⁡𝑏𝑎𝑠𝑒
𝑘2
→𝐹𝑟𝑒𝑒⁡𝑟𝑒𝑡𝑖𝑛𝑎𝑙 (equations 1-3) can be combined with 
the decomposition of peaks, using equation 5, with the inclusion of extinction coefficients to 
convert to concentrations, using equation 6. An error term to handle the dead time when 
loading samples and existing absorbance around 380 nm can be included to give: 
𝐴~𝜀500([𝑇𝑜𝑡𝑎𝑙]𝑒
−𝑘1(𝑡+𝑓))𝑒
−
(𝜆−𝑐1)
2
2𝑤1
2
+  𝜀440([𝑇𝑜𝑡𝑎𝑙] (
𝑘1
𝑘2 − 𝑘1
) (𝑒−𝑘1(𝑡+𝑓) − 𝑒−𝑘2(𝑡+𝑓))𝑒
−
(𝜆−𝑐2)
2
2𝑤2
2
+  𝜀360([𝑇𝑜𝑡𝑎𝑙](1 +
1
𝑘1 − 𝑘2
(𝑘2𝑒
−𝑘1(𝑡+𝑓) − 𝑘1𝑒
−𝑘2(𝑡+𝑓))𝑒
−
(𝜆−𝑐3)
2
2𝑤3
2
⁡⁡(7) 
[Total] refers to the total retinal concentration, and f to the dead time of the experiment. 
Other symbols used here are from equations 1-6 above. 
Fitting time courses of absorbance spectra to this equation allows optimisation of all 
parameters with the largest dataset. With the power of a modern desktop computer, the 
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time taken to optimise the larger number of 
parameters is negligible. Scripts in R were written to 
automate the fitting, plotting, and extraction of 
parameters for unfolding time courses (as described in 
section 2.3.2.1). An example for pSRII unfolding is 
shown in Figure 4.2a.  
4.3.3: Fluorescence 
pSRII contains 6 intrinsic tryptophans (Figure 4.3), 
which were used to investigate its tertiary structure. 
Retinal quenches this fluorescence by a combination of 
Förster resonance energy transfer, which depends on 
distance between donor and acceptor groups, and 
dynamic quenching, which relies on physical contact 
between donor and acceptor (Alexiev and Farrens, 
2014). Three of the six tryptophans in pSRII are within 
1 nm of retinal, and close enough for dynamic quenching. This makes fluorescence emission 
at 335 nm upon excitation at 295 nm a reporter for the folding state of pSRII, as the distances 
between the tryptophans and retinal change during unfolding. 
Exponential growth decay curves describe data which follow the same pattern as exponential 
decay, but increasing to some asymptote, rather than decreasing and are of the form: 
𝑦 = 𝐴(1 − 𝑒−𝑘𝑥) (8) 
where A describes the asymptote towards which the curve tends, henceforth called the 
amplitude of that curve. Initial parameters for A and k can be found from simple features of 
the data. Starting values for A can be found by simply taking the maximum value of y (ymax). 
This is more accurate if the data has been allowed to plateau. 
The rate constant of the curve, k, can be expressed as 
1
𝜏
, where τ, the time constant, is related 
to the half-life of the curve as 𝜏 = 𝑥1
2
/ln⁡(2), so the time at which 𝑦 =
𝐴𝑒𝑠𝑡
2
 gives an estimate 
of τ. An exponential growth decay curve is then fitted to the data with the given starting 
values. 
Fitting of an exponential growth decay curve to the fluorescence did not always give a good 
fit, as can be seen in Figure 4.4a. These time courses had a characteristic residual profile 
(shown as a green line in figure 4.4a), with an early positive region then a smaller negative 
Figure 4.3: Structure of pSRII showing 
tryptophans as blue spheres and retinal in 
yellow sticks. 
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region which diminishes so the residual at the plateau is around 0. Using the same estimation 
process as for the original curve on the residual yields a second, smaller exponential curve. 
Within the unfolding model derived from absorbance spectroscopy there is no physical 
explanation for two parallel processes. In addition, such a model would have to explain the 
division of single and double exponential processes by SDS concentration. 
Referring to the kinetic equations above (equations 1-3), the concentrations of species B and 
C (protonated Schiff base and hydrolysed Schiff base) can each be seen as the superposition 
of two exponential curves, as each contains some multiplication of 𝑒−𝑘1𝑡  and 𝑒−𝑘2𝑡 . 
Derivation of this can be found in section 2.3.2.1. This means that the two exponentials 
detected by fitting can be used as an approximation of the rate equations for B and C in 
consecutive first order reactions. 
If each component in the consecutive reactions is assumed to have a different amount of 
quenching, then 𝐼𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦 = ⁡𝐹𝑁𝑎𝑡𝑖𝑣𝑒[𝑁𝑎𝑡𝑖𝑣𝑒] + 𝐹𝑃𝑟𝑜𝑡𝑜𝑛𝑎𝑡𝑒𝑑[𝑃𝑟𝑜𝑡𝑜𝑛𝑎𝑡𝑒𝑑] +
𝐹𝐴𝑝𝑜𝑝𝑟𝑜𝑡𝑒𝑖𝑛[𝐴𝑝𝑜𝑝𝑟𝑜𝑡𝑒𝑖𝑛] . Here, intensity only increases, so we can say that 𝐹𝑁𝑎𝑡𝑖𝑣𝑒 <
𝐹𝑃𝑟𝑜𝑡𝑜𝑛𝑎𝑡𝑒𝑑 < 𝐹𝐴𝑝𝑜𝑝𝑟𝑜𝑡𝑒𝑖𝑛 . To simplify, we can instead look at ∆𝐼𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦 =
⁡𝐼𝑃𝑟𝑜𝑡𝑜𝑛𝑎𝑡𝑒𝑑[𝑃𝑟𝑜𝑡𝑜𝑛𝑎𝑡𝑒𝑑] + 𝐼𝐴𝑝𝑜𝑝𝑟𝑜𝑡𝑒𝑖𝑛[𝐴𝑝𝑜𝑝𝑟𝑜𝑡𝑒𝑖𝑛], where 𝐼𝑥 = 𝐹𝑥 − 𝐹𝑁𝑎𝑡𝑖𝑣𝑒, so INative = 
0. This allows the contribution from the native protein to be ignored, as well as any change 
in the other reactants in the dead time of the experiment. Substituting in the kinetic 
equations for [Protonated] (equation 2) and [Apoprotein] (equation 3) yields the model 
Figure 4.4: Decomposition of pSRII 
unfolding fluorescence timecourses. 
(a) Single curve fit to an example 
timecourse in 3% SDS. (b) Two 
component fit to the same timecourse. 
(c) Single curve fit to an example 
timecourse in 0.5% SDS. 
a b 
c          
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∆𝐼𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦 = ⁡ 𝐼𝑃𝑟𝑜𝑡[𝑇𝑜𝑡𝑎𝑙] (
𝑘1
𝑘2 − 𝑘1
) (𝑒−𝑘1𝑡 − 𝑒−𝑘2𝑡)
+𝐼𝐴𝑝𝑜[𝑇𝑜𝑡𝑎𝑙] (1 + (
1
𝑘1 − 𝑘2
) (𝑘2𝑒
−𝑘1𝑡 − 𝑘1𝑒
−𝑘2𝑡)) (9)
 
To allow for the noise in the data, when fitting to ΔIntensity a constant value was added to 
the models so a fitted curve could start at values other than zero. The parameters from the 
biexponential growth model were adapted to provide starting values for this model. IProt 
~A2/[Total] and IApo~A1/[Total]. The rate constants were close enough to use as initial 
estimates without any transformation. 
Using the kinetic model to explain the appearance of two exponential curves also explains 
why the second curve is absent in some time courses. In section 4.3.1 above there is an 
explanation of why a low k1 would make the apparent rate [𝐴]0(1 − 𝑒
−𝑘1𝑡) , and as 
fluorescence only increases, this is what is observed at low SDS. 
4.3.3.1: Model selection 
When comparing a model with two curves to a model with one, the model with more 
parameters will always fit at least as well as the simpler model (i.e. amplitude could be set 
to 0 and the second curve makes no contribution), and is likely to outperform it. Even if the 
simpler model is closer to the truth, adding parameters will make it possible to fit to the 
noise of the data. A better measure than simply comparing the residuals is required. There 
are two types of method used to compare models. 
4.3.3.1.1: Information criteria 
The first approach is to impose a penalty on adding parameters to the model, and establish 
a criterion that has a term for the residuals and a term for number of parameters. Several 
model selection criteria exist based on this paradigm with the terms based on different 
theoretical considerations. Akaike’s An Information Criterion (AIC) is the earliest and a 
popular model selection criterion (Akaike, 1974). It has its basis in minimising information 
entropy which is theoretically intensive, but thankfully simple to implement for least squares 
fitting: 
𝐴𝐼𝐶 = 2𝐾 − 𝑛𝑙𝑛(?̂?2) 
Where K is the number of estimated parameters. This is equal to the number of model 
parameters plus one, as the variance of the data from the model is also estimated. σ̂2 is the 
estimated variance, which in this case is equal to the average of the residuals squared and n 
is the sample size. The AIC estimates the relative distance between candidate models and 
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the truth. Thus, a lower AIC is preferred, meaning the addition of a new parameter is 
penalised unless this refinement reduces the estimated variance enough to compensate for 
the increase in the parameter term. A shortcoming of using the AIC is that as sample sizes 
increase, a simple model eventually becomes disfavoured as small effects are magnified. A 
generalisation of information criteria exists that makes fewer assumptions than the AIC, but 
this loses the advantage the AIC has of being very easy to implement. When selecting models 
for the fluorescence data, the initial solution attempted was to take random samples of 500 
points and perform model selection on these. Quite apart from being theoretically dubious, 
this solution also lost some of the simplicity of using the AIC and became closer to the other 
family of model selection methods, so was replaced with cross-validation. 
The same analysis was carried out on molar residue ellipticity (MRE) data acquired from 
circular dichroism (CD). The AIC was used to compare fits between models as for 
fluorescence. As model selection criteria discriminate between models based on bias and 
variance (Hastie et al., 2009), if the variance for both models is very high, bias will become 
the discriminant and the more complex model will be rejected. As the noise was very high, 
the variance for both models was sufficiently high that it is likely even if two exponentials 
underlie the CD data AIC selected the simpler model every time. 
4.3.3.1.2: Cross-validation 
Cross-validation is a model selection technique often used in machine learning and data 
mining. The basic idea is to check for overfitting by fitting the model to some subset of the 
data (the training set), then testing how good the fit is on the rest of the data (the testing 
set). Any noise in the training set that the model fits to will introduce errors when compared 
to the testing set. Different versions of cross-validation with different methods for 
generating the training and testing sets exist, but for the fluorescence data a relatively simple 
method called k-fold cross-validation was used. Briefly, this splits the dataset into k equal 
sized sets (folds). One fold is removed from the data to make the training set and then used 
as the testing set. This is repeated for each fold, and the average residual sum of squares 
(RSS) for each candidate model is compared and the model with the lowest average RSS is 
selected. Details of the procedure can be found in the data analysis section of “Materials and 
Methods”. 
Initially the AIC was used for model selection. After switching to 10-fold cross-validation, the 
model selection was compared for a subset of 9 of the previous results. Both methods 
selected the same model in each case, so no further testing took place. Examples of the 
application of this method to a timecourse for which the more complex model was more 
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appropriate (a and b) and the less complex 
model was more appropriate (c) are shown in 
figure 4.4.  
4.3.4: Refolding and hydroxylamine fitting 
When fitting the unfolding absorbance data, 
the three peaks described above sufficed as a 
model. However, rather than the single peak at 
498 nm used to model native pSRII above, 
spectra of truly native pSRII comprise four 
peaks: the main peak at 498 nm and three 
minor peaks at 460, 420 and 380 nm, which 
arise from vibronic effects in the system (Ren 
et al., 2001). These peaks disappear with 
concentrations of SDS above 0.5%. However, 
upon dilution of SDS, these peaks reappear in 
refolding pSRII. These make a non-negligible 
contribution to spectra and distort fitting if 
ignored. It was also unknown whether the 
contributions of these peaks vary across the 
refolding process. To determine refolding 
progress, therefore, it was necessary to 
construct a native profile of these peaks 
against which to compare. To this end, five native pSRII spectra had five Gaussian peaks 
fitted, including one for the 280 nm protein peak. An example is shown in Figure 4.5a, and 
the areas of each peak in the fitting are shown in Figure 4.5b and c. The inclusion of the 280 
nm peak necessitated the fitting of the UV region with wavelengths below 350nm, previously 
excluded from analysis. In this region, scattering becomes significant, so a scattering baseline 
was added to the model. As scattering is proportional to λ-4, the terms 
𝐷 +
𝐸
𝜆𝐺
(10) 
were added, which includes a linear term because scattering occurs to some extent at all 
wavelengths, so a zero value in the spectrum must be compensated for. Due to the vibronic 
nature of the additional retinal peaks, they are not symmetrical (Barker and Fox, 1980; Siano 
and Metzler, 1969). There are several lineshapes usable for asymmetric peaks, but the 
0%
50%
100%
Jan Mar May Aug Oct
0%
50%
100%
Jan Mar May Aug Oct
Figure 4.5: Fitting native pSRII spectra. (a) Example 
fitting of a native pSRII spectrum used for 
construction of a native profile. (b) Areas of the peaks 
in five native pSRII spectra as a percentage of the total 
area (I) Showing all peaks. The light blue bar shows 
the protein peak at 280nm. The yellow, grey, orange 
and dark blue bars show the chromophore peaks at 
370, 420, 460 and 498nm respectively. (II) as (I), but 
omitting the contribution of the protein peak. 
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simplest implementation for NLS is to replace the width term with a sigmoidal function 
(Stancik and Brauns, 2008). This adds one parameter to the model which controls the skew 
of the peak, so a Gaussian peak like equation 5 becomes: 
𝐴𝑏𝑠𝜆 =∑𝑎𝑥𝑒
−
(𝜆−𝑐𝑥)
2
2
𝑤𝑥
1+𝑒𝑟(𝜆−𝑐𝑥) (11)
 
All terms from equation 5 are the same, with the addition of the parameter r, which controls 
the skew. 
Due to the skew of the peak, the amplitude parameter is no longer directly comparable 
between peaks to compare the contribution to the spectrum. To allow comparison between 
peaks between spectra, the peaks were instead integrated to find the area under the curve 
within the range of the recorded spectra. The areas of the peaks were calculated for the five 
native spectra. In each spectrum the areas were practically identical (figure 4.5b and c), and 
similar to published values (Ren et al., 2001). 
As the kinetics of the different peaks were unknown, no combination of peak amplitudes and 
kinetic profiles was made for overall fitting so that no explicit kinetic model had to be 
assumed to carry out fitting. Instead, each timepoint was fitted separately, and later grouped 
by their centres. The areas of each peak were found and plotted over time. To determine 
whether the increase of the shoulder peaks is at a different rate compared to the 498 nm 
peak, the relative areas of the 380 nm peak and 498 nm peak were plotted against one 
Figure 4.6: Fitting of refolding time courses. (a) Example fitting of refolding of pSRII by diluting SDS 
at (I) 0, (II) 60, and (III) 120 minutes. (b) Example kinetics of refolding pSRII, with the spectra in (a) 
indicated by dashed lines.  
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another and linear regression was carried out between the two (figure 4.12b). Though 
different experiments have different degrees of unfolding, causing them to cluster at 
different positions on the line, there was little deviation from the linear regression, showing 
that the main and the shoulder peaks increase at the same rate. 
Because of the simple relation between the recovery of the native peaks and the decrease 
in the 380 nm peak, the progress of refolding was defined as 
𝑅𝑒𝑓𝑜𝑙𝑑𝑒𝑑 = 1 − (
𝑅𝑒𝑡𝑇 − 𝑅𝑒𝑡𝑛𝑎𝑡𝑖𝑣𝑒
1 − 𝑅𝑒𝑡𝑛𝑎𝑡𝑖𝑣𝑒
) (12) 
The kinetics were modelled as a first-order reaction. The recovery efficiency was found by 
finding the maximum recovery compared to the native profile (figure 4.12a).  
Automation of fitting 
When further refolding experiments were carried out, an automated approach was used. 
The earlier fittings showed that refolding spectra were combinations of a free retinal peak 
with a native-like profile of retinal peaks. For automation, an average fitted profile was 
established by fitting five native spectra, then adjusting the amplitudes of the peaks so that 
they sum to one, then taking the mean of each parameter. A model was created so that each 
spectrum in a time series was fitted as: 
𝐴𝑏𝑠𝑜𝑟𝑏𝑎𝑛𝑐𝑒⁡~⁡𝐷 +
𝐸
𝑥𝐺
+ 𝑃𝑒𝑎𝑘𝐴280 + 𝑃𝑒𝑎𝑘𝐴380 + 𝐵 × 𝑃𝑟𝑜𝑓𝑖𝑙𝑒𝑛𝑎𝑡𝑖𝑣𝑒 (13) 
Where D, E and G refer to the scattering terms in equation 10, the peaks at 280 and 380nm 
are as shown in equation 5, and the native profile is a mixture of three peaks as equation 5, 
and one as equation 11. 
From these fittings, the amplitude of the 380 nm peak and B (the multiplier for the native 
profile) were taken to represent the concentrations of free retinal and refolded pSRII 
respectively. The overall concentration remains constant, and as the effective extinction 
coefficient of the native profile is not certain, the concentration of each species at each 
timepoint were estimated using non-linear least squares fitting by fitting those parameters 
to the model 
𝐶𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛⁡~⁡𝑅𝑒𝑡 × 𝐴380 + 𝑝𝑆𝑅𝐼𝐼 × 𝐵 (14) 
The refolding was incomplete (see section 4.4.1.9), as indicated by absorbance at 380 nm 
beyond the native profile and recorded by residual amplitude of the fitted 380 nm peak (e.g 
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figure 4.6a). The concentrations determined from this amplitude were fitted to an 
exponential decay curve of the form 
𝐶⁡~⁡𝐴𝑒−𝑘𝑡 + 𝑐 (15) 
the c term of which allows for the fitting of incomplete decays. The residual concentration 
estimated by c was divided by the given overall concentration to estimate the fraction of 
pSRII incapable of refolding for that time course. Scripts for the automation of this fitting and 
plotting of the fits were written, tested on a sample dataset as shown in Figure 4.6, and sent 
to Yi Lei Tan at the University of Cambridge. 
Unfolding of pSRII by SDS was also carried out in the presence of hydroxylamine, which reacts 
with exposed Schiff base to rapidly form a retinal oxime. The spectra of this reaction, unlike 
those in the absence of hydroxylamine, have no protonated Schiff base peak and maintain 
the shoulder peaks of native pSRII, so modelling the reaction is similar to modelling refolding 
pSRII, just in the opposite direction. The fitting procedure for native spectra was also used 
for pSRII in low concentrations of SDS. 
4.3.5: Automatic peak picking 
When originally fitting peaks to the refolding spectra, the parameters of the shoulder peaks 
were not immediately obvious and obscured by the much larger main peak dominating that 
area of the spectra. In case these parameters changed over time, an automatic peak picking 
strategy to provide initial estimates was pursued. The algorithm was designed to have the 
option of fitting a baseline, then to fit peaks until model selection found adding more to be 
extraneous. Ultimately, the script was not used for refolding spectra because of the skew of 
the vibronic peaks. No skewing parameter was originally implemented, and after a literature 
search identified the source and nature of the shoulder peaks, the script was unnecessary. 
However, when fitting only symmetrical peaks, the algorithm works, and by using clustering 
strategies, changes over time can be estimated. In future, it is possible that a refinement of 
the original strategy could be extended to automatically fit kinetics to time courses of 
absorbance spectra. 
4.3.5.1: Estimation strategy 
A full description of the peak picking strategy can be found in section 2.3.3. What follows is 
a brief summary. Data can be smoothed by calculating the average of the values around that 
point. This can particularly distort peaks, so was used, in combination with a geometrical 
filter (figure 4.7b), to identify candidate peak positions. A second step used NLS fitting for 
each of these candidates to refine the estimates for a peak in that position. The final step is 
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to establish the number of peaks present by adding these peaks to a total model one by one, 
comparing the AIC between models with and without each peak to establish whether it is 
Figure 4.7: Automatic peak picking. (a) Peak centres acquired from 
oversmoothing algorithm, indicated on a native pSRII spectrum. The 
protein peak at 280nm, due to its separation, was easier to fit and constant 
across time points. (b) Intermediate steps of oversmoothing: (I) Difference 
between smoothed spectrum and raw spectrum, showing the baseline 
identified by the rolling ball filter. (II) The difference spectrum after 
baseline subtraction. (c) Native pSRII spectrum with peaks from nls fitting 
using oversmoothed guesses. (d) Peak parameters for a refolding 
timecourse. Areas of circles indicate the area of the peak, with y-axis 
position indicating the peak centre. Circles are coloured according to 
hierarchical clustering. 
a 
b 
c 
d 
I 
II 
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necessary. Using this, spectra can be automatically fitted very quickly: 100 spectra are fitted 
in an average of 4.5 seconds on a desktop computer, even with the difficulties caused by 
skewed peaks (figure 4.7c).  
4.3.5.2: Clustering 
Treating the final fitted peaks as points in 4-dimensional space, with amplitude, centre, width 
and time as dimensions, peaks across timepoints can be grouped into clusters. In this way, 
the progress of different species might be measured. In the current implementation, a 
number of clusters must be defined manually. There are more advanced clustering methods 
that may be able to detect the number of clusters required. Once the peaks have been 
clustered, average parameters for each peak across timepoints could be used as refined 
estimates for each spectrum with the aim of eliminating outliers and measuring timepoints 
more reliably. On the test data, the algorithm did not always fit realistic peaks, with some 
spectra being dominated by one enormous peak. It is possible these might disappear with an 
improved initial estimation but given the large set of similar spectra it seems wasteful not to 
use the aggregate behaviour to optimise peak picking. Initial attempts were not accurate in 
their clustering, as can be seen in Figure 4.7d, though this may have been due to the poor 
fitting from the lack of a skew parameter in the underlying model. 
4.3.5.3: Fitting skewed Gaussians as symmetrical 
From the fitting carried out, it can be seen that a skewed peak can be approximated by 
symmetrical Gaussians. The parameters of two peaks fitted to a simulated skewed peak vary 
in regular patterns which might be useful for recognising skewed peaks in real data. 
However, the ways a skewed peak and other, nearby peaks combine may make fitting less 
predictable, as can be seen by the skewing of the 460 nm shoulder peak in pSRII causing the 
380 nm peak to be split into two while remaining a single peak itself, as can be seen in Figure 
4.7c. 
4.4: Results 
4.4.1: Biophysical kinetic studies of pSRII 
4.4.1.1: Early changes in absorbance spectra 
pSRII samples took around a minute to load into the spectrophotometer. Within this time, 
especially at higher concentrations of SDS, some changes in the spectra had occurred. The 
transition from a native spectrum to a protonated Schiff base spectrum had already started, 
but there were other changes. 
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First, the absorbance maximum 
of the native peak is red shifted, 
as shown in figure 4.8a. The 
spectra of pSRII in low 
concentrations were fitted in the 
same way as native spectra 
(section 3.4) The fact that with 
higher rates this peak is smaller in 
the first spectrum might cause 
some error in the fitting, but even 
at 0.5% SDS, where this peak is 
still large, the centre has shifted 
from 498nm to ~515nm. If the 
shift was a fitting artefact, the 440nm peak might be expected to red shift or widen to 
compensate, which does not happen. Figure 4.10c shows that beyond 3% SDS the peak 
centre is moved as far as 528nm.  
The shoulder peaks present in native pSRII (indicated in Figure 4.5a) are also absent in 
spectra above 1% SDS. It is possible that they are just rendered too small to detect by the 
unfolding process or could reflect the early loss of protein contacts necessary for the vibronic 
states causing the further peaks.  
The idea of early spectral changes is backed up by later experiments recording the spectra of 
pSRII in low concentrations of SDS, over timescales with no noticeable unfolding. As can be 
seen in Figure 4.8a, the position of the pSRII main absorbance peak shifts from around 496nm 
in the native state and up to 0.1% SDS, to 505nm at 0.3% SDS. This change can be seen both 
in the coefficients for the peak fitting (as discussed in section 4.3.4), and by taking the local 
maximum around 500nm. A decline in the areas of fitted shoulder peaks can also be seen in 
figure 4.8b. The change seems to plateau from 0.2% to 0.3% SDS. 
These changes make the fitting of unfolding time courses in 0.5% SDS difficult. This is the 
lowest SDS concentration with significant unfolding, and though some shoulder peaks are 
visible early on, the decline of these shoulder peaks is not uniform. As can be seen in the 
fluorescence time courses (see section 4.4.1.4), the rates of unfolding reactions are such that 
little of the protonated Schiff base intermediate can be observed, so if the same fitting as for 
         
 
 
 
 
  
 
  
 
            
 
  
 
  
 
  
 
  
 
  
      
      
     
         
 
 
 
 
  
 
 
  
 
  
 
 
 
            
 
 
 
 
 
 
 
 
 
 
 
 
          
            
Figure 4.8: Early 
spectral changes of 
pSRII in SDS. (a) 
Changes in the centre of 
the main pSRII peak as 
measured by fitting of a 
five-peak model 
(circles) and by taking 
the local maximum 
(triangles). Data shown 
as the mean of three 
values +/- standard 
deviation. (b) Changes 
in the balance of 
shoulder peaks in the 
five-peak model. The 
ratio is of the area of 
that peak to the total 
area of all retinal peaks 
in the model. Data 
shown as the mean of 
three values +/- 
standard deviation. 
a 
b 
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higher [SDS] is attempted, an unrealistically broad 440 nm peak is observed (Figure 4.9b). 
The k2 for fitting, which is similar across [SDS] (section 4.4.1.7.2) is also lower for 0.5%. 
Improvements can be made by modelling the reaction as a single first order reaction, rather 
than consecutive reactions as with higher [SDS], as can be seen in the comparison of Figure 
4.9a with 4.9b, though with a poor residual at early timepoints. That the greatest magnitude 
of residual is around 440 nm suggests that the 440 nm peak should be included, it is difficult 
to reconcile with the overall reaction. As can be seen in figure 4.10, the different models for 
unfolding in 0.5% SDS have only minor effects on k1, while the single reaction model brings 
the parameters for the free retinal peak in line with higher SDS concentrations. As the free 
retinal peak should not be much affected by SDS, this favours the single reaction model. The 
centre of the 500 nm peak moves closer to the centre for 0.3% SDS. Due to the improvements 
made to the overall fitting, and the information from fluorescence time courses, the fitting 
of a single reaction was chosen. 
4.4.1.2: Hydrolysis of the Schiff base 
Absorbance of free retinal has a λmax of 387 nm and a deprotonated retinal Schiff base has a 
λmax of 380 nm. The centre of the peak of the third species modelled in absorbance kinetics 
varies between 385 nm and 402 nm. If the unfolding of pSRII in 0.5% SDS is modelled as a 
single reaction, the spread is between 388 and 402nm, as shown in Figure 4.10i. This 
Figure 4.9: Difficulties fitting pSRII unfolding in 0.5% SDS (a) Fitting of pSRII unfolded 
in 0.5% SDS as one reaction at (I) 0 minutes, (II) 60 minutes, and (III) 120 minutes. (b) 
Fitting of the spectra in (a) to two reactions. 
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characteristic confirms the third species in 
unfolding spectra to be free retinal rather 
than deprotonated Schiff base. 
4.4.1.3: Absorbance kinetics 
Rates of transition to 440nm increased with 
[SDS] nearly from ~0.15 min-1 to ~1.05 min-1 
as SDS increased from 1 to 3%. The 440 to 387 
transition did not change with [SDS], 
remaining around 0.03 min-1 (see 4.1.7.1, 
below). 
4.4.1.4: Fluorescence kinetics 
Below 1% SDS, only one process was 
supported by fluorescence time courses. The 
observed rate of this single process was 
below 0.03 min-1. Once two processes could be distinguished, k2 stayed constant at 0.03 min-
1, supporting the idea that only once k1 is higher than k2 can k1 be seen, as outlined in section 
4.3.3.  
4.4.1.5: Fluorescence amplitudes 
As well as the kinetic parameters, fluorescence change amplitudes were acquired from the 
fitting of fluorescence time courses (Figure 4.11d). In the kinetic model, these should reflect 
the fluorescence changes of the different states. The total fluorescence difference between 
native pSRII and pSRII without retinal was assumed to be constant relative to the 
concentration of the sample as the sensitivity of fluorescence quenching to distance is such 
that retinal released to the bulk solution should have no quenching effect on pSRII 
tryptophans. For this reason, the decline in A2 was thought to be accounted for by unfolding 
occurring in the dead time of the experiment. The ratio of A1 to A2 was then used as an 
indicator of the extent of unfolding by SDS at different concentrations because the extent of 
loss of quenching shows the separation of retinal from tryptophans before hydrolysis. Initial 
analysis by linear regression of SDS percentages of 1, 3, 10 and 20% showed a strong positive 
correlation. From previous work on rhodopsin, the geometry of SDS micelles was shown to 
have an importance beyond that of just the concentration (Dutta et al., 2010a). To test this, 
further experiments at 7 and 15% SDS were run (figure 4.11d). The R2 value of the linear 
regression decreased from 0.94 to 0.70. 
Figure 4.10: Changes in parameters of the combined 
kinetic model at different concentrations. Top row: 
500nm peak parameters: extinction coefficient, width 
and centre (left to right). Second row: 440nm peak 
parameters. Bottom row: 380nm peak parameters. Blue 
points show the parameters of the two peak model of 
pSRII unfolding.  
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4.4.1.6: CD fitting 
Changes in MRE at 222nm over time were used to measure the rates of loss of secondary 
structure in unfolding pSRII. The same analysis as for fluorescence time courses was carried 
out on the MRE data. Model selection by AIC consistently chose a single reaction for the data. 
As the second reaction in fluorescence and absorbance data measures the hydrolysis of 
retinal, there is no reason to assume a second process. It should be noted that the noise in 
the data is high because the changes in secondary structure are minor, and model selection 
only selects for the best model supported by the data. For this reason, the selection of a 
single process in this case, with high noise, is less meaningful than between fluorescence 
measurements (see section 4.3.3.1 for details). 
Figure 4.11: Rates of unfolding reactions for pSRII in SDS. (a) Rates for the reactions outlined in the 
text as measured by absorbance spectroscopy (hollow shapes), and fluorescence (filled shapes). 
Where there is significant overlap, symbols have been slightly offset in the x-axis. Where two 
reactions are present, k1 is shown as a circle, and k2 as a triangle. Rates are shown as the mean +/- 
standard deviation for 3 reactions. (b) As (a) with hydroxylamine added. Only single reactions were 
fitted. (c) Comparison of rates with and without hydroxylamine. Linear regression was performed 
between rates for the measurement methods. (d) Dependence of A1 as a fraction of total amplitude 
for fitting of two curves to fluorescence time courses. (e) Comparison of boxplots of k2 as estimated 
by fitting of absorbance and fluorescence time courses. No significant difference was found by t-
test. (f) Comparison of k1 as compared to the overall average of all estimates at that SDS 
concentration. Differences shown as standard deviations from the mean at 0. Absorbance values 
are shown as black circles, fluorescence values as blue triangles. 
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The rate constants extracted from the fitting to CD data increase with SDS concentration. 
The rates are lower than the rates measured for tertiary structure changes. 
4.4.1.7: Comparison of Absorbance and Fluorescence 
Both absorbance and fluorescence data were used to explore the kinetics of pSRII unfolding. 
Though each experimental system could be sensitive to the same changes, and both output 
rate constants for two consecutive reactions, these may not be the same across 
measurements. 
4.4.1.7.1: k2 
The dependence of the rate of the hydrolysis of the Schiff base on [SDS] was estimated by 
ANOVA, and no significant dependence was found for either method of measurement (figure 
4.11e). A Welch’s t-test between the two was carried out and no significant difference was 
found. Treating the process as constant across [SDS] and measurement method, the mean 
k2 was found to be 0.0391 min-1.  
4.4.1.7.2: k1 
No explicit model for the dependence of k1 upon [SDS] was formulated. It increases sharply 
towards 3% SDS, as shown in figure 4.11a. If the rates had been maintained, an exponential 
growth decay model would suffice, but they appear to decline slightly. Instead of fitting to a 
model, k1 between measurements were compared by taking the mean of all k1 at a given SDS 
concentration and calculating how many standard deviations from the mean each 
measurement was and observing any differences between measurement methods, as shown 
in figure 4.11f. Across the range of SDS concentrations, fluorescence tends to be lower than 
the mean, and absorbance higher. This may be because the techniques are responding to 
slightly different changes in pSRII, as discussed below. 
4.4.1.8: Addition of Hydroxylamine 
Hydroxylamine was introduced because in rhodopsin studies it has been used to instantly 
hydrolyse the Schiff base, and the same property here was intended to simplify the kinetics 
of the pSRII unfolding reaction by effectively removing the protonated Schiff base from the 
reaction. Hydroxylamine will react with the Schiff base when it is exposed to the solvent, so, 
as the helical bundle is loosened, instead of a protonated Schiff base absorbing at 440 nm 
forming, a retinal oxime absorbing at 380 nm should form. In the absorbance spectra this 
was achieved; the 440 nm peak present in hydroxylamine free spectra was absent. However, 
the shoulder peaks discussed in the refolding section of the methods development in this 
chapter, absent in the spectra of high SDS denatured pSRII, appear in these unfolding spectra. 
The same procedure used to determine whether these peaks are in a constant ratio with the 
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main peaks used in refolding spectra was used 
here, and the increase in the 380 nm peak was 
determined to be a sufficient measure of pSRII 
unfolding. 
In fluorescence spectra, model selection by both 
AIC and cross-validation chose different time 
courses at the same [SDS] as single and double 
reactions. Both methods made the same model 
selection for each time course. It was decided that 
all reactions should be modelled as single 
processes due to the information supplied by 
absorbance spectra (see Discussion for details). 
The rates measured upon addition of 
hydroxylamine were slower than those in SDS 
only unfolding (figure 4.11b). The relative rate 
change was different between absorbance and 
fluorescence (Figure 4.11c). The correlation 
between mean rates at each concentration of SDS 
+/-Hydroxylamine was estimated by linear 
regression. As can be seen in figure 4.11c, the 
rates as measured by fluorescence are approximately halved, and those measured by 
absorbance are divided by three. 
4.4.1.9: Refolding 
The fraction of pSRII that could not be recovered by dilution of SDS was more dependent 
upon the time spent unfolded than on the percentage of SDS, as can be seen in Figure 4.13a. 
There was a small effect of SDS concentration on the recovery efficiency, though without 
replication and adding further SDS concentrations, it is uncertain whether this is simply due 
to the extra time spent in the unfolded state from faster unfolding. The increase in 
unrecoverable pSRII could be modelled for each concentration as a first-order reaction, with 
half-lives of 1d 16h 23min for 1% SDS and 1d 6h 10 min for 7% SDS. 
The rates of refolding as measured by decrease in free retinal peak could be fit to single 
exponential decay curves. However, the rates for 7% SDS could be better fit, as assessed by 
AIC, as the second reaction of two consecutive first-order reactions, as shown in Figure 
 
 
  
 
   
 
 
  
 
 
 
  
  
 
 
  
 
  
 
  
 
  
 
  
 
  
Figure 4.12: Refolding of pSRII by dilution of SDS. 
(a) The maximum recovery of pSRII unfolded in 
SDS for different times, as assessed by the 
minimum area share taken by the free retinal 
peak. Spectra were fitted into four retinal peaks: 
372nm (aqua), 496nm (yellow), 461nm (green), 
and 435nm (red). (b) Scatter plot of the area 
share of the 496nm and 372nm peaks for all 
spectra. The black line shows the linear regression 
for the shown values, and has an R
2
 value of 
0.9973 on 286 degrees of freedom.  
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4.13b. The nature of the first of the two 
reactions cannot be ascertained from this 
data; possible candidates are slower mixing 
of micelles with higher SDS, or 
compromised mixing of retinal due to 
higher viscosity. As these differences were 
difficult to explain, and inconsistent 
between SDS concentrations, time courses 
were modelled as a single reaction. 
Fitting of the refolding of pSRII showed that 
dilution of SDS is sufficient to refold, as the 
vibronic shoulder peaks of the 
chromophore are restored instantly with 
the main peak. It also allowed the 
construction of chevron plots (by Yi Lei Tan, 
University of Cambridge) for analysis of the 
combined kinetics of folding and unfolding 
(Curnow and Booth, 2007).  
4.4.2: Analysis of pSRII NMR spectra 
4.4.2.1: Principal component analysis 
2D HSQC spectra were recorded of pSRII unfolded in different concentrations of SDS up to 
30% in order that the environments of different regions of pSRII at different degrees of 
unfolding might be compared. There were two problems with this approach found after data 
collection. The first is the volume of data; each of the 239 residues is labelled. Though not all 
appear as peaks in the dataset, analysis of each residue is inefficient. As concentration of SDS 
increases, micelles increase in size (Otzen, 2002), and the resultant slower tumbling of pSRII 
in these micelles increases transverse relaxation. This means a second problem is that the 
number of peaks decreases with concentration of SDS. Principal components analysis was 
applied to the data to address both these problems. 
Principal components analysis (PCA) is used to reduce the dimensionality of a multivariate 
dataset while preserving as much of the original information as possible. This can be used to 
decipher underlying patterns in large datasets, and to cluster samples. It has previously been 
used with NMR spectra (Konuma Tsuyoshi et al., 2012; Sakurai and Goto, 2007). Another 
 
 
  
 
 
 
 
  
 
  
  
  
 
   
 
         
      
      
 
  
 
  
 
  
 
  
 
  
 
  
                     
               
                
               
                
         
 
  
 
         
 
  
 
  
 
  
 
  
 
  
 
  
Figure 4.13: Kinetics of pSRII refolding. (a) Scatter plot 
of the unrecoverable fraction of pSRII unfolded in 7% 
(red) and 1% (black) SDS. These were fitted to single 
exponential growth decay curves with rate constants of 
3.0 and 2.4 x 10
-4
 min
-1
 respectively. (b) Scatter plots of 
the decrease in free retinal for pSRII refolding. Curves 
from 1% SDS timecourses are fit to a single exponential 
decay curve, and those for 7% SDS to the kinetic 
equation for the second of two consecutive first-order 
reactions. Residuals shown bottom left. 
a 
b 
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useful feature of many PCA algorithms is that many incorporate procedures for adding back 
in missing data, known as imputation of values (Dray and Josse, 2015). 
Each peak from HSQC spectra of unfolded states of pSRII was assigned to a residue (Gautier 
et al., 2010), and the chemical shift (both 1H and 15N) and the intensity recorded. PCA is, 
however, sensitive to the scaling of variables, so the representation of different types of 
measurement must be carefully considered. There are reliable methods of scaling 15N 
chemical shifts to 1H chemical shifts (Sakurai and Goto, 2007), but scaling intensity is more 
difficult because the data is of a different kind to the chemical shifts. For the PCA, the spectra 
were represented as rows in a matrix in which each column held a chemical shift, either 1H 
or 15N. 
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Figure 4.14: PCA of pSRII NMR spectra. (a) (I)Sparseness of data points with increasing SDS. The fraction of total 
values missing from the matrix of assigned peaks for spectra with different SDS. The maximum is 402/412 at 30% 
SDS. (II) Plot of the maximum chemical shift change of each residue showing the residues in the trimmed dataset 
are well distributed. (b) The scores for the first two principal components for each spectrum. PC1 (R
2
 = 0.7485) in 
circles, PC2 (R
2
 = 0.1810, cumulative R
2
 = 0.9295) in triangles. The solid line shows an exponential decay curve 
fitted to PC1 (y = 0.895e
-1.12x
-0.33). The dotted line shows the sum of the exponential decay curve for PC1 and an 
exponential decay growth curve (y = 1.15(1-e
-0.35x
)-0.5) (dashed line) that was fitted to PC2. (c) Pie charts of the 
categories of the 56 residues in the trimmed dataset as divided by (I) Domain. The categories are: in the terminal 
loops (N/C-term), in loops (Lo), at the interface between loops and helix (Interface). Residues in helices are divided 
into those pointing into the bundle (in), those pointing towards an internal water (in*), and those pointing out 
(out) (WHAT IS S?); (II) Direction of maximum chemical shift change; and (III) Chemical characteristics of the 
residue. (d) Polar plots as described in the text for (I) Nitrogen chemical shifts, and (II) Hydrogen chemical shifts. 
a 
I II 
b c 
I 
II 
III 
d 
I II 
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4.4.2.1.1: Imputation of values 
PCA using an imputation method is useful for the pSRII dataset, where the disappearance of 
peaks at high [SDS] causes gaps in the matrix. This was the original purpose of PCA suggested 
for the analysis of pSRII NMR spectra, because if the whole dataset is included, only 40% of 
the matrix is occupied, and some variables are only represented in one sample. The gaps are 
also not randomly distributed; their representation increases with increasing [SDS] (figure 
4.14a (I)). The power of the PCA increases with the number of variables used, but simply 
optimising for maximum peaks would involve omitting most [SDS]. Based on the biophysical 
kinetics data, the decision was made to use the spectra up to 10% SDS, as most of the rate 
increase has been achieved at that point, and most residues are missing from higher 
concentrations of SDS. 
For this reduced dataset, variables were ranked according to how many spectra they had 
values for, then variables were removed starting with those present only in the native 
spectrum and continuing until NA values (empty spaces) represented less than 10% of the 
matrix, leaving 56 residues of the original 118 in the data set. In practice, this left 6.61% 
missing values in the dataset due to the block removal process. To make sure that a fair 
representation of the chemical shift changes remained the maximum chemical shift changes 
of the whole and the reduced datasets were compared (see figure 4.14a(II)). There appears 
to be no particular pattern of omission.  
4.4.2.1.2: Principal components as a function of [SDS] 
Probabilistic PCA (ppca) estimates the principal component axes using an expectation 
maximization algorithm, and imputes values well compared with other PCA methods. As the 
gaps in the matrix were one of the key concerns, this method was used to perform PCA. 
There are various methods for choosing the number of principal components to return from 
the analysis (Cangelosi and Goriely, 2007). Many of these are complex to implement and 
carry with them theoretical commitments to one or another statistical outlook. An easy rule 
of thumb is to simply return as many components as cumulatively account for a percentage 
of the total variance. A threshold which often returns component numbers close to the more 
complex methods is 80%. In theory, one fewer principal component as you have variables 
can be returned, but this is not useful for most applications. The first two principal 
components, the vectors from PCA which show the correlation of the input variables, of the 
reduced dataset preserved 92.95% of the variance, so no further principal components were 
calculated. As the samples lie on a continuous variable external to the PCA, rather than 
plotting the principal components against one another, as is often used for categorical data, 
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the principal components were plotted against [SDS]. The first principal component is fitted 
well as an exponential decay against [SDS], and the sum of the principal components as an 
exponential growth decay, so the second principal component is fitted as the sum of these, 
as shown in figure 4.14b. The functions to which the principal components were fitted can 
be found in the figure legend. 
4.4.2.1.3: Loading analysis 
It is very difficult to link the output of PCA to physical phenomena. Some variables contribute 
strongly to one or another principal component, and which principal component correlates 
with which variables can point to a unifying explanation. This is quantified as the loadings of 
each variable in the PCA. To visualise how these are distributed in comparison with 
transitions in the 2D spectra, each residue in the reduced dataset was plotted in a polar plot. 
In a polar plot, data points are represented not with numerical coordinates as in the 
Cartesian system, but as vectors with a direction relative to the origin and a magnitude. Each 
can be converted to the other using simple trigonometry. To combine the PCA information 
from the first two principal components and the chemical shift data, the principal 
components were converted from Cartesian to polar coordinates. The angle of the polar 
coordinate is then taken, but the magnitude of the vector is changed to be the maximum 
chemical shift change for that peak. A circle at 0 was drawn around the origin to make the 
visualisation easier, as the chemical shift change of peaks could be positive or negative. This 
endeavoured to show whether how much a residue correlated with one principal component 
(PC) relative to the other was dependent. As the values used for the PCA are separated into 
the hydrogen and nitrogen chemical shifts, polar plots of this type were constructed for both 
(figure 4.14d). For each, there appears to be some correspondence between the direction of 
chemical change and the direction of correlation with the PCs. Particularly evident in the 
polar plot for nitrogen values, if a residue correlates positively with one PC, and negatively 
with another (making its θ between 90 and 180 or 270 and 360), its chemical shift change is 
more likely to be positive, and the opposite is true if it correlates either positively or 
negatively with both PCs. The axis of this effect is not quite diagonal, nor is it symmetrical, 
with more variables correlating negatively with PC1 and positively with PC2 than the inverse. 
This is more marked with hydrogen values. Residues are more likely to be positive or negative 
in chemical shift change for both H and N than for one and not the other (figure 4.14c (II)), 
so it is difficult to tell whether this has any bearing on the distribution. This approach alone 
did not link the principal components to an underlying physical phenomenon.  
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4.4.2.2: Other strategies for chemical shift change analysis 
4.4.2.2.1: Image analysis 
One of the hopes for PCA of NMR of unfolded pSRII was that it would be able to compensate 
for the disappearance of peaks at higher concentrations of SDS. This aim was only partly 
a b 
c d 
Figure 4.15: Image analysis of pSRII spectra. (a) Bucketed NMR spectrum as a pixel image, with intensity as 
greyscale values. (b) All pixels in the top 1% of values highlighted. (c) The centres of each blob of pixels highlighted 
as red circles. (d) Blob centres from 0% to 30% SDS spectra (on continuum from green to red) superimposed on the 
native spectrum. 
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achieved because of the limits of imputation. Another possible avenue was to treat the 
spectra as images (figure 4.15a) and apply image analysis techniques. Preliminary attempts 
using “BLOB analysis” (see section 2.3.4 for details) met with some success. As can be seen 
in figure 4.15, the image analysis technique was able to identify peaks in spectra. An example 
of peaks identified across spectra is shown in figure 4.15d. The low resolution of the bucketed 
spectra provided prevented the useful comparison of peak coordinates between blob 
analysis and the assigned spectra. 
4.4.2.2.2: Fitting 
The magnitude of chemical shift changes generally increased with increased SDS. In most 
cases, the pattern of changes could be fitted with an exponential growth decay. A small 
number (12 in helices and 6 in loops) failed to fit entirely. The root square errors of the fits 
were used as a measure of goodness of fit, and outliers more than two standard deviations 
from the mean of RSE in the upper bound were examined further. For helices, this meant fits 
with an RSE > 0.0212, and for loops 0.0272 (figure 4.16a). For the good fits, there was no 
significant difference between helices and loops for the amplitude of increase against SDS 
            
 
  
 
  
 
  
 
  
 
  
 
  
         
                    
            
 
  
 
  
 
  
 
  
 
  
 
  
         
                    
  
 
 
 
            
 
  
 
  
 
  
 
  
 
  
 
  
         
                   
  
 
 
 
            
 
  
 
  
 
  
 
  
 
  
 
  
         
                    
  
 
 
 
            
 
  
 
  
 
  
 
  
 
  
 
  
         
                    
            
 
  
 
  
 
  
 
  
 
  
 
  
         
                    
  
 
 
 
            
 
  
 
  
 
  
 
  
 
  
 
  
         
                   
  
 
 
 
            
 
  
 
  
 
  
 
  
 
  
 
  
         
                    
  
 
 
 
            
 
  
 
  
 
  
 
  
 
  
 
  
         
                    
            
 
  
 
  
 
  
 
  
 
  
 
  
          
                    
  
 
 
 
            
 
  
 
  
 
  
 
  
 
  
 
  
          
                   
  
 
 
 
            
 
  
 
  
 
  
 
  
 
  
 
  
          
                    
  
 
 
 
            
 
  
 
  
 
  
 
  
 
  
 
  
          
            
 
  
 
  
 
  
 
  
 
  
 
  
          
  
 
 
 
            
 
  
 
  
 
  
 
  
 
  
 
  
          
  
 
 
 
            
 
  
 
  
 
  
 
  
 
  
 
  
          
  
 
 
 
 
 
  
  
 
  
 
  
  
 
  
 
  
  
 
  
 
  
  
 
  
 
  
  
 
  
 
  
  
 
  
 
  
  
 
  
 
  
  
 
  
 
  
  
 
  
 
  
  
 
  
 
  
  
 
 
  
 
  
  
 
 
  
 
  
  
 
 
  
 
  
  
 
 
  
 
  
  
 
 
  
 
  
  
 
 
  
 
  
  
 
       
 
 
 
 
 
 
      
   
         
  
        
  
 
   
            
 
  
 
  
 
  
 
  
 
  
 
  
        
 
 
 
   
 
 
 
            
 
 
 
 
 
 
        
 
 
  
  
 
 
 
  
 
 
Figure 4.16: Clustering of residues by chemical shift change (a) RSE of fitting a single exponential 
growth decay curve to the chemical shift change profiles of residues, divided into helix and loop 
residues. (b) Scatter plots of the fit parameters (amplitude (I) and rate constant (II) for all residues 
successfully fit to a single exponential curve. Helix residues in black, loop residues in red. (c) All 
residues clustered by normalised chemical shift change as a function of SDS. The hierarchical 
clustering was split into 16 clusters. A χ
2
 test of the clusters against domain has a p-value of 3.09 x 10
-
3
. (I) A barplot of the number of residues of a given domain (by colour) in a given cluster. (II) The 
normalised profiles of the residues used for clustering divided by cluster. 
a c 
b d 
I 
II 
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concentration. However, when each parameter 
was plotted against the residue’s position in 
primary structure, there appeared to be some 
periodic variation in amplitude (figure 4.16b), but 
no satisfactory formal profile could be established.  
The shapes of the poorly fitted residues were 
compared by first normalising them to values 
between 0 and 1 by dividing the magnitude of 
change at a given [SDS] by the maximum 
magnitude for that residue. Each residue was then 
treated as a point in n-dimensional space, where n 
is the number of SDS concentrations at which the 
residue was observed, and its magnitude in each 
dimension is the magnitude of chemical shift 
change at that concentration. The values were 
clustered by the daisy algorithm (Introduction to "Finding groups in data,” 2008) using Gower 
distances (Gower, 1971). They were then separated into 4 groups (4 was chosen arbitrarily) 
in hope that better models for the patterns of their change could be defined, but without 
success. 
Once this had been done, the clustering process was repeated for all residues with a peak in 
at least two spectra, with 8 clusters. A χ2 test was performed on the clusters to see if the 
classification could distinguish residue chemical properties or domains. No significant 
classification in chemical properties was achieved, but the χ2 value for domain classification 
was 82.44 on 42 degrees of freedom, with a p-value of 1.93 x 10-4. The procedure was 
repeated with 16 clusters, which had a χ2 value of 131.07 on 90 degrees of freedom, with a 
p-value of 3.09 x 10-3. The populations of these clusters are shown in figure 4.16c (I). The 
profiles of the residues used for clustering are shown in figure 4.16c (II), divided by cluster. 
The larger clusters have varying profiles, and some clusters have very few members. 
However, clusters 10 and 12 have distinct profiles and are well populated (16 and 6 
respectively).  
Figure 4.17: pSRII structure coloured by cluster. 
Clusters with fewer than five members are not 
coloured. Cluster 1 = red, Cluster 2 = orange, 
Cluster 3 = yellow, Cluster 4 = green, Cluster 6 = 
cyan, Cluster 8 = blue, Cluster 10 = purple, Cluster 
12 = magenta, Cluster 13 = black. 
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4.5: Discussion 
Kinetics of unfolding 
To compare the folding of pSRII with MR and bR, an experimental unfolding system had to 
be devised. Initial experiments with SDS unfolding, the most successful reagent for MR 
unfolding, suggested that pSRII would also be informatively unfolded. A screen of other 
reagents and conditions was carried out by collaborators at the University of Cambridge 
(paper in preparation), but the use of SDS achieved the greatest unfolding without 
aggregation. Though a similar experimental setup was used for pSRII and MR unfolding 
(Dutta et al., 2010a), absorbance time courses of pSRII unfolding showed very different 
kinetics, with much slower disruption of retinal-protein contacts, and faster hydrolysis of the 
Schiff base (figure 4.2), making analysis of the reactions on the same time scale possible. 
Devising a combined kinetics and decomposition model (outlined in section 4.3) allowed the 
separation of two unfolding processes: loss of specific protein contacts and hydrolysis of the 
Schiff base. The early changes in absorbance spectra are indicative of events outside the time 
resolution of the current experiments which may show further differences between 
unfolding of pSRII with different SDS concentrations. BR is closely related to pSRII, with an 
absorbance maximum at 570 nm. Specific residues are responsible for the blue shift of pSRII 
compared with BR, including asparagine 72. The fact that in early spectra the λmax of the 
native-like states of pSRII in low [SDS] are shifted to the red and the shoulder peaks disappear 
suggests that the interaction of this residue is disrupted earlier on compared to other retinal 
binding pocket residues, but the fast kinetics are beyond the reach of the experimental 
setup. 
The separation of processes provided by decomposition of absorbance spectra also allowed 
comparison with fluorescence time courses. After finding a single exponential curve was 
inadequate for modelling the increase in fluorescence upon unfolding, the knowledge of 
kinetics taken from absorbance informed the modelling of this as a superposition of two 
kinetics equations, which was then vindicated by the fact that the second reaction of both 
methods had the same rate, constant across SDS concentrations (figure 4.11e). That the first 
reaction was similar, but not exactly the same between measurement methods (figure 4.11f) 
does not contradict these models, as the changes absorbance spectroscopy is sensitive to 
are not the proximity of tryptophan residues, which is detected by fluorescence. The rates 
recorded by fluorescence are generally lower, but perhaps more interesting is that the 
dependence of these rates upon SDS concentration is also slightly different. For both, the 
rate declines beyond 3% SDS. When this was first observed in kinetics determined by 
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absorbance, it was thought that perhaps mixing was compromised at very high SDS due to 
viscosity. It is possible that this is the explanation for both absorbance and fluorescence 
experiments, and that differences in the experimental setups account for the differences in 
recorded rates. It is also possible that the rate differences are due to artefacts of the fitting 
process, but then it would be reasonable to assume a similar effect on rates of the second 
reaction. Had the rates of the second process for each been different, the models would 
need revision. 
Like the revelation of early absorbance spectral changes revealed by decomposition, the 
modelling of fluorescence time courses revealed more than kinetic information. That the 
fluorescence change between the   as a proportion of the total fluorescence increase is larger 
at higher SDS shows that loosening of the helical bundle is not only faster but to a greater 
extent as SDS increases. Whereas the kinetics reach a peak at 3% SDS and slightly decline at 
higher SDS, the relative share of the first curve continues to increase. Using kinetic models 
means that this is not just due to increased rates, as might be observed with models of 
parallel processes. Without this decomposition, such a conclusion could not have been 
reached. 
Unfolding in the presence of hydroxylamine was intended to simplify the fitting process and 
confirm the rates of the first reaction because in MR, formation of the retinal oxime is 
instantaneous with the formation of the protonated Schiff base. However, in pSRII this is not 
true, and though the overall reaction from native pSRII to release of retinal is increased, the 
reaction is not as rapid as the loosening of the helical bundle. This caused problems with the 
fitting of fluorescence time courses. Whether a single or double exponential is a better model 
at a given SDS concentration more ambiguous than for the same reaction without 
hydroxylamine. This is likely to be because the two reactions occur at similar rates, which has 
a similar profile to a single reaction. 
With these observations, it is somewhat surprising that, in absorbance spectra, no 
protonated Schiff base is observed. Indeed, the shoulder peaks are observed at SDS 
concentrations where they are absent in spectra without hydroxylamine. This implies that 
hydroxylamine reacts with retinal in unfolding pSRII quickly enough to prevent buildup of 
protonated Schiff base or whatever intermediates have altered spectra (see section 4.4.1.8, 
Figure 4.11b), but somehow slowly enough that the overall reaction is not as fast as the first 
reaction in the two consecutive reactions observable without it. It is also interesting that the 
effects on the rate caused by hydroxylamine might be different as measured by fluorescence 
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and absorbance, illustrating the differences between the loss of interactions causing the 
change to protonated Schiff base and the loosening of the bundle which moves the 
tryptophans away from retinal. This may not be a robust conclusion because of the 
difficulties decomposing fluorescence time courses. 
Fitting of CD time courses was less informative. All time courses were better modelled by a 
single exponential curve than two. That the secondary structure should deteriorate in a 
single process would be unsurprising, but it is possible that the noise in the measurements 
might be covering up a second process, so this result is not conclusive. 
Refolding 
Decomposition of the absorbance time courses for refolding was also informative. First, it 
demonstrates that pSRII is already properly refolded without retinal with two observations. 
First is that no protonated Schiff base forms, as no 440 nm peak arises, and second is that 
the native profile of shoulder peaks, dependent on the native vibronic state of retinal with 
pSRII, is instantly established. It also allowed an accurate determination of the proportion of 
pSRII refolded and shows that the time spent in the unfolded state, rather than the extent of 
unfolding, is the greatest determinant of whether pSRII will refold. The confirmation that a 
native profile is instantly established allowed the automation of the refolding kinetics fitting, 
a script for which is currently being used by collaborators in Cambridge to explore refolding. 
The automated refolding assumes a single exponential curve models the refolding reaction, 
which generally serves well. The residuals do have a small, early discrepancy, similar to the 
pattern observed in the fitting of single processes to the consecutive first order reactions in 
fluorescence. These are larger in 7% SDS than in 1% SDS. Fitting two exponential decays to 
the 1% SDS data improves the fit as measured by AIC, but not for 7% SDS. However, using 
the rate equation for the second of two consecutive reactions fits better for 7% SDS. As no 
440 nm peak is observed in this data, it appears that the protein has refolded before binding 
retinal. The improvement in fitting at 7% by using the rate equation might suggest the 
refolding is slightly slower at 7% SDS than 1%, where even a single exponential decay makes 
a better fit, or it could reflect a slower mixing of the c7 into the SDS micelles, which could be 
the first of two reactions which is invisible to absorbance spectroscopy. 
Difficulties in fitting refolding time courses led to the development of an automatic peak 
picking algorithm. The fact that skewed peaks were present in the spectra prevented the 
peak picking automation being useful here. However, the algorithm still showed its 
usefulness to identify small peaks in a noisy background environment. The shoulder peaks in 
pSRII were not detected well by differential peak picking methods, so it was hoped that by 
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“oversmoothing” the data and subtracting this from the dataset they could be distinguished. 
In hindsight, a better optimised method using differentials derived from Savitzky-Golay 
filtering of the data, or some combination of the two, may be useful, as was found for the 
fitting of Ce6 spectra. This method struggled with smaller, broader peaks, but the Savitzky-
Golay filter is highly customizable, so a future implementation may perform better. If the 
current strategy remains useful, there are improvements that can be made, especially in the 
starting estimate stage. 
Noise registers as small peaks at this stage. An extra smoothing filter step between 
oversmoothing and applying the rolling disc is likely to resolve this issue. A second issue is 
the distortion of larger peaks and occasional loss of a broader peak during the application of 
the rolling ball. Again, this does not necessarily find representation in the final fitting but puts 
an undue burden on later stages of the estimation. Using different parameters for the rolling 
disc can mitigate these issues, but as yet no general optimal solution has been found. 
NMR of unfolded states 
HSQC NMR spectra provide a wealth of information that may not be amenable to unaided 
human analysis. The use of PCA on HSQC spectra of pSRII unfolded states was originally 
suggested as a method for imputation of missing values where peaks disappear from the 
spectra. Imputation methods can only add so many values when the dataset is sparse, so this 
aim could not be met. However, the PCA was useful in that the first two principal 
components, which account for 93% of the variance of the data, follow regular patterns 
across SDS concentration. It is important to note here that the PCA does not “know” that the 
different spectra are taken at different SDS concentrations, so this represents the 
identification of two underlying SDS dependent processes observed in the data. The physical 
nature of principal components is difficult to identify, but the analysis of loading values using 
polar plots shows that such an identification may be possible. This might also be explored 
using the clustering of chemical shift change profiles carried out here, which was sensitive to 
the domains of residues. 
Summary 
Building on the work on MR unfolding, an SDS unfolding protocol was established for pSRII. 
The differences in the kinetics of the stages of unfolding meant that the pSRII system lent 
itself well to more sophisticated analysis of absorbance and fluorescence data, allowing the 
development of a kinetic model which enabled the extraction of further information relating 
to specific changes. It was also reversible, and decomposition of absorbance spectra show 
that this refolding is not retinal dependent. Detailed analysis of 2D NMR spectra of the 
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unfolded states of pSRII revealed patterns in the data not available to human observation, 
which may be developed to show whether pSRII strictly follows the two-stage model for 
folding, or also requires proper long-range interactions, as suggested by FIRST analysis. 
The unfolding and refolding reactions of pSRII, analysed by biophysical methods, form a new 
model system for the folding of helical membrane proteins. The ways this system differs from 
the folding of bR and MR will provide a new avenue for determining the factors which 
contribute to different mechanisms of folding. The methods developed here of separating 
different contributions to time courses of absorbance spectra and fluorescence emission 
may also be of interest to those investigating kinetics through such observations. The analysis 
of NMR spectra with PCA is not new (Konuma Tsuyoshi et al., 2012; Sakurai and Goto, 2007), 
though previous use of the other methods applied to the NMR spectra have not been 
observed in the literature. 
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CHAPTER 5: FURTHER DEVELOPMENT OF RHODOPSIN AS A MODEL 
SYSTEM FOR NMR STUDIES OF FOLDING AND MISFOLDING 
5.1: Summary 
Mammalian rhodopsin is a well characterised model system for an important family of 
proteins: the class A G-protein coupled receptors. Its denaturation by SDS yields unfolded 
states which do not aggregate, allowing the characterisation of these states (Dutta et al., 
2010b, 2010a). This makes it a model system for the folding of helical membrane proteins 
(MP), an understudied field due to the difficulties of working with membrane proteins. Unlike 
other helical MP folding model systems, residual structure is found in unfolded states, here 
centred around the extracellular (EC) domain. Samples of rhodopsin with isotope labelled 
methionines were prepared for nuclear magnetic resonance (NMR) spectroscopy due to the 
favourable relaxation characteristics of the methyl group of methionine. Samples were 
prepared in both dodecyl maltoside (DM), the standard detergent for rhodopsin 
experiments, and lauryl maltose neopentyl glycol (LMNG), which has properties favourable 
for NMR. These properties were overshadowed by difficulties with sample preparation. 
Preliminary assignments of the peaks in HMQC spectra were made, and a rationale for using 
thiol specific spin labels to aid assignment was explored. 
This development of rhodopsin as a model system is applicable to future studies of folding 
and has made possible the NMR study of rhodopsin misfolding in the P23H mutant (chapter 
6). 
5.2: Introduction 
5.2.1: Rhodopsin as a folding model 
As discussed in the introduction to chapter 4, the SDS unfolded states of rhodopsin combine 
a high degree of secondary structure loss with a lack of aggregation (Dutta et al., 2010b). 
These states were investigated with a variety of both time-resolved and steady-state 
techniques (Dutta et al., 2010a). In the original investigation, the changes measured were 
global. A combination of NMR and electron paramagnetic resonance (EPR) experiments were 
later conducted on rhodopsin denatured in both different concentrations of SDS and a 
combination of 3% SDS and 8M Urea (3S8U). 
The NMR data showed qualitatively that the cytoplasmic domain of rhodopsin becomes 
progressively more flexible with the addition of SDS, even from 0.05% SDS. The 
transmembrane and extracellular domains lose both secondary and tertiary structure, but 
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retain some rigidity even at 30% SDS, in the maximally unfolded state. It has been argued 
that proteins can never be in a true random coil (Shortle and Ackerman, 2001), and that, for 
membrane proteins, secondary structure is likely to remain in disordered states (Kjaergaard, 
2015). It has also long been observed that SDS can induce non-native helix formation 
(Grourke and Gibbs, 1967) These experiments allowed a higher level of resolution to earlier 
experiments and 1D 1H NMR measurements carried out in the same work, discriminating 
between domains. The EPR experiments introduced labels to individual residues in the 
cytoplasmic and extracellular domains and showed the same general pattern. However, the 
single residue resolution also showed that the residual structure was not retained across the 
whole extracellular domain and that T108, not included in the predicted folding core (Tastan 
et al., 2007), lost rigidity at low concentrations of SDS. There are drawbacks to EPR, however. 
The label introduced is bulky, and introducing it requires mutation.  
5.2.2: Rationale for labelling 
rhodopsin with methionines 
Selectively labelling methionine residues 
reduces the number of peaks in 2D HMQC 
(see section 1.1.4.1) spectra compared to 
full labelling, but the assignment of these 
peaks without mutagenesis is difficult. 
Previous work has focused on 15N-labeled 
amino acids, but the signal intensity was found to be highly variable and overall low, with 
rapid relaxation (J. Klein-Seetharaman et al., 2002; Werner et al., 2007). Incorporating 13C-
labeled amino acids  has been used for improved signal in large complexes (Beatty et al., 
1996; Tugarinov et al., 2003) including GPCRs (Nygaard et al., 2013). We therefore 
investigated NMR studies of 13C,15N-methionine labelled rhodopsin. 
As with 15N-HSQC spectra, there are chemical shift changes associated with the side chain 
conformations of aliphatic residues. The methyl group of methionine is very flexible and has 
three proton resonances. The sulphur connecting the methyl carbon has unique effects upon 
its resonance, and the trans/gauche conformation (Figure 5.1a) has been correlated with 
specific chemical shift changes by comparing resonances from the BioMagRes database with 
angles obtained from examination of crystal structures from the protein data bank 
(Butterfoss et al., 2010). 
 
  
 
  
   
 
 
 
   
     
  
Figure 5.1: Estimation of methionine chemical shifts. (a) 
View of methionine, showing the angle of trans/gauche 
rotamerism. (b) Structure of methionine. 
a b 
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Rhodopsin contains sixteen methionines. These are well distributed throughout, with three 
in loops, five at the interface of helices, and the rest buried in transmembrane helices (figure 
5.2a). Importantly for their use in investigating the folding of rhodopsin, four are within 5Å 
of the folding core. One of these, M207, is within the folding core, as shown in figure 5.2b. 
The methionines are also well distributed between the faces of rhodopsin. Nine are closer to 
the extracellular side, meaning five residues are in a similar place to the folding core, without 
being involved in it, making a useful comparison.  
5.2.3: Amphiphiles for solubilisation of Rhodopsin for NMR 
n-Dodecyl β-D-Maltoside (DM, Figure 5.3a) solubilises rhodopsin from both rod outer 
segments and cultured cells and maintains rhodopsin’s stability better than many other 
39 
44 
49 
86 
143 
155 
163 
183 
207 
253 257 
288 
308 
309 
317 
Figure 5.2: Positions of methionines and 
the folding core (a) Secondary structure 
representation of rhodopsin. 
Methionines are highlighted red, folding 
core residues circles in green. 
Methionines at the positions 86, 163, 
and 183 are within 5Å of the folding core. 
M207 is part of the folding core. These 
methionines are indicated by green 
arrows. The position of P23 is indicated 
by a blue arrow. (b) 3D structure of 
rhodopsin, showing the backbone in 
grey. Folding core residues are 
represented as green spheres, except 
M207, highlighted in red. Other 
methionines are shown as red ball-and-
stick. 
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detergents (Loewen et al., 2001; Ramon et al., 2003). Solubilisation is necessary for many 
biochemical and biophysical experiments. It is the detergent used for the other rhodopsin 
experiments in this thesis and was used to prepare initial NMR samples. 
Lauryl maltose neopentyl glycol (LMNG, Figure 5.3b) has been used to solubilise different 
rhodopsin complexes (Gao et al., 2017; Jastrzebska et al., 2013). Previous NMR work on the 
β2-adrenoreceptor showed distinct functional states in LMNG that were not accessible with 
the protein solubilised in DM (Chung et al., 2012). Better protein stability and lower 
aggregate mass resulting in better resolution were also reported. 
The preceding amphiphiles are traditional detergents.  Other compounds with similar 
properties have been engineered for use in studies of membrane proteins (Bayburt and 
Sligar, 2010; Popot et al., 2003; Seddon et al., 2004). Amphiphiles based around a triazine 
core have been designed (Beecham Matthew P. et al., 2013) to incorporate methylamines, 
which can be kosmotropes, or molecules which stabilize proteins (Kane et al., 2003). It is 
hoped that the modifiable groups on these amphiphiles can be tailored for particular 
purposes for particular proteins, for example, incorporation of kosmotropes improves 
crystallization of membrane proteins, and other modifications have been used to inhibit 
aggregation (De Bernardez Clark et al., 1999). One of these (molecule 19 in the above 
  
    
  
     
      
  
              
 
   
  
   
 
 
 
 
 
  
  
  
 
 
 
  
 
 
 
 
 
 
  
  
 
 
 
 
 
 
 
a b 
c d 
Figure 5.3: Structures of the amphiphiles used to solubilize rhodopsin. (a) n-
Dodecyl β-D-Maltoside (DM). (b) Lauryl maltose neopentyl glycol (LMNG). (c) 
Triazine based amphiphile courtesy of Andrew Marsh (AM-2). (d) Amphipol A8-35 
(A835) 
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reference, referred to here as AM-2, Figure 5.3c) including morpholino and dodecyl groups 
was the kind gift of Andrew Marsh (University of Warwick). 
Amphipols are unlike traditional detergents. Rather than being small, well defined 
molecules, amphipols are large polymers with hydrophilic backbones derivatized with 
hydrophobic groups (Tribet et al., 1996). Amphipols with polyacrylate backbones are highly 
flexible and do not form intramolecular hydrogen bonds, and those with low weights have 
been used to solubilise membrane proteins, even from inclusion bodies (Dahmane et al., 
2009; Flötenmeyer Matthias et al., 2007) and cell-free expression systems (Etzkorn et al., 
2013). Benefits of solubilising in amphipols can be greater stability (Bazzacco et al., 2009; 
Calabrese et al., 2015) and that they bind almost irreversibly to membrane proteins, so no 
critical micelle concentration must be maintained in the bulk solution as for detergents. One 
of these amphipols, A8-35 (Figure 5.3d), named in (Tribet et al., 1996) for its approximate 
mass (8kDa) and proportion of derivatized groups (~35%), was tested for its ability to 
solubilise rhodopsin.  
5.3: Results 
5.3.1: Amphiphile screen 
The four amphiphiles described in the introduction were tested for their ability to solubilise 
rhodopsin from rod outer segment (ROS) suspension. The remaining rhodopsin in the pellets 
from this solubilisation was further treated with DM so comparisons to DM could better be 
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Figure 5.4: Use of different amphiphiles 
with rhodopsin (a) Solubilisation of 
rhodopsin in different amphiphiles. The 
dark bar shows the yield of rhodopsin from 
solubilisation in the indicated amphiphile. 
The lighter bar indicates the recovery of 
rhodopsin from the pellet by solubilisation 
in DM. (b) Elution of rhodopsin in LMNG 
buffer. Fractions E1 to E9 in pH 6 NaPi 
buffer, thereafter in PBS (dashed line). (c) 
Comparison of rhodopsin in LMNG eluted 
using NaPi and PBS buffers. Fractions with 
similar A500 have been selected for 
comparison. 
b 
a 
Solvent 
Pellet 
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made. As can be seen in figure 5.4a, DM is best able to solubilise rhodopsin. LMNG and AM-
2 are each able to solubilise a little over half the rhodopsin of which DM is capable, and A8-
35 around a quarter.  
5.3.2: NMR of methionine labelled wild-type rhodopsin in DM 
HMQC spectra of rhodopsin in DM were recorded and tentatively assigned using the 
prediction strategy described in section 5.2.2 (Butterfoss et al., 2010). Predicted values for 
the peaks are compared with observed values in figure 5.6b. Figure 5.6a shows how these 
values compare with recorded peaks. Assigning 13C shifts of methionine terminal methyl 
group (ε) carbons is considered reliable outside the region between 16.5 and 18 ppm. As can 
be seen in figure 5.6a, many of the recorded peaks fall within this region. 
The calculated values are not the only information useful for the assignment of peaks. The 
relative flexibility of different regions provides information about the expected broadness of 
peaks. 
Spectra were recorded at 298K and at 308K, the latter for the greater resolution at higher 
temperatures, and the former so that comparison could be made with other samples 
d 
a b 
c 
e 
308K 298K 
+MTSL 
DM 
LMNG 
Figure 5.5: HMQC spectra of rhodopsin 
labelled with [
13
C5, 
15
N]methionine (a) in 
DM, MTSL labelled, 308K, 256 scans; (b) in 
DM, MTSL labelled, 298K, 256 scans; (c) in 
DM, 308K, 256 scans; (d) in DM, 298K, 224 
scans; (e) in LMNG, 298K, 256 scans. All 
scans at 800MHz proton frequency. 
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potentially unstable at 35oC. The spectra are generally similar, notable differences being the 
possible loss of a peak at (1.6,19.5) ppm. The peak assigned as M257 is adjacent, so this could 
merely be the narrowing of that peak. 
 
5.3.3: MTSL labelling of 13C,15N-met rhodopsin 
Though many of the peaks in figure 5.6 were assigned from the predictions made from the 
χ3 rotamer predictions, some of these values are found within the range between 18 and 
16.5 ppm and are therefore ambiguous. It was therefore decided to attempt the 
unambiguous assignment of some peaks using a combination of added paramagnetic 
relaxation enhancement (PRE) active reagents, which increase the transverse relaxation rate 
of nearby nuclei (as described in section 1.1.4.1). The effect of these is to diminish the peaks 
in the space around themselves, so peaks disappearing upon their addition will be close to 
the reagent.  
There are existing protocols which can be adapted to introduce such a reagent to the 
cytoplasmic face of rhodopsin. S-(1-oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-
yl)methyl methanesulfonothioate (MTSL) is a thiol specific spin label that has previously been 
Qe
shift 
Chemical 
shift Dihedrals 13C shift
M86 0.215 2.345 1.445 16.8
M39 0.137 2.267 1.677 18.4
M253 0.115 2.245 2.674 19.1
M1 0.084 2.214 -1.288 15.7
M309 0.042 2.172 1.151 14.7
M308 0.027 2.157 -1.185 15.0
M143 0.013 2.143 -1.323 15.9
M49 0.013 2.143 -1.595 17.9
M155 -0.009 2.121 1.490 17.2
M317 -0.041 2.089 1.457 16.9
M257 -0.131 1.999 2.064 19.8
M288 -0.295 1.835 1.630 18.1
M183 -0.489 1.641 -2.214 19.9
M207 -0.913 1.217 1.233 15.3
M44 -1.039 1.091 -1.032 14.0
M163 -1.211 0.919 -1.459 16.9
Figure 5.6: WT rhodopsin in DM with 
assignments. (a) Overlay of the predicted 
peak positions for methionines (blue circles) 
with figure 3(d). Red dashed lines connect the 
assigned peaks with the theoretical overlay. 
Dotted-dashed lines indicate the boundaries, 
16.5 and 18ppm between which 13C shifts are 
unreliable. (b) Table showing the predictions 
for each residue. Qe shift is from a 
pseudoatom at the centre of He1, He2, He3). 
1H shift is from a reference of 2.13 ppm, 
calculated as in Bundi and Wüthrich, 1979. 
Dihedrals are and reported as radians, from 
which 13C shift is calculated from Butterfoss
et. al 2010, as outlined in the chapter 
introduction. (c) Overlay of figure 2(d) (black, 
298K) with figure 2(c) (blue, 308K)
a b
c
1.6, 19.5
M257
1H (ppm)
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used for EPR spectroscopy (Klein-Seetharaman, 2002) with rhodopsin, and is also, as a spin 
1
3
9
44
49
8
6
143
15516
3
18
3
207
253 257
288
308
30
9
317
Within 
25 Å
Crystal 
surface
Surface 
with 
detergent1. M183 is barely on the 
solvent accessible 
surface
2. M49 and M86 
borderline
20
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d
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ce
Methionine
Figure 5.7: Rationale behind MTSL labelling/Soluble PRE reagent. (a) Venn
diagram showing the theoretical effects of different PRE reagents on methionines.
Residues which are marginal for an effect are placed on the borderlines. (b) The
sum of the PRE effects on different residues. The closest distances between each
methionine and the labelled cysteines was measured (r). The PRE effect is
proportional to r-6, and the points represent the sum of these, assuming no
synergistic effects. The orange line shows the r-6 for 25Å, the quoted value for the
limit of PRE effects. The y-axis is logarithmic due to the orders of magnitude
difference between residues. Values above the orange line will be affected by
MTSL, those below will not. (c) Model of rhodopsin displaying labelled cysteines
(red spheres), methionines within 25Å of those cysteines (green) and those
outside that radius (blue). (d) Model of rhodopsin, displaying methionines on the
surface of the crystal structure (magenta), and those buried in the structure
(green). Of the nine magenta residues, only four (positions 1, 143, 183, 307) are
unlikely to be covered by detergent.
a
b
c d
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label, useful for PRE. Therefore, protocols exist for the MTSL labelling of rhodopsin, though 
not in the quantities used for NMR. MTSL reacts with accessible cysteines, which in rhodopsin 
means C140 and C316, both found on the cytosolic side (see figure 5.7c). Past usage of MTSL 
labelling shows that the biophysical characteristics of rhodopsin are little affected by the 
label. Existing protocols were modified (see Methods) in an attempt to label only C140. There 
are also PRE reagents which are soluble, so act upon the residues near the surface.  
The rationale for the use of these reagents, alone and in combination, is shown in figure 5.7. 
The PRE from spin-labels depends on the separation between groups to the power of six, so 
the magnitude of the effect upon different peaks was used to distinguish peaks near the 
derivatized residues. The ratio of the effect was estimated by measuring the distance 
between the thiol group of cysteines 140 and 316 and the methyl groups of each methionine, 
then adding the two distances to the power of six for each methionine, assuming the effects 
combine linearly. The added effects are shown in figure 5.7b. The effective range of PRE 
reagents is usually quoted as 25Å, and 25-6 is shown as an orange line. The methionine 
residues affected by MTSL labelling from these calculations are 86, 143, 155, 163, 247, 253, 
308, 309 and 317. M49 is very close to the line with calculations done this way. M183 is not 
within 25Å of either cysteine, but the combined effects, assuming they are additive, would 
make it one of the residues affected.  
Figure 5.8: Rhodopsin with MTSL labelling (a) MTSL-rhodopsin in DM at 308K (b) MTSL-rhodopsin in 
DM at 298K (c) Overlay of (a) with rhodopsin in DM at 308K. (d) Overlay of (b) with rhodopsin in DM at 
298K. 
a b 
c d 
M25
3 
M309 
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The extent of labelling achieved by the tested protocols is not entirely certain, though based 
on previous work with cysteine labelling with PDS (Cai et al., 1999; Judith Klein-Seetharaman 
et al., 1999) suggest that due to the short time and small concentration chosen, a single 
cysteine, C316, should be labelled, with possible labelling of a smaller percentage of C140. 
The positions of peaks in MTSL-rhodopsin are not affected, but some of the relative 
intensities are (Figure 5.8). The only peak consistently attenuated is the one assigned as 
M309, which at 298K (Figure 5.8b/d) is at 50% intensity, and at 308K is at 71% intensity 
(Figure 5.8a/c). The peak assigned as M253 shows 89% intensity at 308K, but 110% intensity 
at 298K.  
5.3.4: Rhodopsin in LMNG 
DM has strong peaks in NMR, overlapping with the region where methyl resonances are 
found. Lauryl maltose neopentyl glycol (LMNG) exhibits less interference, and has previously 
been used for rhodopsin experiments (Gao et al., 2017; Jastrzebska et al., 2013). For these 
reasons, the possibility of recording NMR spectra in LMNG was explored. A comparison 
showing the lower interference in LMNG can be seen in figure 5.9b 
5.3.4.1: Elution 
The solubilisation of rhodopsin by LMNG from ROS suspension was tested, and found not to 
be sufficiently effective when compared to DM, as shown in figure 5.4b. For this reason, 
Figure 5.9: HMQC spectrum of rhodopsin in LMNG (a) HMQC spectrum as figure 2e. (b) 
Overlay of figure 2e (cyan, LMNG at 298K) and figure 2d (black, DM at 298K). (c) Structure 
of rhodopsin, with methionines 253, 257 and 308 highlighted in blue. 
1.6, 19.5 
1.3, 19 
1.0, 19.5 
1.6, 16.5 
1.95, 19.5 
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rhodopsin was solubilised in DM, then exchanged for LMNG during purification as described 
in section 2.2.1.4.2.2. 
When eluting from the 1D4-Sepharose column, 0.001% LMNG in NaPi buffer was first 
attempted. However, the yield was very low. An increase in LMNG concentration to 0.01% 
was first attempted, then it was found that switching buffer to PBS, maintaining 0.01% LMNG 
was necessary. This may increase the portion of misfolded opsin eluted (Liu et al., 1996), but 
achieved satisfactory elution yields (around 80%). 
5.3.4.2: NMR spectra 
The HMQC spectrum of rhodopsin in LMNG, shown in Figure 5.9, was not substantially 
different from that in DM. A large amount of the signal around 13C 12ppm has been lost 
compared with the DM sample. There are also substantial changes in the spectrum between 
13C 19 and 20ppm: the peak(s) around (1.6,19.5) in the DM spectrum have also vanished in 
the LMNG spectrum. This peak was assigned to M257 in the DM spectrum. The peak at (1.3, 
19), assigned to M187, has also disappeared, and an intense peak has appeared at (1.0, 19.5). 
The peaks assigned to M308 and M253 (at (1.6,16.5) and (1.95,19.5) respectively) have also 
shifted. This may be of interest, as the residues 308, 253 and 257 are very close. Otherwise, 
peaks are similar between spectra in the two detergents. Currently, due to the difficulties in 
solubilisation with LMNG and the overall similarity between the NMR spectra in both 
detergents, DM is more convenient for NMR experiments.  
5.4: Discussion 
Introducing 13C into rhodopsin via methionine is useful as a labelling strategy to ease 
interpretation of NMR spectra of membrane proteins due to methionine’s relative scarcity 
in proteins and slow relaxation characteristics giving relatively sharp lines. Furthermore, 
focusing on the methyl group in methionine has the advantage that three protons are 
averaged, multiplying the signal intensity by 3 as compared to a single proton. In rhodopsin, 
it is also useful because the distribution of methionines is across the protein, including some 
residues in and near the predicted folding core (figure 1). The assignment strategy using 
correlations between dihedral angles in crystal structure and chemical shift can be useful but 
was limited here because the highly dynamic structure of rhodopsin loosened the correlation 
at the temperatures used for NMR. There are issues with comparing NMR and crystal 
structures, mainly due to the fact crystallography is conducted ~200K below NMR. This 
means that there are borderline values for the chemical shifts of methionine for which the 
conformations are uncertain. Similar difficulties have been encountered in the use of these 
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strategies with the related β1AR (Daniel Nietlispach, personal communication). The 1H 
chemical shifts are very sensitive to ring currents, so any change of the relative positions of 
these protons to the aromatic residues of rhodopsin will affect peak position. 
Expression systems previously used for labelling of other residues have been useful here 
(Getmanova et al., 2004; J. Klein-Seetharaman et al., 2002; Klein-Seetharaman et al., 2004, 
1999; Loewen et al., 2001, p. 19), and have yielded NMR spectra. Though DM has some 
disadvantages as a detergent for NMR spectroscopy, its utility with rhodopsin has so far 
outweighed these, though optimisation of elution protocols with LMNG may make this 
superior in future. It is clear that such improvements are possible as other groups have had 
greater success (Gao et al., 2017; Jastrzebska et al., 2013). That the amphipol tested here is 
capable of solubilising rhodopsin is intriguing, due to the potential advantages for NMR of 
using amphipols over traditional detergents (Etzkorn et al., 2013). The low yield in 
preliminary tests described here may be improved upon, as amphipols are sensitive to buffer 
conditions (Popot et al., 2003). 
The spatial resolution of the use of PRE reagents may make their use a helpful technique in 
assignment of spectra, but here the goal has not been fully realised. Very little real change 
was observed, and the changes disagree with the predicted differences. For example, that 
the peak assigned to M317 is unaffected is surprising due to its proximity to C316. The peaks 
that were affected, assigned to M253 and M309, are among those predicted to be strongly 
affected by MTSL, but the effect upon M253 changes with temperature. Proper 
determination of the extent of MTSL labelling and optimization of the protocol would 
improve matters when using the cysteine labelling, and the use of soluble PRE reagents will 
be more informative than MTSL alone.   
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CHAPTER 6: RHODOPSIN MISFOLDING 
6.1: Summary 
The P23H mutation to rhodopsin is a cause of autosomal dominant retinitis pigmentosa 
(ADRP). The mutant protein can be recombinantly expressed in sufficient quantities for 
biochemical and biophysical experiments. Previously, western blots qualitatively showed 
that both P23H and N15S, another ADRP rhodopsin mutant, show aberrant glycosylation. 
These blots were further analysed to aid interpretation of the qualitative data and supply 
quantitative analysis. This analysis ascertains that both mutants display different 
glycosylation from wild-type and that P23H shows more aberrant glycosylation and 
aggregation than N15S. Samples of methionine labelled P23H in DM were prepared for NMR 
spectroscopy, building on the work described in chapter 5. Significant differences between 
wild-type and P23H rhodopsin can be observed in recorded spectra. During attempts to use 
paramagnetic relaxation enhancement reagents to assign peaks in these spectra, it was 
found that labelling of P23H cysteines destabilises the protein. 
6.2: Introduction 
Misfolding of proteins is the underlying cause for a number of diseases (Booth and Curnow, 
2006, see section 1.1.2), and a mechanistic understanding of how proteins fold and misfold 
can have important clinical implications. Furthermore, understanding protein folding is often 
aided by the study of specific mutations causing misfolding (Dobson, 2003; Fersht, 2000), so 
efforts to explore membrane protein folding with rhodopsin will benefit from studies of 
P23H,  which misfolds and has compromised thermal stability and light sensitivity (Chen et 
al., 2014) compared with wild-type. It also displays different glycosylation in Western blots 
compared to wild-type (Kaushal and Khorana, 1994; Krebs et al., 2010), even when 
reconstituted with retinal. When reconstituted with 9-cis-retinal, the absorbance of the 
chromophore moves to 476 nm from the more wild-type-like 492 nm displayed when 
reconstituted with 11-cis-retinal (Opefi et al., 2013). Photobleaching and meta II formation 
are also compromised in reconstituted P23H rhodopsin. Developments of rhodopsin as a 
folding model, some described in chapter 5, along with the enhancement in P23H expression 
levels achievable by administrating 9-cis-retinal (Noorwez et al., 2004) make it desirable to 
produce comparable results between wild-type and P23H mutant rhodopsin. It is of further 
interest that P23 is one of the ADRP mutations found in the predicted folding core of 
rhodopsin (Klein-Seetharaman, 2005) (see Figure 1.5), as structural and dynamic data for 
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P23H might show effects consistent with a compromised folding core, and relate these to 
the other deficiencies in P23H function.  
    
 
  
 
  
  
 
  
 
 
 
  
 
  
 
  
    
 
  
 
  
  
 
  
 
 
 
  
 
 
  
 
 
  
 
 
  
 
         
       
      
      
      
      
  
 
 
  
 
   
 
 
  
 
  
 
 
  
 
         
 
  
 
  
 
  
         
         
    
 
 
 
  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
      
          
             
 
 
 
 
 
 
 
 
 
 
        
  
  
    
  
   
   
               
 
  
 
  
 
  
 
  
            
  
  
 
 
   
  
 
Figure 6.1: Deglycosylation analysis of rhodopsin. (a) 
Example blot with rhodopsin mutation (N15S, P23H and 
WT), and PNGase F treatment (+/-) by lane indicated (b) 
Use of the ladder to obtain molecular weights for 
mobility values for the blot shown in (a). (I) Peak picking 
was performed automatically by selecting the local 
maxima. (II) Linear regression performed on ln(MW) and 
ln(Position). This was then rearranged so molecular 
weights could be estimated for each pixel. (c) Density 
profiles aligned by the process in (b) for WT rhodopsin. 
Black and red lines show profiles before and after 
PNGase F treatment respectively. (d) Boxplots of centres 
of peaks fitted to profiles (e.g. (c)). Box widths are 
proportional to the relative area occupied by that peak 
in the region from 20 to 50 kDa. (e) Boxplots of the area 
fraction of density profiles separated by lane from 
numerical integration between 20 and 50kDa (white) 
and above 50kDa (red). (f) Scatterplot of the area 
fraction of the density profiles of all lanes in a gel from 
numerical integration of the categories as in (e). 
a 
b 
c d 
e f 
I II 
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6.3: Results 
6.3.1: Analysis of deglycosylated rhodopsin immunoblots 
Aggregation and glycosylation defects of P23H have been observed (Garriga et al., 1996; 
Kaushal and Khorana, 1994; Krebs et al., 2010; Tam and Moritz, 2009) (also paper under 
revision), and to study the phenomena, PNGase F treatment, which removes a variety of N-
linked glycosylation (Tarentino et al., 1989), was carried out on P23H and N15S, a mutant 
affecting one of the glycosylation sites. This treatment removes N-linked glycosylation, and 
purified naïve and deglycosylated samples of wild-type, P23H, and N15S rhodopsin were 
resolved by SDS-PAGE and developed by Western blot using the 1D4 antibody raised against 
the C-terminal nonapeptide of rhodopsin, TETSQVAPA (Molday and MacKenzie, 2002). 
Previous scans of blots comparing the effects of PNGase F treatment were used (Figure 6.1a). 
These blots had not been scanned for densitometric analysis, so the scans were saturated, 
and common analytic techniques could not be applied. They also had no loading controls, so 
comparison had to be made between relative density of bands. This caused challenges which 
had to be addressed by the development of a method to obtain information for such 
saturated scans. 
6.3.1.1: Methods development 
6.3.1.1.1: Obtaining molecular weights from pixels 
Pixel density along a lane can be obtained by using ImageJ (Schneider et al., 2012). This is 
commonly used for analysis of gels, and has a built-in module for the purpose. However, for 
comparison between blots, the lane profiles were exported as .csv and loaded into R. The 
peaks corresponding to ladders were picked as described in Methods, and the natural log 
pixel position in the profile was fitted against the known molecular weight (MW) of this band 
by linear regression (Figure 6.1b). From the fitted values, each pixel position could be 
assigned a molecular weight, which could be compared between different blots (Figure 6.1c). 
6.3.1.1.2: Filtering lane profiles 
The saturated values of the scans effectively hold no data, so all values at higher than 95% 
intensity were removed from the data. To subtract the background of each lane, a 
geometrical “rolling disc” filter was applied, a 2D implementation of the rolling ball filter. 
6.3.1.1.3: Fitting bands in lane profiles 
To try to recover the data lost by the saturated scans, each band was fitted as a Gaussian 
peak. For narrow peaks, which had relatively little lost data, the fit of these to the remaining 
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data was very good, so it was assumed this shape continued into the saturated values. 
However, for the aggregation bands, the overall distribution was less certain because so 
many values were missing and the sides of any fitted peak were very steep, implying 
unrealistically high density values, so this strategy was only employed on bands between 20 
and 50 kDa. 
The fitted peaks were integrated between 20 and 50 kDa, and their area was calculated as a 
fraction of the total area of all peaks. The centre of the peak was given as the band’s MW 
and used to construct box and whisker plots (Figure 6.1d). The mean area fraction of each 
band across the four blots was indicated as the width of its box.  
6.3.1.2: Position and density of bands 
For WT, there is a single band, found at 37 kDa without PNGase F treatment, and at 31 kDa 
after. 
In P23H, before treatment, one band at 35 and a second, minor band at 29 kDa are 
observable, and after treatment a single peak at 33 kDa. 
N15S has two bands both before and after PNGase F treatment. Before, these are found at 
43 and 33 kDa. After, they are found at 35 and 30 kDa. 
6.3.1.3: Comparison with aggregated bands 
The areas of the lane profiles below and above 50 kDa were calculated using the trapezoidal 
rule, and the fraction these areas occupied of the total area was compared between lanes 
(Figure 6.1e,f). After PNGase F treatment, all rhodopsin forms appear to be the same. 
However, before treatment, both N15S and WT have a greater share of the area in the higher 
molecular weights. 
The increased aggregation found in P23H, even when reconstituted with retinal, suggest 
associated changes which structural techniques may be able to quantify and use to explain 
P23H misfolding. 
6.3.2: Evidence for structural impairment from Elution Profile  
Long incubation times with nonapeptide were required for the elution of WT rhodopsin in 
LMNG, as shown in section 5.3.4.1, and more misfolded opsin is eluted because of the 
requirement of using PBS as a buffer instead of NaPi, as can be seen from the higher A280 of 
a rhodopsin sample eluted in PBS in Figure 5.4c. Its compromised thermal stability (Chen et 
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al., 2014) led to sample loss during the relatively short elution times required when in DM, 
so to maintain usable yields, P23H was not exchanged to LMNG. 
6.3.3: NMR of 
methionine labelled 
P23H rhodopsin 
The HSQC spectra of P23H 
were found to be different 
from WT spectra recorded 
under the same conditions 
(Figure 6.2b). A major 
difference was the 
appearance of a strong 
extra peak at 
~(1.8,18)ppm in the P23H 
spectrum. The position of 
this peak is within the 
range of predicted values 
for the N-terminal 
methionine (M1). The N-
terminal domain is 
thought to be destabilised 
by the P23H mutation, 
leading to the 
destabilisation of the 
protein and misfolding, so the appearance of this peak could reflect the difference. The 
strong signal intensity implies that the N-terminus of rhodopsin has become more flexible in 
P23H as compared to WT. 
There are other, smaller differences in peak positions and relative intensities attesting to the 
conclusion that long-range perturbations in structure are also present. 
To determine whether the strong peak observed in the expected region for M1 in the P23H 
spectrum, absent from the WT spectrum, was indeed that residue, MTSL spin labels were 
introduced. The overall rationale for MTSL labelling is described in chapter 5, and in Figure 
5.7a it can be seen that M1 could theoretically be uniquely identified using this method.  
Figure 6.2: HMQC spectra of P23H rhodopsin (a) [
13
C5, 
15
N]methionine rhodopsin 
P23H in DDM, recorded at 298 K with 256 scans at 800 MHz proton frequency. (b) 
Overlay of (a) (red) with [
13
C5, 
15
N]methionine rhodopsin (wild type) in DDM, 
recorded at 298 K with 224 scans at 800 MHz proton frequency. 
a 
b 
1.8, 18 
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6.3.4: Cysteine derivatization 
MTSL derivatization. Cysteines serve as excellent reporters for structure and dynamics in 
rhodopsin (Klein-Seetharaman, 2002).The reaction of P23H with two types of labels were 
investigated. In the first series of experiments, the thiol-specific spin label MTSL, a P23H NMR 
sample (section 2.2.3.3) was treated with MTSL on the column, but when elution was 
attempted, yield was negligible.  
MTSL has been used with rhodopsin for many EPR experiments (see section 5.3.3), and 
previous samples of wild-type labelled with MTSL had been eluted successfully, and used for 
the NMR spectra in Figure 5.8. The loss of yield indicates that MTSL labelling made the P23H 
protein unstable, most likely through exposure of normally buried cysteines as a result of the 
P23H mutation.   
PDS labelling. To further test the hypothesis that cysteine accessibility in P23H rhodopsin 
was altered, cysteine labelling was carried out using 4-PDS, a thiol label, the binding of which 
causes an absorbance peak at 323 nm. In WT rhodopsin, two cysteines are accessible (Klein-
Seetharaman, 2002), so two PDS molecules react, which is reflected in absorbance spectra. 
When conducted on P23H rhodopsin, more than two PDS molecules per rhodopsin reacted. 
Decomposition of the absorbance spectra suggest all six accessible cysteines reacted (Figure 
6.3b II). This indicated that the helical bundle is opened to allow access to PDS to 
transmembrane helical cysteines. As implied by the MTSL labelling result, derivatization of 
these cysteines may destabilize P23H rhodopsin. To test this hypothesis, stability of P23H 
Figure 6.3: Destabilisation of P23H by PDS. (a) Spectra taken from timecourses of 0.5μM P23H 
in 0.05% DM at 37
o
C (I) in the absence and (II) in the presence of 25μM PDS. (b) The 
concentration of P23H relative to t=0 for P23H with (crosses) and without (circles) PDS over 
time. (c) The reaction of PDS with P23H over time. Also shows fitted curves of a single (black) 
exponential and a double (red) exponential, and the component curves (red dashed line) of 
the double exponential. The double exponential was preferred by the AIC. 
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was measured by losses in chromophore absorbance over time (Figure 6.3b I), and found to 
be lower in samples with PDS added than in control samples. 
Quantifying the rates of reactions are not straightforward because the kinetics of this 
reaction are complex. This is because we cannot purify PDS-labelled P23H due to the inability 
to elute from the column, analogous to the MTSL labelling experiment described above. 
Therefore, chromophore stability was measured in the presence of PDS added.  The reaction 
of PDS with P23H clearly causes destabilisation, which could cause the additional accessibility 
of cysteines, causing further labelling and possibly increasing destabilisation. Because these 
interactions could be so non-linear, only rudimentary kinetic analysis was conducted on the 
time courses obtained. Due to the convenience of PDS as a spectrophotometric measure of 
cysteine labelling, MTSL labelling was assumed to have the same effect and was not further 
tested.  
6.4: Discussion 
6.4.1: Deglycosylation analysis 
Analysis of sub-optimal scans of immunoblots has been performed, and show that significant 
differences in the glycosylation states of rhodopsin mutants can be detected. The differences 
continue to be observed between the mutants and wild type even after PNGase F treatment. 
Though the difference between WT and P23H treated with PNGase F is hard to quantify, the 
persistence of two bands in N15S indicates a difference between two states that is 
unaffected by PNGase F treatment. 
The difference between mutants in the distribution of the higher MW bands could not be 
well determined with the scans used because of the missing data. For example, from the lane 
profiles, it looks like P23H has about the same distribution as the others, but from a cursory 
examination of the blots, it is clear that its high MW bands are much stronger. Unfortunately, 
due to the missing data in these strong bands, and the relatively strong low MW bands, this 
cannot be seen in the profile. While reasonable conclusions can be drawn about the 
distribution of bands below 50 kDa from the existing data, anything more would require new 
scans tailored for the purpose.  
6.4.2: P23H NMR 
HMQC spectra of methionine labelled P23H rhodopsin show dramatic differences to WT. 
Without firm assignments of all peaks, what this shows is not certain, but it demonstrates 
that methionine is a good residue to label, and that the effects of the mutation are far 
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reaching. It is possible that, if the extra peak is M1, this residue is missing in the WT construct. 
However, this is not the case in the original construct and such a spontaneous mutation is 
unlikely. If necessary, tryptic digests of rhodopsin could be used with mass spectrometry to 
check the N-terminus. The spectra in DM do have some interference from the DM signal, but 
the comparison of WT spectra recorded in LMNG suggest that the losses are minimal 
compared to recording a spectrum in a more NMR-favourable detergent. 
While it is unfortunate that MTSL labelling was not viable with P23H rhodopsin, the 
subsequent PDS experiments were informative. The data fit into an emerging picture of P23H 
misfolding and abnormal activation behaviour drawn from a combination of molecular 
dynamics simulations and terahertz spectroscopy recently applied to rhodopsin (Woods, 
2014; Woods et al., 2017). From personal communication (Dr K Woods), the P23H mutation 
introduces strain in the N-terminus disrupting the Cys110-Cys187 disulphide bond. This leads 
to an influx of water molecules which disrupt hydrogen bonding, leading to misfolding 
throughout the protein. The disruption by water molecules is also consistent with abnormal 
activation and Metarhodopsin II formation. Though thiol-specific reagents may not be useful 
for assignment of P23H peaks, the use of a soluble PRE reagent in future may be helpful for 
distinguishing surface and buried residues for wild-type. 
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CHAPTER 7: SUMMARY AND FUTURE WORK 
7.1: Summary 
Work in this thesis has contributed to our understanding of structure and dynamics in 
membrane proteins, in particular mammalian rhodopsin and sensory rhodopsin. 
Understanding of folding and dynamics in membrane proteins lags behind that of soluble 
proteins (Booth and Curnow, 2006), and developing methods applicable to membrane 
proteins, establishing model systems for studying folding and dynamics and interpretation 
of results obtained to date are all important contributions to the field of membrane protein 
research. This thesis has made strides in each of these directions. 
First, to improve our understanding of rhodopsin and vision, I have investigated in detail the 
interaction of chlorin e6 (Ce6) with rhodopsin and confirmed the enhanced photobleaching 
of rhodopsin by red light in the presence of Ce6. I have also shown that this effect is 
dependent on the ratio of Ce6 to rhodopsin. Detailed and deliberate analysis with a low 
sample requirement has yielded results for the treatment of rhodopsin with an allosteric 
reagent. I have also shown that both the proposed Ce6 binding site and the G-protein binding 
domain are well conserved between Malacosteus niger and Bos taurus rhodopsins, so the 
observed disruption of G-protein binding to bovine rhodopsin by Ce6 should be maintained 
in M niger. Though it is not as efficient as other reconstitution methods, it is possible to 
reconstitute rhodopsin with 14-fluororhodopsin in-cuvette. Unfortunately, it is too slow to 
follow by 19F NMR, but the samples produced are adequate for steady-state spectra, and 
show no difference in the presence of Ce6. Thus, I have shown it is unlikely that the effects 
of Ce6 proceed by direct energy transfer, which might be expected to alter the retinal 
environment. 
Second, I have contributed to the establishment of a new model system for membrane 
protein folding, namely another retinal binding protein, sensory rhodopsin. By modelling the 
kinetics of pSRII unfolding as measured by different biophysical techniques, I have explored 
the potential to obtain detailed information about the unfolding reactions from 
spectroscopic studies. I have written automatic scripts for analysing refolding reactions 
which have also been used by Yi Lei Tan (University of Cambridge) to analyse their kinetics 
and efficiency. Adding pSRII to the group of retinal binding proteins which already serve as 
folding models for membrane proteins further corroborates that proteins with 
chromophores are particularly useful model systems. Applying principles developed in the 
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analysis of absorbance spectra, data has been recovered from previous experiments 
comparing Western blots of rhodopsin with misfolding mutants. 
Third, I have progressed the role of rhodopsin in understanding membrane protein folding. 
NMR experiments have been used to further establish rhodopsin as a model system for class 
A GPCR folding. The distribution throughout the protein and strong signals given by labelled 
methionines make this a good starting point for further experiments into rhodopsin folding 
through examination of unfolded states.  
Finally, I have advanced our understanding of rhodopsin misfolding by conducting 
mechanistic studies of the retinitis pigmentosa mutant, P23H, using NMR spectroscopy of 
the 13C,15N-methionine labelled protein. The production of useful yields of a misfolding 
mutant labelled in the same way shows this to be a viable system to explore reasons for 
folding going wrong as another avenue to understanding the process as a whole. Even 
without experiments looking at unfolded states, the differences between the spectra of wild-
type and mutant rhodopsin support the destabilisation of the previously identified folding 
core as particularly detrimental to the folding ability and stability of the entire protein. 
Adding to the NMR experiments, I made a serendipitous discovery that cysteine labelling 
further destabilises P23H, a result consistent with predictions made from molecular 
dynamics. 
These contributions have opened doors to a number of future studies, described in detail 
below. They are organized by immediate experiments that logically follow from the work of 
this thesis, and by long-term studies that will significantly advance the field of membrane 
protein research. 
 
7.2: Future Work 
7.2.1: Immediate goals of future work 
7.2.1.2: Rhodopsin and vision 
7.2.1.2.1: Enhancement of bleaching by Chlorin e6 
That Ce6 enhances the bleaching of rhodopsin with light in the far red has been 
demonstrated in previous work. It also appears that this is somewhat specific, as the dark 
noise of rhodopsin is not similarly enhanced, as shown in chapter 3. Further specifying the 
light-dependence of this enhancement might further illuminate the mechanism. If the 
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enhancement is wavelength dependent, the proposed triplet energy transfer mechanism 
would be further supported. More wavelength specific filters, including bandpass filters, are 
available and could be used to narrow down the wavelengths at which the greatest 
enhancement takes place. Another possibility would be to use lasers, which can be tuned to 
specific wavelengths, and might be more cost-efficient than specific filters. 
Another possibility would be to use neutral density filters and the standard yellow filter used 
for rhodopsin bleaching to determine whether a more general bleaching enhancement 
occurs. For any of this to be informative, a more reproducible protocol needs to be 
developed. Though a general increase of the enhancement is observed with a higher 
Ce6:rhodopsin ratio, the rates of bleaching are highly variable, especially at higher Ce6. 
Refinements in the illumination procedure and the reliable addition of quantities of Ce6 
might improve reproducibility. Once this is achieved, given the low affinity of Ce6 for 
rhodopsin, higher Ce6:rhodopsin ratios might be tested to find the limits of bleaching rate 
enhancement. 
It has been shown that Ce6 enhances rhodopsin stability (Fernanda Balem et al., 2009), and 
also tentatively shown that it at least does not increase thermal activation. The data show 
some reduction in thermal activation, but have not been replicated. Repeats should be 
performed to measure the effect at different temperatures. 
For Ce6 to enhance rhodopsin’s bleaching rate, some form of association between the two 
molecules must occur. The nature of this association is being explored through THz 
spectroscopy (Woods et al., 2017), but absorbance and phosphorescence spectroscopy may 
also have additional information to offer. Past fluorescence spectroscopy has not shown 
energy transfer (Ilyas Washington et al., 2004), which has been interpreted as lack of singlet 
energy transfer. Instead, a triplet energy transfer model has been proposed but not tested. 
Intersystem crossing to enable triplet energy transfer would provide another path for triplet 
states to follow and cause quenching of Ce6 phosphorescence upon addition of rhodopsin, 
and characterising this interaction would put some constraints on the nature of the 
mechanism at work. Such experiments require the detection of chlorin phosphorescence. 
The calculated emission spectrum for Ce6 phosphorescence has a λmax of 1080nm (Gattuso 
et al., 2017). 
A characteristic of porphyrins is their ability to bind metals in the macrocycle. Rhodopsin 
binds several zinc atoms. Though no obvious changes indicating zinc binding were observed 
in the recorded spectra, rhodopsin samples were prepared with EDTA during the Ce6 
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experiments and it may be worth investigating how zinc free these samples are and whether 
this affects the effects of Ce6. On one hand, the changes metal ion binding causes to chlorin 
spectra are dramatic; the Q-band would be reduced to two peaks rather than four. On the 
other, Ce6’s affinity for rhodopsin is low, so with the high ratios of chlorin to rhodopsin used 
only a minority of Ce6 molecules would be bound to rhodopsin. Alternatives might be to add 
zinc and/or EDTA to rhodopsin/Ce6 mixtures and measure bleaching rates. From trying to 
observe the effects of chlorin upon SDS denaturation of rhodopsin it was observed that Ce6 
absorbance spectra are sensitive to SDS concentration, at least in the range from 0 to 3% 
SDS. Refinements in fitting methods applied to Ce6 spectra might be able to isolate different 
changes in Ce6 spectra with better sensitivity, including some minor effects that might be 
discernible in properly decomposed spectra of rhodopsin/Ce6 mixtures. The transitions that 
lead to the different absorbance bands of porphyrins are well understood, and detailed 
information of this kind might be applied to any changes in chlorin spectra so absorbance 
spectroscopy could provide insight into Ce6 binding to rhodopsin. 
7.2.1.2.2: NMR of Rhodopsin and Ce6 
The in-cuvette reconstitution of rhodopsin with 14-fluororetinal was only 43% efficient. 
Though the addition of Ce6 does not appear to have any effect upon its NMR spectrum, for 
any other experiments on this system, a better sample may offer greater sensitivity. Existing 
reconstitution protocols have higher yields of fluororhodopsin (Steinberg et al., 1993), and 
as the kinetics of reconstitution are not accessible to a 19F NMR experiment, these could be 
used instead. The current samples also have a background of excess 14-fluororetinal, which 
would not be an issue with other preparation methods. Binding reconstituted rhodopsin 
onto a 1D4 column and washing away excess retinal will address this issue. The comparison 
of fluororhodopsin with the fluororetinal used to reconstitute it shows changes in peaks 
associated with the free pigment of other fluorine analogues, a result which will need 
explanation. 
15N labelling lysines in rhodopsin has been used in the past for NMR studies highlighting the 
cytoplasmic domain (J. Klein-Seetharaman et al., 2002). This could also be used to test the 
predicted cytoplasmic Ce6 binding site. K339 in particular is very flexible, showing a signal 
like that of lysine in solution. If Ce6 binds the C-terminal domain (including the seven 
predicted residues missing from M. niger’s partial sequence) it is possible this flexibility 
would be reduced. 
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7.2.1.3: Establishment of pSRII as an experimental model system for unfolding 
7.2.1.3.1: Biophysical kinetic studies of pSRII 
Analysis of pSRII spectra has established a sensible model for its unfolding with SDS, but the 
experimental setup used has limited this to relatively late events. The first spectra were 
recorded after a minute or more, and already represent a significant departure from a native 
spectrum. New models are likely to be necessary for rapid-mixing experiments proposed by 
our Cambridge collaborators, especially for the different kinetics that may be observed for 
the disappearance of shoulder peaks in the absorbance spectra. It will also be interesting to 
establish whether the transition between the native maximum absorbance and the red-
shifted species observed can be captured with early spectra. 
The ambiguity in hydroxylamine fluorescence time courses suggests that two processes with 
similar rates are occurring, the loosening of the helical bundle, and the formation of retinal 
oxime. The second rate may be close enough to the first that the two curves cannot be 
separated effectively by model selection methods. If the unreliable fitting of the time courses 
truly is physical rather than artifactual, hydroxylamine may be useful for further exploring 
the amplitude of the fluorescence curves as sources of information about the distances 
between retinal and pSRII’s tryptophans, and thus, the nature of the loosened helical bundle 
caused by SDS unfolding. 
For expediency and ease of fitting, the model for fitting of fluorescence time courses used 
omitted the contribution of native pSRII. It is possible that this, while useful at the time, 
caused loss of information that could be valuable. The kinetic model finally used for the 
fitting of absorbance spectra introduced an error term for the dead time of the experiment. 
A model including this might be able to fit kinetics curves for all three species. It is not certain 
this will yield any new information from existing time courses, but given the dominance of 
native pSRII at early time points, it may be useful for stopped-flow experiments. 
Automatic peak picking 
With the forgiving Levenberg-Marquardt algorithm for non-linear least squares, fairly poor 
initial estimates often find a good fit. The estimates provided by the peak picking algorithm 
are close to those yielded by the final model and little optimisation is required. It is 
unfortunate that the underlying assumption of symmetrical peaks was not realistic. The peak 
picking performed well on the data when the maximum number of peaks was externally 
defined, but once model selection for the number of peaks was implemented, the 
skewedness of the shoulder peaks distorted the output, adding a peak to the fit. It is possible 
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that a different model selection method, such as cross-validation, would not be “fooled” by 
this, though this was not observed when comparing choices between fluorescence time 
course models. Later fits were improved by the addition of a flexible scattering baseline, 
which might prove useful in predicting peaks. 
The skew observed in pSRII is not obvious by visual inspection and the recognition of such 
features by computer may not be simple either. The exhaustive solution would be to add 
skew to each peak in turn and test whether it improves the model, but as skewed peaks may 
not be common, the added processing time might limit the utility of such an approach. It is 
also likely that, in a spectrum with multiple skewed peaks, the skews might interact in 
unpredictable ways so that a single skewed peak may not improve a fit, but two or more 
might. Fitting this behaviour would require adding skew to all combinations of peaks. As this 
algorithm is only likely to be useful with many, overlapping peaks, processing times would 
become untenable. 
Even the simple clustering approach used here identified reasonable patterns in the peaks, 
especially given the variability caused by the unrealistic model. More advanced techniques 
are far more capable, so the refinement of a single time point by using the entire dataset is 
a promising avenue for improving prediction. The real promise of such a method is that it 
might make the recognition of kinetics in the species present possible. For example, any 
peaks that have a statistically significant change over time could be made candidates for 
kinetic analysis. Any peaks in a constant ratio could be treated as one species, then guesses 
as to the kinetics of remaining candidate species could be made, given the number of species 
present and known rate equations. Ideally, time courses of spectra which a user suspects 
display some unknown kinetics could be used as input, and parameters for a kinetic model 
like that derived for pSRII unfolding in SDS would be the output. With the limited success of 
the relatively undeveloped algorithm described, this does not seem unrealistic, given the 
low-hanging fruit of the optimisation candidates described above. 
7.2.1.3.2: Analysis of pSRII NMR spectra 
The original goal of using PCA on pSRII was to impute values for missing peaks. However, the 
sparse spectra at higher concentrations of SDS limit this goal, and the greatest amount of 
imputation that can be relied upon has probably been achieved, as the expectation 
maximization algorithm used performs robustly compared with other methods. The fact two 
principal components were sufficient to explain so much of the variation, and that the scores 
for these principal components follow a definite pattern, suggest that the PCA has identified 
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underlying physical processes. The regularity also displayed by the loadings for each residue 
when a polar plot was used further suggest that these processes might be amenable to 
further human inspection. 
A major shortcoming of the PCA analysis is that the 1H and 15N chemical shifts of a residue 
are separated, so significant information is lost. There are analogous methods to PCA for 3-
dimensional arrays, where PCA operates on a 2-dimensional matrix. This would allow 
association of the chemical shifts for each residue by having one dimension as [SDS], one as 
the residue number, and one as the atom. This would also allow proper incorporation of peak 
intensity data also. In this analysis, peak intensity was discarded because of the difficulty of 
scaling this data with chemical shifts, but working with the higher dimensional methods may 
mitigate some of the issues of poor scaling encountered with PCA. Attempts were made to 
use the Tucker3 algorithm (Andersson and Bro, 1998) on the chemical shift dataset, but in 
the implementation used there is no imputation process, so the dataset was further limited. 
In future, either the dataset as imputed by pPCA will be used with the Tucker3 algorithm, or 
another implementation will be used. There are two readily available R packages that may 
be suitable, PTAk and rTensor, or the N-way toolbox for MATLAB, which includes an 
Expectation Maximization algorithm for imputation. 
Clustering the profiles of chemical shift change against SDS concentration showed significant 
dependence of these profiles on the domain of the residue. This was relatively crude, as it 
only looked at the magnitude of the change in the 13C and a scaled 15N dimension. Use of 
clustering methods applied to a more sophisticated representation of the data which allows 
both positive and negative changes in multiple dimensions may be even more sensitive and 
provide insight as to the physical nature of the grouping of residues. 
Ultimately, the aim of blob analysis, which is a simple algorithm for recognising objects in 
images, was to perform it on all spectra, then try to identify similar blobs across spectra to 
track the motion of peaks. There are techniques used in computer vision to track and predict 
future positions of some feature. The Kalman filter is relatively simple to implement, and 
performs well in this regard. However, it relies on iteration, so the small number of 
measurements in the NMR dataset may be too few for this to be effective. By using some 
feature recognition and prediction algorithms to weight regions of spectra, it may be possible 
to bring out peaks from noise without relying on some model for their movement. In the 
future, feature detection performed on higher resolution spectra may be useful for 
recovering data when there is good reason to suppose a regular pattern between spectra. 
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7.2.1.4: Further Development of Rhodopsin as a model system for NMR studies of 
folding and misfolding 
Methionine labelling of rhodopsin shows great promise as a method for probing its folding 
core by NMR spectroscopy. The assignments made from the theoretical calculations based 
on torsion angles are consistent with expectations of flexibility, though they are held to be 
ambiguous between chemical shifts of 16.5 and 18. Practical problems with the sample 
preparation of MTSL labelled samples have prevented this technique from making more 
definitive assignments, so the use of a more optimised protocol might allow more use to be 
made of the HMQC spectra already acquired, as described in the original plan for the MTSL 
spectra. A further possibility using current samples would be to attempt assignment of M308 
and M309 using a through-bond HNCO experiment. However, HNCO experiments have been 
challenging with rhodopsin in the past and generally only work for highly flexible residues 
since they require use of the backbone 15N resonance(J. Klein-Seetharaman et al., 2002). 
Mutagenesis has been required in past assignment strategies (Werner et al., 2008) and the 
introduction of mutants can cause distortions of the protein, resulting in unwanted chemical 
shift changes. Surface residues can be separated from buried residues by H/D exchange and 
PRE experiments with MTSL labels can be carried out for WT, where MTSL label does not 
interfere with protein stability. 
Once definitive assignments have been made, NMR relaxation experiments can be carried 
out to assess the flexibility of the different regions. Unfolding experiments in SDS can take 
advantage of these experiments and the determination of ideal unfolding conditions for 
rhodopsin previously established. 
7.2.1.5: Misfolding of rhodopsin 
7.2.1.5.1: P23H NMR spectra 
The first priority in the improvement of P23H NMR data is to improve the yields of pure 
methionine labelled P23H samples. Similar yields of P23H were found in cell lysate when 
retinal was administered to spinner flasks as were found in wild type samples. The difference 
in elution of P23H from 1D4 columns using PBS elution buffer rather than sodium phosphate 
suggest significant improvements might be made by using PBS buffers straight away. This 
was attempted when eluting MTSL labelled sample, but the destabilising effect of cysteine 
labelling meant that this could not serve as a test of using that protocol to improve yields. 
The differences shown between the HMQC spectra of WT and P23H rhodopsin show promise 
for demonstrating the importance of residues in the proposed folding core. However, the 
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assignment of the massively increased peak as M1 should be confirmed by the use of MTSL 
labelling and the use of a soluble PRE reagent. This cannot be demonstrated directly, as the 
labelling of cysteines causes catastrophic degradation of P23H. Instead, the comparison with 
properly MTSL assigned WT spectra must be made. It is possible that some confirmation can 
be made using a soluble PRE reagent. 
7.2.1.5.2: Cysteine labelling 
That PDS labelling, usually benign for WT rhodopsin, should destabilise P23H, is very 
interesting. The methods used to fit the spectra required the fixing of some parameters in 
the model after obtaining estimates. This was avoided in the fitting of SDS unfolding time 
courses by using a combined kinetics model, allowing the use of the whole dataset to 
estimate the parameters for individual peaks. Ideally, this would be done for PDS unfolding 
too, but the kinetics are very complex and non-linear, as described in the discussion section 
of that chapter. One possibility for simplifying the kinetics would be by mutagenesis, 
removing cysteines from the protein, which would also determine which of the cysteines 
destabilise the protein after labelling. This would be a very effortful approach, and the 
rewards may not justify the effort. One lower-effort improvement to the experiment might 
be in the analysis. Non-linear mixed-effects models (NLME) allow different levels of fitting 
for different parameters when fitting a multivariate dataset. Using an NLME model, the 
widths and positions of peaks could be held to be constant across time points, with variation 
due to random error, while the amplitudes could be allowed to vary freely over time. This 
would allow the use of the whole dataset to most accurately estimate the peaks’ shapes 
without an explicit kinetic model. Another refinement of the experiment is to choose some 
time points at which to stop the reaction by adding cysteine to the cuvette. By using several 
of these time points, the kinetics of the labelling of whichever cysteine causes destabilisation 
could be estimated by the extent of unfolding caused at different times of arresting the 
labelling. This could be compared with the kinetics of labelling to determine how quickly the 
labelling occurs to give clues as to which residue(s) are important. 
It is also important that the constructs used are checked so it is certain that the wild type 
construct includes an N-terminal methionine. The possible digests of rhodopsin are well 
chararacterised, so mass spectrometry can be used to confirm this. 
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7.2.2: Long term goals of future work 
7.2.2.1: Rhodopsin and vision 
The enhancement of rhodopsin bleaching by red light upon addition of Ce6 has been 
demonstrated both in previous literature, and more definitively here. That this enhancement 
in vitro causes a similar enhancement of vision in vivo is less certain. There have been 
demonstrations in mouse models of an increased retina response to both blue and red light 
with addition of Ce6, though a G-protein binding assay shows activation is inhibited by Ce6 
(paper in preparation), so the role of chlorin is still uncertain. If it works as a red filter, rather 
than a simple signal booster, as proposed in the discussion of the Rhodopsin and Vision 
chapter, the effect might be challenging to demonstrate. However, if the thermal activation 
reduction hinted at by preliminary results can be better characterised, and the bleaching rate 
enhancement more reliably demonstrated, computational models accounting for these 
effects and the inhibition of G-protein activation might be devised to show that increasing 
the sensitivity of cells to the activation of rhodopsin molecules, as suggested for the use of 
tapeta in eyes with less pigment, would be able to better detect the reflection of red 
bioluminescence. 
What else chlorin might enhance might give clues as to the nature of the chlorin-rhodopsin 
interaction. If chlorin binds other GPCRs, that would be interesting because it shows Ce6 to 
be a promiscuous partner for that whole family. If chlorin enhances the activity of other 
retinal binding proteins, that shows the interaction is not protein specific, and suggests the 
bleaching enhancement is simply due to general energy transfer. If the effect is present, but 
different, for retinal binding proteins, the differences between proteins might give clues to 
the nature of the interaction. If neither case can be shown, despite the rhodopsin bleaching 
enhancement across such an evolutionary distance as between M. niger and B. taurus, that 
would be remarkable and represent some unappreciated role of chlorophyll derivatives in 
the evolution of animal vision. 
7.2.2.2: pSRII as a folding model 
The biophysical characterisation of the unfolding kinetics of pSRII in SDS was useful for 
establishing the system as an experimental model. However, these do not directly address 
the question of similarities and differences between MR, pSRII, and bR. However, the various 
analytical techniques used to explore the rich NMR dataset may yet distinguish between local 
and long-range interactions in the unfolded states. Exploring the loadings of different 
residues in the PCA may be aided by comparison with improved clustering approaches to 
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chemical shift change data. The incorporation of peak intensity data will provide information 
about the flexibility of different regions and may provide further principal components which 
can be associated with particular regions in unfolding and checked against FIRST analysis 
results for pSRII. 
7.2.2.3: Rhodopsin as a folding model 
Long term, the long-range interactions model for rhodopsin needs to be demonstrated by 
testing specific predictions made against the two-stage model. With even partial 
assignments of the methionine spectra, differences caused in unfolding by SDS may be 
amenable to similar analysis carried out on pSRII.  
The use of PRE reagents will be informative for the reliable assignment of peaks, which will 
be helpful to both further NMR experiments into rhodopsin unfolding and potentially the 
NMR experiments of other investigators, as methionine’s characteristics make it a useful 
residue to label. Use of MTSL and soluble PRE reagents might help directly with 
interpretation of NMR spectra of unfolding rhodopsin in other ways. If the soluble reagents 
show solvent accessibility in some way, the extent of unfolding might be detectable, and 
possibly even kinetics if the acquisition can be fast enough. If some peaks that disappear 
after proper MTSL preparation reappear after unfolding, it might show that the methionines 
get further away from the MTSL labelled cysteines. Those are not on the folding core side, 
so the SDS dependence of any effect like this might be informative. 
7.2.2.4: Misfolding of rhodopsin 
Even the comparisons made between native WT and P23H NMR spectra in this thesis have 
shown differences. The possibilities discussed above for NMR spectroscopy of WT rhodopsin 
could also be contrasted with the same experiments carried out on P23H. For example, any 
changes shown in unfolding WT might be comparable to native P23H, or happen at lower 
SDS in P23H. 
The destabilisation of P23H by thiol-specific reagents may also be of interest in future 
experiments. The central role of the conserved disulphide bond to the stability of rhodopsin 
is well recorded, and there are preliminary results from molecular dynamics simulations that 
this bond is somewhat compromised in P23H (Dr Kristina Woods, personal communications). 
It may be that cysteine labelling could offer productive avenues to the study of misfolding in 
P23H and other rhodopsin mutants, especially those associated with retinitis pigmentosa. 
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